_pmid,_doi,_publicationTitle,_year,_context,_confidence,_verdict,_usageType,insertName
PMID:31545171,10.7554/eLife.48983,Optical dopamine monitoring with dLight1 reveals mesolimbic phenotypes in a mouse model of neurofibromatosis type 1.,,We employed the genetically encoded optical dopamine sensor dLight1 to monitor dopaminergic neurotransmission in the ventral striatum of NF1 mice,0.95,Accept,Experimental Usage,dLight1.2
PMID:31545171,10.7554/eLife.48983,Optical dopamine monitoring with dLight1 reveals mesolimbic phenotypes in a mouse model of neurofibromatosis type 1.,,pAAV-hSyn-dLight1.2 Addgene Plasmid#: 111068 RRID: Addgene_111068 Gift on Lin Tian; produced by UC Davis Vector Core,0.95,Accept,Experimental Usage,pAAV-hSyn-dLight1.2
PMID:31545171,10.7554/eLife.48983,Optical dopamine monitoring with dLight1 reveals mesolimbic phenotypes in a mouse model of neurofibromatosis type 1.,,pAAV-hSyn-hChR2(H134R)-EYFP Addgene Plasmid#: 26973 RRID: Addgene_26973 Gift of Karl Deisseroth; produced by UNC Vector Core,0.9,Accept,Experimental Usage,pAAV-hSyn-hChR2(H134R)-EYFP
PMID:31545171,10.7554/eLife.48983,Optical dopamine monitoring with dLight1 reveals mesolimbic phenotypes in a mouse model of neurofibromatosis type 1.,,AAV9-Th-PI-Cre-SV40 Addgene Plasmid#: 107788 RRID: Addgene_107788 Addgene viral prep#: 107788-AAV9; gift of James M. Wilson,0.9,Accept,Experimental Usage,AAV9-Th-PI-Cre-SV40
PMID:31545171,10.7554/eLife.48983,Optical dopamine monitoring with dLight1 reveals mesolimbic phenotypes in a mouse model of neurofibromatosis type 1.,,pAAV-DJ-Ef1α-DO-eNpHR3.0-eYFP-WPRE-pA Addgene Plasmid#: 37087 RRID: Addgene_37087 Gift of Bernardo Sabatini,0.9,Accept,Experimental Usage,pAAV-DJ-Ef1α-DO-eNpHR3.0-eYFP-WPRE-pA
PMID:31545171,10.7554/eLife.48983,Optical dopamine monitoring with dLight1 reveals mesolimbic phenotypes in a mouse model of neurofibromatosis type 1.,,"Mono Fiber-Optic Cannula Doric Lenses, Inc Cat#: MFC_400/430–0.48_5 mm_ZF1.25_FLT OD: 400 μm, Length: 5 mm",0.85,Accept,Experimental Usage,Mono Fiber-Optic Cannula
PMID:31545171,10.7554/eLife.48983,Optical dopamine monitoring with dLight1 reveals mesolimbic phenotypes in a mouse model of neurofibromatosis type 1.,,pUCmini-iCAP-PHP.eB Addgene Plasmid#: 103005 RRID: Addgene_103005,0.9,Accept,Experimental Usage,pUCmini-iCAP-PHP.eB
PMID:31545171,10.7554/eLife.48983,Optical dopamine monitoring with dLight1 reveals mesolimbic phenotypes in a mouse model of neurofibromatosis type 1.,,"In order to create Th-VAST, a PCR fragment containing the 2.5 kb rat tyrosine hydroxylase promoter was subcloned into pAAV-ihSyn1-tTA-WPRE",0.85,Accept,Development,Th-VAST
PMID:12057013,10.1186/1471-2164-3-13,Complex splicing pattern generates great diversity in human NF1 transcripts.,,RNA was isolated from fresh blood leukocytes from two normal individuals using TRIzol LS Reagent (Invitrogen) according to the manufacturer's instructions.,0.85,Accept,Experimental Usage,TRIzol LS Reagent (Invitrogen)
PMID:12057013,10.1186/1471-2164-3-13,Complex splicing pattern generates great diversity in human NF1 transcripts.,,Total RNA (2 μg) was reverse transcribed using SuperScript II Reverse transcriptase (Invitrogen) and random hexamers (Amersham Biosciences).,0.85,Accept,Experimental Usage,SuperScript II Reverse transcriptase (Invitrogen)
PMID:12057013,10.1186/1471-2164-3-13,Complex splicing pattern generates great diversity in human NF1 transcripts.,,Total RNA (2 μg) was reverse transcribed using SuperScript II Reverse transcriptase (Invitrogen) and random hexamers (Amersham Biosciences).,0.85,Accept,Experimental Usage,random hexamers (Amersham Biosciences)
PMID:12057013,10.1186/1471-2164-3-13,Complex splicing pattern generates great diversity in human NF1 transcripts.,,The PCR products were cloned in the pCR2.1-TOPO-vector (Invitrogen) and transformed into TOP-10F' cells.,0.9,Accept,Experimental Usage,pCR2.1-TOPO-vector (Invitrogen)
PMID:12057013,10.1186/1471-2164-3-13,Complex splicing pattern generates great diversity in human NF1 transcripts.,,All transcripts with a different restriction pattern were sequenced using the Thermo Sequenase fluorescent labelled primer cycle sequencing kit (Amersham Biosciences),0.85,Accept,Experimental Usage,Thermo Sequenase fluorescent labelled primer cycle sequencing kit (Amersham Biosciences)
PMID:33817379,10.1016/j.heliyon.2021.e06518,Clinical assessment of the use of topical liquid diclofenac following laser microporation of cutaneous neurofibromas in individuals with neurofibromatosis type 1.,,researchers topically applied one drop of diclofenac 25 mg/ml (Voltaren®) to the surface of the T neurofibromas,0.8,Accept,Experimental Usage,Voltaren®
PMID:41149489,10.3390/curroncol32100569,Small Extracellular Vesicles Derived from NF2-Associated Schwannoma Cells Modulate Tumor Progression and Immunity via HSP90.,,"Schwannoma tissues were dissected into smaller fragments and enzymatically digested with dispase grade II (1.25 U/mL, Roche, Basel, Switzerland)",0.85,Accept,Experimental Usage,"dispase grade II (1.25 U/mL, Roche, Basel, Switzerland)"
PMID:41149489,10.3390/curroncol32100569,Small Extracellular Vesicles Derived from NF2-Associated Schwannoma Cells Modulate Tumor Progression and Immunity via HSP90.,,"enzymatically digested with dispase grade II (1.25 U/mL, Roche, Basel, Switzerland) and collagenase type I (160 U/mL, Sigma, St. Louis, MO, USA)",0.85,Accept,Experimental Usage,"collagenase type I (160 U/mL, Sigma, St. Louis, MO, USA)"
PMID:41149489,10.3390/curroncol32100569,Small Extracellular Vesicles Derived from NF2-Associated Schwannoma Cells Modulate Tumor Progression and Immunity via HSP90.,,"Cell viability was evaluated using the Cell Counting Kit-8 (CCK8, Dojindo Laboratories, Kumamoto, Japan)",0.85,Accept,Experimental Usage,"Cell Counting Kit-8 (CCK8, Dojindo Laboratories, Kumamoto, Japan)"
PMID:41149489,10.3390/curroncol32100569,Small Extracellular Vesicles Derived from NF2-Associated Schwannoma Cells Modulate Tumor Progression and Immunity via HSP90.,,"We utilized the Bio-Plex Pro Human Cytokine Group I Panel 27-plex, following the manufacturer's instructions meticulously to ensure optimal results",0.85,Accept,Experimental Usage,Bio-Plex Pro Human Cytokine Group I Panel 27-plex
PMID:20200958,10.1002/jbmr.42,Local low-dose lovastatin delivery improves the bone-healing defect caused by Nf1 loss of function in osteoblasts.,,"...infection with adenovirus Ad5-CMV-Cre or Ad5-CMV-eGFP (2500 viral particles per cell; Vector Development Lab, Houston, TX, USA)...",0.9,Accept,Experimental Usage,Ad5-CMV-Cre adenovirus
PMID:20200958,10.1002/jbmr.42,Local low-dose lovastatin delivery improves the bone-healing defect caused by Nf1 loss of function in osteoblasts.,,"...infection with adenovirus Ad5-CMV-Cre or Ad5-CMV-eGFP (2500 viral particles per cell; Vector Development Lab, Houston, TX, USA)...",0.9,Accept,Experimental Usage,Ad5-CMV-eGFP adenovirus
PMID:20200958,10.1002/jbmr.42,Local low-dose lovastatin delivery improves the bone-healing defect caused by Nf1 loss of function in osteoblasts.,,...Real-time quantitative PCR (RT-qPCR) was performed using TaqMan gene expression assays...,0.8,Accept,Experimental Usage,TaqMan gene expression assays
PMID:31836666,10.1074/jbc.RA119.010934,Biochemical and structural analyses reveal that the tumor suppressor neurofibromin (NF1) forms a high-affinity dimer.,,"...PCR amplification of portions of the NF1 gene from Addgene construct 70423, which contains a codon-optimized version of human NF1 isoform 2...",0.9,Accept,Experimental Usage,Addgene construct 70423
PMID:31836666,10.1074/jbc.RA119.010934,Biochemical and structural analyses reveal that the tumor suppressor neurofibromin (NF1) forms a high-affinity dimer.,,...PCR amplicons were cloned into pDonr255 and fully sequence-verified...,0.85,Accept,Experimental Usage,pDonr255
PMID:31836666,10.1074/jbc.RA119.010934,Biochemical and structural analyses reveal that the tumor suppressor neurofibromin (NF1) forms a high-affinity dimer.,,...generate final expression clones in baculovirus Destination vectors pDest-635 (pFastBac1 with N-terminal His 6 tag)...,0.85,Accept,Experimental Usage,pDest-635
PMID:31836666,10.1074/jbc.RA119.010934,Biochemical and structural analyses reveal that the tumor suppressor neurofibromin (NF1) forms a high-affinity dimer.,,...and pDest-636 (pFastBac1 with N-terminal His 6 -MBP tag)...,0.85,Accept,Experimental Usage,pDest-636
PMID:31836666,10.1074/jbc.RA119.010934,Biochemical and structural analyses reveal that the tumor suppressor neurofibromin (NF1) forms a high-affinity dimer.,,"...E. coli Destination vector pDest-566 (N-terminal His6-MBP tag, Addgene catalog no. 11517)...",0.85,Accept,Experimental Usage,pDest-566
PMID:33078583,10.1002/jcsm.12632,Cell autonomous requirement of neurofibromin (Nf1) for postnatal muscle hypertrophic growth and metabolic homeostasis.,,Mouse lines used in this study were described before: Myf5 Cre,0.9,Accept,Experimental Usage,Myf5 Cre
PMID:33078583,10.1002/jcsm.12632,Cell autonomous requirement of neurofibromin (Nf1) for postnatal muscle hypertrophic growth and metabolic homeostasis.,,"Mouse lines used in this study were described before: Myf5 Cre, Lbx1 Cre",0.9,Accept,Experimental Usage,Lbx1 Cre
PMID:33078583,10.1002/jcsm.12632,Cell autonomous requirement of neurofibromin (Nf1) for postnatal muscle hypertrophic growth and metabolic homeostasis.,,"Mouse lines used in this study were described before: Myf5 Cre, Lbx1 Cre, Nf1 flox",0.9,Accept,Experimental Usage,Nf1 flox
PMID:33078583,10.1002/jcsm.12632,Cell autonomous requirement of neurofibromin (Nf1) for postnatal muscle hypertrophic growth and metabolic homeostasis.,,"Mouse lines used in this study were described before: Myf5 Cre, Lbx1 Cre, Nf1 flox, and Rosa26 mTmG",0.9,Accept,Experimental Usage,Rosa26 mTmG
PMID:25851896,10.3988/jcn.2015.11.2.172,Preclinical assessment of the anticancer drug response of plexiform neurofibroma tissue using primary cultures.,,"digested tissue fascicles were mechanically dissociated by straining through a 100 µm steel mesh screen (Partec, Münster, Germany)",0.8,Accept,Experimental Usage,"100 µm steel mesh screen (Partec, Münster, Germany)"
PMID:18670322,10.1097/MLG.0b013e318177e20b,Vestibular schwannoma quantitative polymerase chain reaction expression of estrogen and progesterone receptors.,,"total RNA was extracted from VS and control nerve samples using the Trizol reagent (Gibco Invitrogen, Carlsbad, CA) per the manufacturer's instructions",0.85,Accept,Experimental Usage,"Trizol reagent (Gibco Invitrogen, Carlsbad, CA)"
PMID:18670322,10.1097/MLG.0b013e318177e20b,Vestibular schwannoma quantitative polymerase chain reaction expression of estrogen and progesterone receptors.,,"mRNA was selected by running total RNA over oligo-dT columns (Invitrogen, Carlsbad, CA)",0.8,Accept,Experimental Usage,"oligo-dT columns (Invitrogen, Carlsbad, CA)"
PMID:18670322,10.1097/MLG.0b013e318177e20b,Vestibular schwannoma quantitative polymerase chain reaction expression of estrogen and progesterone receptors.,,"mRNA (5 μg per 50 μL sample) was reverse transcribed using the Gene AMP kit (Perkin-Elmer; Waltham, MA)",0.85,Accept,Experimental Usage,"Gene AMP kit (Perkin-Elmer; Waltham, MA)"
PMID:18670322,10.1097/MLG.0b013e318177e20b,Vestibular schwannoma quantitative polymerase chain reaction expression of estrogen and progesterone receptors.,,"Taqman Universal PCR Master Mix (2× buffer containing polymerase; Applied Biosystems, Foster City, CA) was used in a 15 μL reaction",0.85,Accept,Experimental Usage,"Taqman Universal PCR Master Mix (Applied Biosystems, Foster City, CA)"
PMID:18670322,10.1097/MLG.0b013e318177e20b,Vestibular schwannoma quantitative polymerase chain reaction expression of estrogen and progesterone receptors.,,"20× solution of primers and fluorophor-labeled probe (Taqman Gene Expression Assays; Applied Biosystems, Foster City, CA)",0.85,Accept,Experimental Usage,"Taqman Gene Expression Assays (Applied Biosystems, Foster City, CA)"
PMID:29897904,10.1371/journal.pone.0197350,Traditional and systems biology based drug discovery for the rare tumor syndrome neurofibromatosis type 2.,,"Cell viability results showed that three agents (GSK2126458, Panobinostat, CUDC-907) had the greatest activity across schwannoma and meningioma cell systems",0.85,Accept,Experimental Usage,GSK2126458
PMID:29897904,10.1371/journal.pone.0197350,Traditional and systems biology based drug discovery for the rare tumor syndrome neurofibromatosis type 2.,,"Cell viability results showed that three agents (GSK2126458, Panobinostat, CUDC-907) had the greatest activity across schwannoma and meningioma cell systems",0.85,Accept,Experimental Usage,Panobinostat
PMID:29897904,10.1371/journal.pone.0197350,Traditional and systems biology based drug discovery for the rare tumor syndrome neurofibromatosis type 2.,,"Cell viability results showed that three agents (GSK2126458, Panobinostat, CUDC-907) had the greatest activity across schwannoma and meningioma cell systems",0.85,Accept,Experimental Usage,CUDC-907
PMID:30617350,10.1038/s41596-018-0105-7,"A cerebellopontine angle mouse model for the investigation of tumor biology, hearing, and neurological function in NF2-related vestibular schwannoma.",,"NF2 −/− cells should be transduced before use so they express the GLuc reporter gene, which is a secreted reporter that can be detected in the blood of tumor-bearing animals.",0.85,Accept,Experimental Usage,GLuc reporter gene
PMID:30617350,10.1038/s41596-018-0105-7,"A cerebellopontine angle mouse model for the investigation of tumor biology, hearing, and neurological function in NF2-related vestibular schwannoma.",,"GLuc vector and assay kits are commercially available from various biotech companies, such as Thermo Fisher Scientific (cat. no. 16146)",0.9,Accept,Experimental Usage,"GLuc vector (Thermo Fisher Scientific, cat. no. 16146)"
PMID:30617350,10.1038/s41596-018-0105-7,"A cerebellopontine angle mouse model for the investigation of tumor biology, hearing, and neurological function in NF2-related vestibular schwannoma.",,GLuc vector and assay kits are commercially available from various biotech companies...and New England BioLabs (cat. no. N8084S).,0.9,Accept,Experimental Usage,"GLuc vector (New England BioLabs, cat. no. N8084S)"
PMID:27956228,10.1053/j.gastro.2016.12.002,Genome-Wide CRISPR Screen Identifies Regulators of Mitogen-Activated Protein Kinase as Suppressors of Liver Tumors in Mice.,,"We infected p53−/−; Myc; Cas9 hepatocytes with the mGeCKOa lentiviral library of 67,000 single-guide RNAs (sgRNAs), targeting 20,611 mouse genes",0.9,Accept,Experimental Usage,mGeCKOa lentiviral library
PMID:27956228,10.1053/j.gastro.2016.12.002,Genome-Wide CRISPR Screen Identifies Regulators of Mitogen-Activated Protein Kinase as Suppressors of Liver Tumors in Mice.,,sgRNA oligos (IDT) were annealed and cloned into the pX330 vector (addgene 42230) or lentiV2 (addgene 52961),0.85,Accept,Experimental Usage,pX330 vector
PMID:27956228,10.1053/j.gastro.2016.12.002,Genome-Wide CRISPR Screen Identifies Regulators of Mitogen-Activated Protein Kinase as Suppressors of Liver Tumors in Mice.,,sgRNA oligos (IDT) were annealed and cloned into the pX330 vector (addgene 42230) or lentiV2 (addgene 52961),0.85,Accept,Experimental Usage,lentiV2
PMID:27956228,10.1053/j.gastro.2016.12.002,Genome-Wide CRISPR Screen Identifies Regulators of Mitogen-Activated Protein Kinase as Suppressors of Liver Tumors in Mice.,,"Effects of the MEK inhibitors AZD6244, U0126, and trametinib, or the multi-kinase inhibitor sorafenib, were examined",0.8,Accept,Experimental Usage,AZD6244
PMID:27956228,10.1053/j.gastro.2016.12.002,Genome-Wide CRISPR Screen Identifies Regulators of Mitogen-Activated Protein Kinase as Suppressors of Liver Tumors in Mice.,,"Effects of the MEK inhibitors AZD6244, U0126, and trametinib, or the multi-kinase inhibitor sorafenib, were examined",0.8,Accept,Experimental Usage,U0126
PMID:27956228,10.1053/j.gastro.2016.12.002,Genome-Wide CRISPR Screen Identifies Regulators of Mitogen-Activated Protein Kinase as Suppressors of Liver Tumors in Mice.,,"Effects of the MEK inhibitors AZD6244, U0126, and trametinib, or the multi-kinase inhibitor sorafenib, were examined",0.8,Accept,Experimental Usage,trametinib
PMID:27956228,10.1053/j.gastro.2016.12.002,Genome-Wide CRISPR Screen Identifies Regulators of Mitogen-Activated Protein Kinase as Suppressors of Liver Tumors in Mice.,,"Effects of the MEK inhibitors AZD6244, U0126, and trametinib, or the multi-kinase inhibitor sorafenib, were examined",0.8,Accept,Experimental Usage,sorafenib
PMID:24595234,10.1371/journal.pone.0090853,In vivo functional analysis of the human NF2 tumor suppressor gene in Drosophila.,,Transgenes expressing the indicated NF2 proteins were cloned with N-terminal Flag epitope tags in the pUASt transformation vector.,0.85,Accept,Experimental Usage,pUASt transformation vector
PMID:24595234,10.1371/journal.pone.0090853,In vivo functional analysis of the human NF2 tumor suppressor gene in Drosophila.,,ectopic expression of the NF2 isoforms under the control of the apterous-Gal4 driver,0.9,Accept,Experimental Usage,apterous-Gal4
PMID:24595234,10.1371/journal.pone.0090853,In vivo functional analysis of the human NF2 tumor suppressor gene in Drosophila.,,Total RNA was prepared from 20 wing imaginal discs from larvae... using Trizol (Invitrogen),0.85,Accept,Experimental Usage,Trizol (Invitrogen)
PMID:24595234,10.1371/journal.pone.0090853,In vivo functional analysis of the human NF2 tumor suppressor gene in Drosophila.,,cDNA was produced using the Taqman kit (ABI),0.85,Accept,Experimental Usage,Taqman kit (ABI)
PMID:24595234,10.1371/journal.pone.0090853,In vivo functional analysis of the human NF2 tumor suppressor gene in Drosophila.,,quantitative PCR performed using the LightCycler FastStart SYBR green system (Roche),0.9,Accept,Experimental Usage,LightCycler FastStart SYBR green system (Roche)
PMID:40394150,10.1038/s41416-025-03055-9,Mass spectrometric insights into the protein composition of human cutaneous neurofibromas: comparison of neurofibromas with the overlying skin.,,"...sonicated for five cycles of 30 s on, 30 s off in 50 µL of 100 mM triethylammonium bicarbonate buffer supplemented with Complete Mini protease inhibitors (Roche, Basel, Switzerland)...",0.85,Accept,Experimental Usage,Complete Mini protease inhibitors (Roche)
PMID:40394150,10.1038/s41416-025-03055-9,Mass spectrometric insights into the protein composition of human cutaneous neurofibromas: comparison of neurofibromas with the overlying skin.,,"...After acidification with phosphoric acid and addition of the S-Trap binding buffer, the samples were applied to S-Trap micro spin columns (ProtiFi, Farmingdale, NY, USA)...",0.85,Accept,Experimental Usage,S-Trap micro spin columns (ProtiFi)
PMID:40394150,10.1038/s41416-025-03055-9,Mass spectrometric insights into the protein composition of human cutaneous neurofibromas: comparison of neurofibromas with the overlying skin.,,...incubation with the CONFIRM anti-Ki67 (clone 30-9) rabbit monoclonal primary antibody (Roche) and detection with the UltraView Universal DAB detection kit (Roche)...,0.85,Accept,Experimental Usage,UltraView Universal DAB detection kit (Roche)
PMID:40394150,10.1038/s41416-025-03055-9,Mass spectrometric insights into the protein composition of human cutaneous neurofibromas: comparison of neurofibromas with the overlying skin.,,"...The labeling was carried out using the peroxidase-based Dako EnVision kit (Agilent Dako, Santa Clara, CA, USA) according to the manufacturer's protocol...",0.85,Accept,Experimental Usage,Dako EnVision kit (Agilent Dako)
PMID:21726432,10.1186/1741-7015-9-82,MIA is a potential biomarker for tumour load in neurofibromatosis type 1.,,"...RNA was isolated from the knee cartilage...using peqGOLD TriFast (PeqLab Biotechnologie GmbH, Erlangen, Germany)...",0.85,Accept,Experimental Usage,peqGOLD TriFast (PeqLab Biotechnologie GmbH)
PMID:21726432,10.1186/1741-7015-9-82,MIA is a potential biomarker for tumour load in neurofibromatosis type 1.,,"...cDNA was synthesized from 1 μg of total RNA with MuLV Reverse Transcriptase (Applied Biosystems, Carlsbad, CA, USA)...",0.85,Accept,Experimental Usage,MuLV Reverse Transcriptase (Applied Biosystems)
PMID:21726432,10.1186/1741-7015-9-82,MIA is a potential biomarker for tumour load in neurofibromatosis type 1.,,...TaqMan Universal PCR Master Mix was then performed on an ABI PRISM 7900 Cycler (Applied Biosystems)...,0.8,Accept,Experimental Usage,TaqMan Universal PCR Master Mix
PMID:21726432,10.1186/1741-7015-9-82,MIA is a potential biomarker for tumour load in neurofibromatosis type 1.,,...TaqMan Universal PCR Master Mix was then performed on an ABI PRISM 7900 Cycler (Applied Biosystems)...,0.85,Accept,Experimental Usage,ABI PRISM 7900 Cycler
PMID:21726432,10.1186/1741-7015-9-82,MIA is a potential biomarker for tumour load in neurofibromatosis type 1.,,"...The MIA ELISA kit was purchased from (Roche Diagnostics, Indianapolis, IN, USA) and the measurements were conducted...",0.9,Accept,Experimental Usage,MIA ELISA kit (Roche Diagnostics)
PMID:21726432,10.1186/1741-7015-9-82,MIA is a potential biomarker for tumour load in neurofibromatosis type 1.,,"...The streptavidin-biotin method was performed using an automated staining system TechMate (Dako, Hamburg, Germany)...",0.8,Accept,Experimental Usage,TechMate (Dako)
PMID:19191334,10.1002/glia.20845,Microarray analyses reveal regional astrocyte heterogeneity with implications for neurofibromatosis type 1 (NF1)-regulated glial proliferation.,,"The Nf1 gene was inactivated in passage 1 Nf1 flox / astrocytes by infection with adenovirus (Ad5) containing Cre recombinase (University of Iowa Gene Transfer Vector Core, Iowa City, IA)",0.85,Accept,Experimental Usage,Ad5-Cre adenovirus
PMID:19191334,10.1002/glia.20845,Microarray analyses reveal regional astrocyte heterogeneity with implications for neurofibromatosis type 1 (NF1)-regulated glial proliferation.,,Control flox Nf1 flox / astrocytes (wild-type) were treated identically with an adenovirus encoding LacZ,0.85,Accept,Experimental Usage,Ad5-LacZ adenovirus
PMID:29402968,10.1038/s41598-018-20894-0,Integrating Functional Analysis in the Next-Generation Sequencing Diagnostic Pipeline of RASopathies.,,"We introduced a single-base substitution into the corresponding expression vector using Q5® Site-Directed Mutagenesis Kit (NEB, UK)",0.85,Accept,Experimental Usage,Q5® Site-Directed Mutagenesis Kit
PMID:29402968,10.1038/s41598-018-20894-0,Integrating Functional Analysis in the Next-Generation Sequencing Diagnostic Pipeline of RASopathies.,,"We introduced pGal-LUC (Clontech), pGal-ELK1 and the expression plasmids into HEK-293T cells",0.85,Accept,Experimental Usage,pGal-LUC
PMID:29402968,10.1038/s41598-018-20894-0,Integrating Functional Analysis in the Next-Generation Sequencing Diagnostic Pipeline of RASopathies.,,"We introduced pGal-LUC (Clontech), pGal-ELK1 and the expression plasmids into HEK-293T cells",0.85,Accept,Experimental Usage,pGal-ELK1
PMID:29402968,10.1038/s41598-018-20894-0,Integrating Functional Analysis in the Next-Generation Sequencing Diagnostic Pipeline of RASopathies.,,"The luciferase activity was measured using a Dual-Luciferase® Reporter assay system (Promega, WI, USA)",0.85,Accept,Experimental Usage,Dual-Luciferase® Reporter assay system
PMID:29402968,10.1038/s41598-018-20894-0,Integrating Functional Analysis in the Next-Generation Sequencing Diagnostic Pipeline of RASopathies.,,"Transfection efficiencies were normalised to the control plasmid, which was pSV-RLuc (Promega, WI, USA) expressing Renilla luciferase",0.85,Accept,Experimental Usage,pSV-RLuc
PMID:29402968,10.1038/s41598-018-20894-0,Integrating Functional Analysis in the Next-Generation Sequencing Diagnostic Pipeline of RASopathies.,,"the in-frame coding sequence of RAF1, A2ML1 and RIT1 were subcloned into the pCMV6-AC-GFP vector",0.85,Accept,Experimental Usage,pCMV6-AC-GFP vector
PMID:29402968,10.1038/s41598-018-20894-0,Integrating Functional Analysis in the Next-Generation Sequencing Diagnostic Pipeline of RASopathies.,,"GFP-tagged RNA transcripts were synthesised using the mMESSAGE mMACHINE T7 Transcription Kit (Thermo Fisher Scientific, MA, USA)",0.85,Accept,Experimental Usage,mMESSAGE mMACHINE T7 Transcription Kit
PMID:31015291,10.1126/scisignal.aau8749,Proximity biotinylation identifies a set of conformation-specific interactions between Merlin and cell junction proteins.,,mApple-N1 (Addgene plasmid no. 54567) was a gift from M. Davidson,0.9,Accept,Experimental Usage,mApple-N1 (Addgene plasmid no. 54567)
PMID:31015291,10.1126/scisignal.aau8749,Proximity biotinylation identifies a set of conformation-specific interactions between Merlin and cell junction proteins.,,pSK ZO-1 (Addgene plasmid no. 30316) was a gift from J. Anderson and A. Fanning,0.9,Accept,Experimental Usage,pSK ZO-1 (Addgene plasmid no. 30316)
PMID:31015291,10.1126/scisignal.aau8749,Proximity biotinylation identifies a set of conformation-specific interactions between Merlin and cell junction proteins.,,CMV-GFP-NMHC II-B (Addgene plasmid no. 11348) was a gift from R. Adelstein,0.9,Accept,Experimental Usage,CMV-GFP-NMHC II-B (Addgene plasmid no. 11348)
PMID:31015291,10.1126/scisignal.aau8749,Proximity biotinylation identifies a set of conformation-specific interactions between Merlin and cell junction proteins.,,pGFP(C3)-vinculin (Addgene plasmid no. 30312) was a gift from K. Hahn,0.9,Accept,Experimental Usage,pGFP(C3)-vinculin (Addgene plasmid no. 30312)
PMID:31015291,10.1126/scisignal.aau8749,Proximity biotinylation identifies a set of conformation-specific interactions between Merlin and cell junction proteins.,,pKvenus-Scrib (Addgene plasmid no. 58738) was a gift from I. Macara,0.9,Accept,Experimental Usage,pKvenus-Scrib (Addgene plasmid no. 58738)
PMID:31015291,10.1126/scisignal.aau8749,Proximity biotinylation identifies a set of conformation-specific interactions between Merlin and cell junction proteins.,,"pEGFP-C3-hYAP1 and pEGFP C3-Lats1 (Addgene plasmid nos. 19053 and 17843, respectively) were gifts from M. Sudol",0.9,Accept,Experimental Usage,pEGFP-C3-hYAP1 (Addgene plasmid no. 19053)
PMID:31015291,10.1126/scisignal.aau8749,Proximity biotinylation identifies a set of conformation-specific interactions between Merlin and cell junction proteins.,,"pEGFP-C3-hYAP1 and pEGFP C3-Lats1 (Addgene plasmid nos. 19053 and 17843, respectively) were gifts from M. Sudol",0.9,Accept,Experimental Usage,pEGFP C3-Lats1 (Addgene plasmid no. 17843)
PMID:31015291,10.1126/scisignal.aau8749,Proximity biotinylation identifies a set of conformation-specific interactions between Merlin and cell junction proteins.,,HA-AMOT p130 (Addgene plasmid no. 32821) was a gift from K. Guan,0.9,Accept,Experimental Usage,HA-AMOT p130 (Addgene plasmid no. 32821)
PMID:31015291,10.1126/scisignal.aau8749,Proximity biotinylation identifies a set of conformation-specific interactions between Merlin and cell junction proteins.,,pcDNA3.1-ccdB-NLuc (Addgene plasmid no. 87067) was a gift from M. Taipale,0.9,Accept,Experimental Usage,pcDNA3.1-ccdB-NLuc (Addgene plasmid no. 87067)
PMID:31015291,10.1126/scisignal.aau8749,Proximity biotinylation identifies a set of conformation-specific interactions between Merlin and cell junction proteins.,,p4XBS2WT-Luc (Addgene plasmid no. 16593) was a gift from B. Vogelstein,0.9,Accept,Experimental Usage,p4XBS2WT-Luc (Addgene plasmid no. 16593)
PMID:31015291,10.1126/scisignal.aau8749,Proximity biotinylation identifies a set of conformation-specific interactions between Merlin and cell junction proteins.,,p8xGTIIC-luciferase (Addgene plasmid no. 34615) was a gift from S. Piccolo,0.9,Accept,Experimental Usage,p8xGTIIC-luciferase (Addgene plasmid no. 34615)
PMID:31015291,10.1126/scisignal.aau8749,Proximity biotinylation identifies a set of conformation-specific interactions between Merlin and cell junction proteins.,,pcDNA3 p53 WT (Addgene plasmid no. 69003) was a gift from D. Meek,0.9,Accept,Experimental Usage,pcDNA3 p53 WT (Addgene plasmid no. 69003)
PMID:40225167,10.1155/2023/9628049,Functional Assays Combined with Pre-mRNA-Splicing Analysis Improve Variant Classification and Diagnostics for Individuals with Neurofibromatosis Type 1 and Legius Syndrome.,,Anti-FLAG affinity beads were from Sigma-Aldrich...NF-SPRED1 complexes were immunoprecipitated using anti-FLAG affinity beads (Sigma-Aldrich),0.85,Accept,Experimental Usage,Anti-FLAG affinity beads
PMID:40225167,10.1155/2023/9628049,Functional Assays Combined with Pre-mRNA-Splicing Analysis Improve Variant Classification and Diagnostics for Individuals with Neurofibromatosis Type 1 and Legius Syndrome.,,"glutathione-sepharose was from GE Healthcare (Uppsala, Sweden)...GTP-bound RAS was subsequently isolated using glutathione-agarose beads",0.8,Accept,Experimental Usage,glutathione-sepharose
PMID:40225167,10.1155/2023/9628049,Functional Assays Combined with Pre-mRNA-Splicing Analysis Improve Variant Classification and Diagnostics for Individuals with Neurofibromatosis Type 1 and Legius Syndrome.,,NF1 minigene exon trap constructs and NF expression plasmids were generated using standard cloning techniques...Exon trap experiments were performed as described previously,0.9,Accept,Development,NF1 minigene exon trap constructs
PMID:40225167,10.1155/2023/9628049,Functional Assays Combined with Pre-mRNA-Splicing Analysis Improve Variant Classification and Diagnostics for Individuals with Neurofibromatosis Type 1 and Legius Syndrome.,,NF1 minigene exon trap constructs and NF expression plasmids were generated using standard cloning techniques,0.9,Accept,Development,NF expression plasmids
PMID:40225167,10.1155/2023/9628049,Functional Assays Combined with Pre-mRNA-Splicing Analysis Improve Variant Classification and Diagnostics for Individuals with Neurofibromatosis Type 1 and Legius Syndrome.,,"To investigate the NF-SPRED interaction, FLAG-SPRED1 (WT or variant) and NF (WT or variant) were coexpressed in HEK 293 T cells",0.85,Accept,Experimental Usage,FLAG-SPRED1 construct
PMID:40225167,10.1155/2023/9628049,Functional Assays Combined with Pre-mRNA-Splicing Analysis Improve Variant Classification and Diagnostics for Individuals with Neurofibromatosis Type 1 and Legius Syndrome.,,"To estimate RAS GAP activity, HA-H-RAS was expressed together with either wild-type (WT) or variant NF in COS-7 or HEK 293 T cells",0.85,Accept,Experimental Usage,HA-H-RAS construct
PMID:40225167,10.1155/2023/9628049,Functional Assays Combined with Pre-mRNA-Splicing Analysis Improve Variant Classification and Diagnostics for Individuals with Neurofibromatosis Type 1 and Legius Syndrome.,,GTP-bound RAS was subsequently isolated using glutathione-agarose beads coated with recombinant GST-RAF-RBD,0.85,Accept,Experimental Usage,GST-RAF-RBD
PMID:21199799,10.1158/0008-5472.CAN-10-2732,Dose-dependent effects of focal fractionated irradiation on secondary malignant neoplasms in Nf1 mutant mice.,,"Coverslips were mounted using Vectashield with DAPI (Vector Laboratories), and visualized with a Zeiss LSM 510 Meta confocal microscope.",0.85,Accept,Experimental Usage,Vectashield with DAPI (Vector Laboratories)
PMID:24824755,10.1371/journal.pone.0096733,BNIP3 regulates AT101 [(-)-gossypol] induced death in malignant peripheral nerve sheath tumor cells.,,"AT101 was provided by Ascenta Therapeutics (Malvern, PA). BOC-aspartyl (Ome)-fluoromethyl ketone (BAF) and ferric citrate were purchased",0.9,Accept,Experimental Usage,AT101
PMID:24824755,10.1371/journal.pone.0096733,BNIP3 regulates AT101 [(-)-gossypol] induced death in malignant peripheral nerve sheath tumor cells.,,"BNIP3 and HIF-1α siRNA (siGENOME SMARTPool) was purchased from Thermo Scientific (Waltham, MA) and reconstituted according to the manufacturers' instructions",0.9,Accept,Experimental Usage,BNIP3 siRNA
PMID:24824755,10.1371/journal.pone.0096733,BNIP3 regulates AT101 [(-)-gossypol] induced death in malignant peripheral nerve sheath tumor cells.,,"BNIP3 and HIF-1α siRNA (siGENOME SMARTPool) was purchased from Thermo Scientific (Waltham, MA) and reconstituted according to the manufacturers' instructions",0.9,Accept,Experimental Usage,HIF-1α siRNA
PMID:32699356,10.1038/s41467-020-17382-3,Murine models of IDH-wild-type glioblastoma exhibit spatial segregation of tumor initiation and manifestation during evolution.,,The floxed p53 alleles ( p53 floxE2–10 ) and ( p53 LSLR172H ) have been described previously,0.85,Accept,Experimental Usage,p53 floxE2–10
PMID:32699356,10.1038/s41467-020-17382-3,Murine models of IDH-wild-type glioblastoma exhibit spatial segregation of tumor initiation and manifestation during evolution.,,The floxed p53 alleles ( p53 floxE2–10 ) and ( p53 LSLR172H ) have been described previously,0.85,Accept,Experimental Usage,p53 LSLR172H
PMID:32699356,10.1038/s41467-020-17382-3,Murine models of IDH-wild-type glioblastoma exhibit spatial segregation of tumor initiation and manifestation during evolution.,,"p53 null CKO ( p53 ΔE2–10 CKO, hGFAP-cre+; p53 floxE2–10/floxE2–10 )",0.85,Accept,Experimental Usage,hGFAP-cre
PMID:32699356,10.1038/s41467-020-17382-3,Murine models of IDH-wild-type glioblastoma exhibit spatial segregation of tumor initiation and manifestation during evolution.,,p53 ΔE5–6 CKO (hGFAP-cre+; p53 floxE5–6/floxE5–6 ),0.85,Accept,Experimental Usage,p53 floxE5–6
PMID:32699356,10.1038/s41467-020-17382-3,Murine models of IDH-wild-type glioblastoma exhibit spatial segregation of tumor initiation and manifestation during evolution.,,p53 ∆E5–6 Rictor ∆/∆ CKO (hGFAP-cre+; p53 floxE5–6/floxE5–6 ; Rictor flox/flox ),0.85,Accept,Experimental Usage,Rictor flox
PMID:24040940,10.1186/1479-5876-11-213,Molecular-guided therapy predictions reveal drug resistance phenotypes and treatment alternatives in malignant peripheral nerve sheath tumors.,,"Synthesis of cDNA was performed using 500 ng of RNA according to manufacturer's instructions (High Capacity cDNA Reverse Transcription Kit, Invitrogen)",0.85,Accept,Experimental Usage,High Capacity cDNA Reverse Transcription Kit
PMID:24040940,10.1186/1479-5876-11-213,Molecular-guided therapy predictions reveal drug resistance phenotypes and treatment alternatives in malignant peripheral nerve sheath tumors.,,Total RNA was extracted from cultured MPNST cell lines and benign neurofibroma-derived cell lines during logarithmic cell growth using TRIzol reagent (Invitrogen),0.85,Accept,Experimental Usage,TRIzol reagent
PMID:24040940,10.1186/1479-5876-11-213,Molecular-guided therapy predictions reveal drug resistance phenotypes and treatment alternatives in malignant peripheral nerve sheath tumors.,,Reactions were performed in duplicate at 10 μl volume using Sybr Select master mix (Applied Biosystems) according to manufacturer's instructions,0.85,Accept,Experimental Usage,Sybr Select master mix
PMID:24040940,10.1186/1479-5876-11-213,Molecular-guided therapy predictions reveal drug resistance phenotypes and treatment alternatives in malignant peripheral nerve sheath tumors.,,Amplified cDNA was then fragmentated and labelled (NuGen Encore Biotin Module) and hybridized to GeneChip Human Genome U133 Plus 2.0 Array,0.9,Accept,Experimental Usage,GeneChip Human Genome U133 Plus 2.0 Array
PMID:33673681,10.3390/cancers13050999,Hybrid Minigene Assay: An Efficient Tool to Characterize mRNA Splicing Profiles of ,,"...blood was collected in PAXgene whole blood samples (Becton Dickinson, Franklin Lakes, NJ, USA) and extraction was carried out...",0.85,Accept,Experimental Usage,PAXgene whole blood samples
PMID:33673681,10.3390/cancers13050999,Hybrid Minigene Assay: An Efficient Tool to Characterize mRNA Splicing Profiles of ,,"...extraction was carried out with the PAXgene™ Blood RNA System (Qiagen, Hilden, Germany) according to the manufacturer's instruction...",0.85,Accept,Experimental Usage,PAXgene™ Blood RNA System
PMID:33673681,10.3390/cancers13050999,Hybrid Minigene Assay: An Efficient Tool to Characterize mRNA Splicing Profiles of ,,"...library preparation with a Haloplex HS or SureSelect kits (Agilent Technologies, Santa Clara, CA, USA)...",0.85,Accept,Experimental Usage,Haloplex HS
PMID:33673681,10.3390/cancers13050999,Hybrid Minigene Assay: An Efficient Tool to Characterize mRNA Splicing Profiles of ,,"...library preparation with a Haloplex HS or SureSelect kits (Agilent Technologies, Santa Clara, CA, USA)...",0.85,Accept,Experimental Usage,SureSelect kits
PMID:33673681,10.3390/cancers13050999,Hybrid Minigene Assay: An Efficient Tool to Characterize mRNA Splicing Profiles of ,,"...libraries were run on a MiniSeq apparatus (Illumina, San Diego, CA, USA)...",0.85,Accept,Experimental Usage,MiniSeq apparatus
PMID:33673681,10.3390/cancers13050999,Hybrid Minigene Assay: An Efficient Tool to Characterize mRNA Splicing Profiles of ,,"...using the SALSA MLPA kits P081/P082 (MRC Holland, Amsterdam, The Netherlands) according to manufacturer's protocol...",0.9,Accept,Experimental Usage,SALSA MLPA kits P081/P082
PMID:33673681,10.3390/cancers13050999,Hybrid Minigene Assay: An Efficient Tool to Characterize mRNA Splicing Profiles of ,,"...DNA was extracted also from other tissues using the Gentra Puregene kit (Puregene Cell and Tissue kit plus Qiagen GmbH, Hilden, Germany)...",0.85,Accept,Experimental Usage,Gentra Puregene kit
PMID:33673681,10.3390/cancers13050999,Hybrid Minigene Assay: An Efficient Tool to Characterize mRNA Splicing Profiles of ,,"...amplified from patients' genomic DNA and cloned into the beta-globin vector, as previously described...",0.85,Accept,Experimental Usage,beta-globin vector
PMID:33673681,10.3390/cancers13050999,Hybrid Minigene Assay: An Efficient Tool to Characterize mRNA Splicing Profiles of ,,"...transfected with 1 µg of the wild type or the mutated minigene using Lipofectamine 2000 (ThermoFisher Scientific, Watham, MA, USA)...",0.85,Accept,Experimental Usage,Lipofectamine 2000
PMID:33673681,10.3390/cancers13050999,Hybrid Minigene Assay: An Efficient Tool to Characterize mRNA Splicing Profiles of ,,"...total RNA was extracted with TRIzolTM (ThermoFisher Scientific, Watham, MA, USA)...",0.85,Accept,Experimental Usage,TRIzolTM
PMID:33673681,10.3390/cancers13050999,Hybrid Minigene Assay: An Efficient Tool to Characterize mRNA Splicing Profiles of ,,"...retrotranscribed using SuperScript II reverse transcriptase (ThermoFisher Scientific, Watham, MA, USA)...",0.85,Accept,Experimental Usage,SuperScript II reverse transcriptase
PMID:33673681,10.3390/cancers13050999,Hybrid Minigene Assay: An Efficient Tool to Characterize mRNA Splicing Profiles of ,,"...purified bands were subcloned using the TOPO TA Cloning kit (ThermoFisher Scientific, Watham, MA, USA)...",0.85,Accept,Experimental Usage,TOPO TA Cloning kit
PMID:34630515,10.3389/fgene.2021.721045,Assessment of Mosaicism and Detection of Cryptic Alleles in CRISPR/Cas9-Engineered Neurofibromatosis Type 1 and ,,"we used Phusion polymerase (M0530S; New England Biolabs, Inc., Ipswitch, MA) to synthesize a gRNA in vitro transcription template",0.85,Accept,Experimental Usage,Phusion polymerase (M0530S)
PMID:34630515,10.3389/fgene.2021.721045,Assessment of Mosaicism and Detection of Cryptic Alleles in CRISPR/Cas9-Engineered Neurofibromatosis Type 1 and ,,used for in vitro transcription of gRNA according to the manufacturer instructions (MEGAshortscript T7 Transcription Kit (AM1354); ThermoFisher Scientific),0.9,Accept,Experimental Usage,MEGAshortscript T7 Transcription Kit (AM1354)
PMID:34630515,10.3389/fgene.2021.721045,Assessment of Mosaicism and Detection of Cryptic Alleles in CRISPR/Cas9-Engineered Neurofibromatosis Type 1 and ,,In vitro transcription reactions were cleaned up according to manufacturer instructions (MEGAclear Transcription Cleanup Kit (AM1908); ThermoFisher Scientific),0.85,Accept,Experimental Usage,MEGAclear Transcription Cleanup Kit (AM1908)
PMID:34630515,10.3389/fgene.2021.721045,Assessment of Mosaicism and Detection of Cryptic Alleles in CRISPR/Cas9-Engineered Neurofibromatosis Type 1 and ,,"using the SF Cell Line 4D-Nucleofector ™ X Kit S (Lonza, Basel, Switzerland) and the EN-150 protocol of a 4D Nucleofector ™ (Lonza)",0.9,Accept,Experimental Usage,SF Cell Line 4D-Nucleofector X Kit S
PMID:34630515,10.3389/fgene.2021.721045,Assessment of Mosaicism and Detection of Cryptic Alleles in CRISPR/Cas9-Engineered Neurofibromatosis Type 1 and ,,"PCR was performed using Q5® Hot Start High-Fidelity DNA Polymerase (New England Biolabs, Inc.) according to manufacturer's suggestions",0.85,Accept,Experimental Usage,Q5 Hot Start High-Fidelity DNA Polymerase
PMID:34630515,10.3389/fgene.2021.721045,Assessment of Mosaicism and Detection of Cryptic Alleles in CRISPR/Cas9-Engineered Neurofibromatosis Type 1 and ,,"Copy number variation (CNV) analysis was performed using digital PCR (dPCR; QX200 Droplet Digital PCR System, Bio-Rad Laboratories, Inc.)",0.9,Accept,Experimental Usage,QX200 Droplet Digital PCR System
PMID:32457840,10.3389/fonc.2020.00687,"TGFβ Signaling Increases Net Acid Extrusion, Proliferation and Invasion in Panc-1 Pancreatic Cancer Cells: SMAD4 Dependence and Link to Merlin/NF2 Signaling.",,"Merlin siRNA (SASI_Hs_01_00188862, Sigma) sense sequence 5′-CCUCAAAGCUUCGUGUUAA-3",0.95,Accept,Experimental Usage,Merlin siRNA (SASI_Hs_01_00188862)
PMID:32457840,10.3389/fonc.2020.00687,"TGFβ Signaling Increases Net Acid Extrusion, Proliferation and Invasion in Panc-1 Pancreatic Cancer Cells: SMAD4 Dependence and Link to Merlin/NF2 Signaling.",,siRNAs employed were: NHE1 siRNA: ON-TARGET SMART pool (Thermo Scientific),0.9,Accept,Experimental Usage,NHE1 siRNA: ON-TARGET SMART pool
PMID:32457840,10.3389/fonc.2020.00687,"TGFβ Signaling Increases Net Acid Extrusion, Proliferation and Invasion in Panc-1 Pancreatic Cancer Cells: SMAD4 Dependence and Link to Merlin/NF2 Signaling.",,"NBCn1 siRNA (SASI_Hs01_00030755, Sigma-Aldrich) sense sequence 5′-CAUUAACUGGGAUUGCCUA-3′",0.9,Accept,Experimental Usage,NBCn1 siRNA (SASI_Hs01_00030755)
PMID:32457840,10.3389/fonc.2020.00687,"TGFβ Signaling Increases Net Acid Extrusion, Proliferation and Invasion in Panc-1 Pancreatic Cancer Cells: SMAD4 Dependence and Link to Merlin/NF2 Signaling.",,"SMAD4 (EHU018671 esiRNA siRNA mixture, Sigma)",0.9,Accept,Experimental Usage,SMAD4 (EHU018671 esiRNA siRNA mixture)
PMID:33273014,10.1074/jbc.RA120.014960,mTOR kinase inhibition disrupts neuregulin 1-ERBB3 autocrine signaling and sensitizes NF2-deficient meningioma cellular models to IGF1R inhibition.,,"full length cDNA coding sequence of NF2 (isoform 1, NCBI accession # NM_000268) cloned into the lentiviral vector CSCW2",0.85,Accept,Experimental Usage,NF2-CSCW2
PMID:33273014,10.1074/jbc.RA120.014960,mTOR kinase inhibition disrupts neuregulin 1-ERBB3 autocrine signaling and sensitizes NF2-deficient meningioma cellular models to IGF1R inhibition.,,Ben-Men-1 cells were transduced with either NF2-CSCW2 or V-CSCW2 at a multiplicity of infection of 50,0.85,Accept,Experimental Usage,V-CSCW2
PMID:33273014,10.1074/jbc.RA120.014960,mTOR kinase inhibition disrupts neuregulin 1-ERBB3 autocrine signaling and sensitizes NF2-deficient meningioma cellular models to IGF1R inhibition.,,"RNA was isolated from all MN-relevant lines using TRIzol reagent (15596026, ThermoFisher Scientific)",0.8,Accept,Experimental Usage,TRIzol reagent
PMID:33273014,10.1074/jbc.RA120.014960,mTOR kinase inhibition disrupts neuregulin 1-ERBB3 autocrine signaling and sensitizes NF2-deficient meningioma cellular models to IGF1R inhibition.,,"mRNA libraries for RNA-seq were made in triplicate and sextuplicate, respectively, using TruSeq Stranded mRNA Library Preparation Kits (RS-122-2101, RS-122-2102, or RS-122-2103; Illumina)",0.85,Accept,Experimental Usage,TruSeq Stranded mRNA Library Preparation Kits
PMID:33273014,10.1074/jbc.RA120.014960,mTOR kinase inhibition disrupts neuregulin 1-ERBB3 autocrine signaling and sensitizes NF2-deficient meningioma cellular models to IGF1R inhibition.,,"inhibitor drugs lapatinib, erlotinib, INK128/TAK-228, and BMS-754807 (Selleck Chemicals)",0.8,Accept,Experimental Usage,INK128
PMID:33273014,10.1074/jbc.RA120.014960,mTOR kinase inhibition disrupts neuregulin 1-ERBB3 autocrine signaling and sensitizes NF2-deficient meningioma cellular models to IGF1R inhibition.,,"inhibitor drugs lapatinib, erlotinib, INK128/TAK-228, and BMS-754807 (Selleck Chemicals)",0.8,Accept,Experimental Usage,BMS-754807
PMID:33273014,10.1074/jbc.RA120.014960,mTOR kinase inhibition disrupts neuregulin 1-ERBB3 autocrine signaling and sensitizes NF2-deficient meningioma cellular models to IGF1R inhibition.,,Drug screening assays for all cell lines were carried out in a 384-well format using the CellTiter-Glo cell viability kit (Promega),0.85,Accept,Experimental Usage,CellTiter-Glo cell viability kit
PMID:41022755,10.1038/s41467-025-63619-4,Development of an adeno-associated virus vector for gene replacement therapy of NF1-related tumors.,,"This tailored vector, AAV-NF, exhibits greatly reduced liver uptake, enhanced tumor targeting across various NF1-related MPNST, neurofibromas and glioma models",0.95,Accept,Development,AAV-NF
PMID:41022755,10.1038/s41467-025-63619-4,Development of an adeno-associated virus vector for gene replacement therapy of NF1-related tumors.,,"Two or three weeks after the ST88-14 or RHT92 implantation, respectively, 1012 vg (viral genome) AAV-GRDC24 were injected via the tail vein",0.95,Accept,Development,AAV-GRDC24
PMID:41022755,10.1038/s41467-025-63619-4,Development of an adeno-associated virus vector for gene replacement therapy of NF1-related tumors.,,pscAAV-GFP and pscAAV-GRDC24 (2163 bp between ITRs) were used to generate AAV-GFP and AAV-GRDC24,0.9,Accept,Development,pscAAV-GRDC24
PMID:30571760,10.1371/journal.pone.0208835,Neurofibromin haploinsufficiency results in altered spermatogenesis in a mouse model of neurofibromatosis type 1.,,Dsk9 is a missense mutation in the GTPase-activating protein related domain of neurofibromin.,0.85,Accept,Experimental Usage,Dsk9 mutation
PMID:21111000,10.1016/j.jneumeth.2010.10.021,A novel imaging-compatible sciatic nerve schwannoma model.,,These cell lines have been transduced with lentivirus expressing Fluc and mCherry genes as described previously,0.8,Accept,Experimental Usage,lentivirus expressing Fluc and mCherry
PMID:24958239,10.1186/gb-2014-15-6-r80,SVA retrotransposon insertion-associated deletion represents a novel mutational mechanism underlying large genomic copy number changes with non-recurrent breakpoints.,,"The deletions analyzed in this study were identified by MLPA analysis (P122-C1 NF1-area kit, MRC-Holland, The Netherlands)",0.9,Accept,Experimental Usage,P122-C1 NF1-area kit
PMID:24958239,10.1186/gb-2014-15-6-r80,SVA retrotransposon insertion-associated deletion represents a novel mutational mechanism underlying large genomic copy number changes with non-recurrent breakpoints.,,"we performed targeted array CGH using 8 × 15 K arrays (Agilent Technologies, Santa Clara, CA, USA)",0.85,Accept,Experimental Usage,8 × 15 K arrays
PMID:24958239,10.1186/gb-2014-15-6-r80,SVA retrotransposon insertion-associated deletion represents a novel mutational mechanism underlying large genomic copy number changes with non-recurrent breakpoints.,,"Breakpoint-spanning PCRs were performed using the Expand Long Template PCR system (Roche, Mannheim, Germany)",0.9,Accept,Experimental Usage,Expand Long Template PCR system
PMID:24958239,10.1186/gb-2014-15-6-r80,SVA retrotransposon insertion-associated deletion represents a novel mutational mechanism underlying large genomic copy number changes with non-recurrent breakpoints.,,"The resulting PCR products were gel-purified (Zymoclean™ Gel DNA Recovery Kit, Zymo Research, Irvine, CA, USA)",0.85,Accept,Experimental Usage,Zymoclean™ Gel DNA Recovery Kit
PMID:24958239,10.1186/gb-2014-15-6-r80,SVA retrotransposon insertion-associated deletion represents a novel mutational mechanism underlying large genomic copy number changes with non-recurrent breakpoints.,,"sequenced with the BigDye Terminator v3.1 Cycle Sequencing Kit (Life Technologies, Darmstadt, Germany)",0.9,Accept,Experimental Usage,BigDye Terminator v3.1 Cycle Sequencing Kit
PMID:24958239,10.1186/gb-2014-15-6-r80,SVA retrotransposon insertion-associated deletion represents a novel mutational mechanism underlying large genomic copy number changes with non-recurrent breakpoints.,,"To perform GenomeWalker™ analysis (Clontech, Saint-Germain-en-Laye, France), genomic DNA (2.5 μg per experiment) was restriction digested",0.9,Accept,Experimental Usage,GenomeWalker™
PMID:24958239,10.1186/gb-2014-15-6-r80,SVA retrotransposon insertion-associated deletion represents a novel mutational mechanism underlying large genomic copy number changes with non-recurrent breakpoints.,,PCRs were performed with the Advantage® 2 PCR Kit (Clontech),0.85,Accept,Experimental Usage,Advantage® 2 PCR Kit
PMID:24958239,10.1186/gb-2014-15-6-r80,SVA retrotransposon insertion-associated deletion represents a novel mutational mechanism underlying large genomic copy number changes with non-recurrent breakpoints.,,"The corresponding PCR products were gel-purified (S.N.A.P.™ UV-Free Gel Purification Kit, Invitrogen, USA)",0.85,Accept,Experimental Usage,S.N.A.P.™ UV-Free Gel Purification Kit
PMID:38931352,10.3390/ph17060685,PET Imaging of Neurofibromatosis Type 1 with a Fluorine-18 Labeled Tryptophan Radiotracer.,,"We studied a fluorine-18 labeled tryptophan positron emission tomography (PET) radiotracer, 1-(2-[18F]FETrp",0.85,Accept,Development,L-[18F]FETrp
PMID:38931352,10.3390/ph17060685,PET Imaging of Neurofibromatosis Type 1 with a Fluorine-18 Labeled Tryptophan Radiotracer.,,Static and dynamic PET imaging in wild-type and NF1 tumor mice was performed in a PerkinElmer G4 microPET scanner,0.8,Accept,Experimental Usage,PerkinElmer G4 microPET scanner
PMID:38931352,10.3390/ph17060685,PET Imaging of Neurofibromatosis Type 1 with a Fluorine-18 Labeled Tryptophan Radiotracer.,,"the radioactivity in these organs was assayed using an automated PerkinElmer 2480 gamma counter (Downers Grove, IL, USA)",0.8,Accept,Experimental Usage,PerkinElmer 2480 gamma counter
PMID:28126595,10.1016/j.ebiom.2017.01.020,Global Proteome and Phospho-proteome Analysis of Merlin-deficient Meningioma and Schwannoma Identifies PDLIM2 as a Novel Therapeutic Target.,,Phospho-proteins were isolated from cell lysates using the commercially available phospho-protein purification kit from Qiagen®,0.85,Accept,Experimental Usage,phospho-protein purification kit from Qiagen®
PMID:28126595,10.1016/j.ebiom.2017.01.020,Global Proteome and Phospho-proteome Analysis of Merlin-deficient Meningioma and Schwannoma Identifies PDLIM2 as a Novel Therapeutic Target.,,"Cultured cells were seeded at 80% confluency before transfection with lentiviral particles (10 μl/6 well, 2 μl labtek) directed towards PDLIM2 (Sigma)",0.9,Accept,Experimental Usage,PDLIM2 shRNA lentiviral particles (Sigma)
PMID:28126595,10.1016/j.ebiom.2017.01.020,Global Proteome and Phospho-proteome Analysis of Merlin-deficient Meningioma and Schwannoma Identifies PDLIM2 as a Novel Therapeutic Target.,,Five different shRNA clones were tested...cloned into the plasmid pLKO.1-puro,0.85,Accept,Experimental Usage,pLKO.1-puro plasmid
PMID:28126595,10.1016/j.ebiom.2017.01.020,Global Proteome and Phospho-proteome Analysis of Merlin-deficient Meningioma and Schwannoma Identifies PDLIM2 as a Novel Therapeutic Target.,,Protein dephosphorylation was achieved by treating 20 μg of protein lysate with λ-phosphatase (New England Biolabs) following the instructions of the supplier,0.85,Accept,Experimental Usage,λ-phosphatase (New England Biolabs)
PMID:28126595,10.1016/j.ebiom.2017.01.020,Global Proteome and Phospho-proteome Analysis of Merlin-deficient Meningioma and Schwannoma Identifies PDLIM2 as a Novel Therapeutic Target.,,"To ascertain the cellular location of PDLIM2, a cytoplasmic and nuclear extraction assay (Thermo Scientific) was performed",0.85,Accept,Experimental Usage,cytoplasmic and nuclear extraction assay (Thermo Scientific)
PMID:39996452,10.1111/cns.70287,Cas9 Mouse Model of Skull Base Meningioma Driven by Combinational Gene Inactivation in Meningeal Cells.,,"We then prepared lentivirus vector pLentiCre/gRNA, which could express the elements blocking the function of four genes: Nf2, P15",0.9,Accept,Development,pLentiCre/gRNA
PMID:39996452,10.1111/cns.70287,Cas9 Mouse Model of Skull Base Meningioma Driven by Combinational Gene Inactivation in Meningeal Cells.,,"Therefore, according to the pLentiCre/gRNA strategy, we constructed an AAV vector of pAAVCre/gRNA, which could import Cre and the four gRNAs.",0.9,Accept,Development,pAAVCre/gRNA
PMID:34935315,10.1117/1.JBO.26.12.125001,Analysis of muscle tissue in vivo using fiber-optic autofluorescence and diffuse reflectance spectroscopy.,,"...coupled via a servo-actuated shutter, bandpass filter (FB405-10, Thorlabs), and microscope lens...",0.75,Accept,Experimental Usage,FB405-10
PMID:34935315,10.1117/1.JBO.26.12.125001,Analysis of muscle tissue in vivo using fiber-optic autofluorescence and diffuse reflectance spectroscopy.,,"...within a fan-out style bundle (BF72HS01, Thorlabs) terminating distally in a six-around-one configuration...",0.75,Accept,Experimental Usage,BF72HS01
PMID:34935315,10.1117/1.JBO.26.12.125001,Analysis of muscle tissue in vivo using fiber-optic autofluorescence and diffuse reflectance spectroscopy.,,"...collected using the bundle's central fiber and long pass filtered at 425 nm (DMLP425, Thorlabs)...",0.75,Accept,Experimental Usage,DMLP425
PMID:34935315,10.1117/1.JBO.26.12.125001,Analysis of muscle tissue in vivo using fiber-optic autofluorescence and diffuse reflectance spectroscopy.,,"...before detection by a USB spectrometer with a wavelength range of 345 to 1041 nm (USB 4000, Ocean Optics)...",0.75,Accept,Experimental Usage,USB 4000
PMID:34935315,10.1117/1.JBO.26.12.125001,Analysis of muscle tissue in vivo using fiber-optic autofluorescence and diffuse reflectance spectroscopy.,,"...A stabilized tungsten–halogen light source (SLS201L/M, Thorlabs) was used for DR measurements...",0.75,Accept,Experimental Usage,SLS201L/M
PMID:8582272,10.1242/dev.121.11.3583,Neurofibromin-deficient fibroblasts fail to form perineurium in vitro.,,"...200 ng of each oligonucleotide primer (NeoTkp, NF31a, NF31b) ( Brannan et al., 1994 )...",0.8,Accept,Experimental Usage,NeoTkp primer
PMID:8582272,10.1242/dev.121.11.3583,Neurofibromin-deficient fibroblasts fail to form perineurium in vitro.,,"...200 ng of each oligonucleotide primer (NeoTkp, NF31a, NF31b) ( Brannan et al., 1994 )...",0.8,Accept,Experimental Usage,NF31a primer
PMID:8582272,10.1242/dev.121.11.3583,Neurofibromin-deficient fibroblasts fail to form perineurium in vitro.,,"...200 ng of each oligonucleotide primer (NeoTkp, NF31a, NF31b) ( Brannan et al., 1994 )...",0.8,Accept,Experimental Usage,NF31b primer
PMID:8582272,10.1242/dev.121.11.3583,Neurofibromin-deficient fibroblasts fail to form perineurium in vitro.,,"...0.25 units of Taq polymerase (Perkin-Elmer Cetus) and a mixture of dATP, dCTP, dGTP and dTTP...",0.85,Accept,Experimental Usage,Taq polymerase (Perkin-Elmer Cetus)
PMID:8582272,10.1242/dev.121.11.3583,Neurofibromin-deficient fibroblasts fail to form perineurium in vitro.,,"...Schwann cells were amplified for 1 week in recombinant human glial growth factor (rhGGF2, Cambridge Neuroscience)...",0.85,Accept,Experimental Usage,rhGGF2 (Cambridge Neuroscience)
PMID:25329635,10.1371/journal.pgen.1004575,Genetic modifiers of neurofibromatosis type 1-associated café-au-lait macule count identified using multi-platform analysis.,,"...mixed with an equal volume of 70% ethanol and immediately loaded onto RNeasy mini columns (Qiagen, Valencia, CA, USA)...",0.85,Accept,Experimental Usage,RNeasy mini columns
PMID:25329635,10.1371/journal.pgen.1004575,Genetic modifiers of neurofibromatosis type 1-associated café-au-lait macule count identified using multi-platform analysis.,,"...10 µL PCR reactions containing KAPA 2G Fast HS ReadyMix PCR Kit (KAPA Biosystems, Woburn, MA, USA)...",0.88,Accept,Experimental Usage,KAPA 2G Fast HS ReadyMix PCR Kit
PMID:33442015,10.1038/s41591-020-01193-6,Cabozantinib for neurofibromatosis type 1-related plexiform neurofibromas: a phase 2 trial.,,"Levels of circulating sAXL were measured in human plasma using the Human AXL DuoSet ELISA kit (R&D Systems, DY154)",0.9,Accept,Experimental Usage,"Human AXL DuoSet ELISA kit (R&D Systems, DY154)"
PMID:33442015,10.1038/s41591-020-01193-6,Cabozantinib for neurofibromatosis type 1-related plexiform neurofibromas: a phase 2 trial.,,"Levels of circulating sAXL were measured in mouse plasma using the Mouse AXL DuoSet ELISA kit (R&D Systems, DY854)",0.9,Accept,Experimental Usage,"Mouse AXL DuoSet ELISA kit (R&D Systems, DY854)"
PMID:33442015,10.1038/s41591-020-01193-6,Cabozantinib for neurofibromatosis type 1-related plexiform neurofibromas: a phase 2 trial.,,The FragEL™ DNA Fragmentation Detection Kit (Sigma Aldrich #QIA21) was used according to manufacturer's instructions,0.9,Accept,Experimental Usage,FragEL DNA Fragmentation Detection Kit (Sigma Aldrich #QIA21)
PMID:29715273,10.1371/journal.pone.0196726,Neurofibromatosis type 2 tumor suppressor protein is expressed in oligodendrocytes and regulates cell proliferation and process formation.,,"For stable transfection of Merlin in cell lines, the plasmid pcNf2hflag containing a CMV promoter and a neomycin resistance cassette was used",0.9,Accept,Experimental Usage,pcNf2hflag plasmid
PMID:29715273,10.1371/journal.pone.0196726,Neurofibromatosis type 2 tumor suppressor protein is expressed in oligodendrocytes and regulates cell proliferation and process formation.,,An empty vector pcDNA3.1 was used as a control,0.85,Accept,Experimental Usage,pcDNA3.1 vector
PMID:24509877,10.1038/onc.2013.506,MAF mediates crosstalk between Ras-MAPK and mTOR signaling in NF1.,,"MPNST cells were infected with purified Ad-NF1-GRD or control Ad-GFP, in triplicate, for 2 h in serum-free medium",0.9,Accept,Experimental Usage,Ad-NF1-GRD
PMID:24509877,10.1038/onc.2013.506,MAF mediates crosstalk between Ras-MAPK and mTOR signaling in NF1.,,"MPNST cells were infected with purified Ad-NF1-GRD or control Ad-GFP, in triplicate, for 2 h in serum-free medium",0.85,Accept,Experimental Usage,Ad-GFP
PMID:24509877,10.1038/onc.2013.506,MAF mediates crosstalk between Ras-MAPK and mTOR signaling in NF1.,,"Constitutive expression used mCherry tagged MAF (EX-Y2046-Lv111, GeneCopoeia) and mCherry control lentivirus",0.95,Accept,Experimental Usage,"mCherry tagged MAF (EX-Y2046-Lv111, GeneCopoeia)"
PMID:24509877,10.1038/onc.2013.506,MAF mediates crosstalk between Ras-MAPK and mTOR signaling in NF1.,,Inducible expression used lentiviral vectors containing the MAF ORF or empty pLVX-Tight-Puro vector (GeneCopoeia),0.9,Accept,Experimental Usage,pLVX-Tight-Puro vector (GeneCopoeia)
PMID:24509877,10.1038/onc.2013.506,MAF mediates crosstalk between Ras-MAPK and mTOR signaling in NF1.,,...in a modified pTight backbone (Clonetech) with pLVX-Tet-On doxycycline inducible vector (Clonetech),0.9,Accept,Experimental Usage,pLVX-Tet-On doxycycline inducible vector (Clonetech)
PMID:24509877,10.1038/onc.2013.506,MAF mediates crosstalk between Ras-MAPK and mTOR signaling in NF1.,,Cells were transfected using FuGENE HD (Roche) with 100ng per well of an AP-1 luciferase (Stratagene) reporter vector,0.9,Accept,Experimental Usage,AP-1 luciferase (Stratagene) reporter vector
PMID:24509877,10.1038/onc.2013.506,MAF mediates crosstalk between Ras-MAPK and mTOR signaling in NF1.,,Total RNA was isolated from cells using the RNeasy kit (Qiagen) and used as a template for cDNA synthesis,0.85,Accept,Experimental Usage,RNeasy kit (Qiagen)
PMID:24509877,10.1038/onc.2013.506,MAF mediates crosstalk between Ras-MAPK and mTOR signaling in NF1.,,...used as a template for cDNA synthesis (ABI High capacity archive kit) and RT-PCR,0.85,Accept,Experimental Usage,ABI High capacity archive kit
PMID:33767727,10.3389/fgene.2021.603195,Molecular Diagnosis of Neurofibromatosis by Multigene Panel Testing.,,"Genomic DNA was extracted from the peripheral blood, skin lesions, hair, oral mucosa, and tumor tissues separately using the AxyPrep Blood Genomic DNA Miniprep Kit (Axygen, Corning, Jiangsu, China)",0.85,Accept,Experimental Usage,AxyPrep Blood Genomic DNA Miniprep Kit
PMID:33767727,10.3389/fgene.2021.603195,Molecular Diagnosis of Neurofibromatosis by Multigene Panel Testing.,,"Genomic DNA was extracted from the peripheral blood, skin lesions, hair, oral mucosa, and tumor tissues separately using the AxyPrep Blood Genomic DNA Miniprep Kit (Axygen, Corning, Jiangsu, China) and DNeasy Blood & Tissue Kit (Qiagen, Germany)",0.85,Accept,Experimental Usage,DNeasy Blood & Tissue Kit
PMID:33767727,10.3389/fgene.2021.603195,Molecular Diagnosis of Neurofibromatosis by Multigene Panel Testing.,,The DNA purity was determined using a NanoDrop one spectrophotometer and quantified with a Qubit 2.0 Fluorometer,0.8,Accept,Experimental Usage,NanoDrop one spectrophotometer
PMID:33767727,10.3389/fgene.2021.603195,Molecular Diagnosis of Neurofibromatosis by Multigene Panel Testing.,,The DNA purity was determined using a NanoDrop one spectrophotometer and quantified with a Qubit 2.0 Fluorometer using the Qubit dsDNA HS Assay Kit,0.8,Accept,Experimental Usage,Qubit 2.0 Fluorometer
PMID:33767727,10.3389/fgene.2021.603195,Molecular Diagnosis of Neurofibromatosis by Multigene Panel Testing.,,"quantified with a Qubit 2.0 Fluorometer using the Qubit dsDNA HS Assay Kit (Life Technologies, Thermo Fisher Scientific, Inc.)",0.85,Accept,Experimental Usage,Qubit dsDNA HS Assay Kit
PMID:33767727,10.3389/fgene.2021.603195,Molecular Diagnosis of Neurofibromatosis by Multigene Panel Testing.,,the capture probe from the Roche NimbleGen Sequence Capture SeqCap EZ Library was used to capture a total of 569 genes associated with hereditary dermatosis,0.85,Accept,Experimental Usage,Roche NimbleGen Sequence Capture SeqCap EZ Library
PMID:33767727,10.3389/fgene.2021.603195,Molecular Diagnosis of Neurofibromatosis by Multigene Panel Testing.,,"DNA was cropped into approximately 300-bp fragments using focused ultrasonicators (Covaris M220, United States)",0.8,Accept,Experimental Usage,Covaris M220
PMID:33767727,10.3389/fgene.2021.603195,Molecular Diagnosis of Neurofibromatosis by Multigene Panel Testing.,,"Sequencing was carried out on an Illumina HiSeq X Ten System (Illumina, San Diego, CA, United States)",0.85,Accept,Experimental Usage,Illumina HiSeq X Ten System
PMID:33767727,10.3389/fgene.2021.603195,Molecular Diagnosis of Neurofibromatosis by Multigene Panel Testing.,,"An ABI PRISM 3730XL analyzer (Applied Biosystems, Foster City, CA, United States) was used for Sanger sequencing",0.85,Accept,Experimental Usage,ABI PRISM 3730XL analyzer
PMID:23328114,10.18632/oncotarget.793,Genomic imbalance of HMMR/RHAMM regulates the sensitivity and response of malignant peripheral nerve sheath tumour cells to aurora kinase inhibition.,,the AURKA specific inhibitor MLN8237 (Selleck Chemicals). Mice were treated by gavage once daily with 30mg/kg MLN8237,0.9,Accept,Experimental Usage,MLN8237
PMID:23328114,10.18632/oncotarget.793,Genomic imbalance of HMMR/RHAMM regulates the sensitivity and response of malignant peripheral nerve sheath tumour cells to aurora kinase inhibition.,,Small-molecule AKIs were dissolved and diluted in DMSO/DMEM and included the pan-aurora inhibitors C1368 (Sigma),0.85,Accept,Experimental Usage,C1368
PMID:23328114,10.18632/oncotarget.793,Genomic imbalance of HMMR/RHAMM regulates the sensitivity and response of malignant peripheral nerve sheath tumour cells to aurora kinase inhibition.,,"pan-aurora inhibitors C1368 (Sigma) and VX680 (Selleck Chemicals), and the AURKA specific inhibitor MLN8237",0.85,Accept,Experimental Usage,VX680
PMID:23328114,10.18632/oncotarget.793,Genomic imbalance of HMMR/RHAMM regulates the sensitivity and response of malignant peripheral nerve sheath tumour cells to aurora kinase inhibition.,,"Lentivirus packaging, envelope and control non-hairpin (NHP) pLKO.1 plasmids (Addgene) were used with shRNA",0.85,Accept,Experimental Usage,pLKO.1 plasmids (Addgene)
PMID:23328114,10.18632/oncotarget.793,Genomic imbalance of HMMR/RHAMM regulates the sensitivity and response of malignant peripheral nerve sheath tumour cells to aurora kinase inhibition.,,pLKO.1 plasmids (Addgene) were used with shRNA against RHAMM and TPX2 (Sigma),0.85,Accept,Experimental Usage,shRNA against RHAMM (Sigma)
PMID:23328114,10.18632/oncotarget.793,Genomic imbalance of HMMR/RHAMM regulates the sensitivity and response of malignant peripheral nerve sheath tumour cells to aurora kinase inhibition.,,pLKO.1 plasmids (Addgene) were used with shRNA against RHAMM and TPX2 (Sigma),0.85,Accept,Experimental Usage,shRNA against TPX2 (Sigma)
PMID:23328114,10.18632/oncotarget.793,Genomic imbalance of HMMR/RHAMM regulates the sensitivity and response of malignant peripheral nerve sheath tumour cells to aurora kinase inhibition.,,"siRNA (Qiagen, Table S1) were transfected at 10 pmol/well using Lipofectamine2000™",0.85,Accept,Experimental Usage,siRNA (Qiagen)
PMID:23328114,10.18632/oncotarget.793,Genomic imbalance of HMMR/RHAMM regulates the sensitivity and response of malignant peripheral nerve sheath tumour cells to aurora kinase inhibition.,,"siRNA (Qiagen, Table S1) were transfected at 10 pmol/well using Lipofectamine2000™ according to manufacturer's protocols (Invitrogen)",0.85,Accept,Experimental Usage,Lipofectamine2000™ (Invitrogen)
PMID:23328114,10.18632/oncotarget.793,Genomic imbalance of HMMR/RHAMM regulates the sensitivity and response of malignant peripheral nerve sheath tumour cells to aurora kinase inhibition.,,Labeled samples were competitively hybridized to 2 × 400k Human CGH Arrays (Agilent Technologies) as recommended,0.9,Accept,Experimental Usage,2 × 400k Human CGH Arrays (Agilent Technologies)
PMID:39890807,10.1038/s41598-024-84493-y,Global proteomics and affinity mass spectrometry analysis of human Schwann cells indicates that variation in and loss of neurofibromin (NF1) alters protein expression and cellular and mitochondrial metabolism.,,"To create an isogenic NF1 null cell line, we utilized CRISPR Cas9 targeting of NF1 exon 2 to create inactivating indels...",0.85,Accept,Experimental Usage,CRISPR Cas9
PMID:39890807,10.1038/s41598-024-84493-y,Global proteomics and affinity mass spectrometry analysis of human Schwann cells indicates that variation in and loss of neurofibromin (NF1) alters protein expression and cellular and mitochondrial metabolism.,,The wild type (WT) mNf1 cDNA plasmid was developed by GeneCopoeia and is commercially available... We used traditional subcloning to replace the BlpI and NotI restriction fragment in mNf1 cDNA (GeneCopoeia NM_010897.2),0.9,Accept,Experimental Usage,mNf1 cDNA (GeneCopoeia NM_010897.2)
PMID:39890807,10.1038/s41598-024-84493-y,Global proteomics and affinity mass spectrometry analysis of human Schwann cells indicates that variation in and loss of neurofibromin (NF1) alters protein expression and cellular and mitochondrial metabolism.,,"We utilized a StepTactin XT System from IBA Lifesciences (Gottingen, Germany). Whole cell lysates were generated by collecting cells...",0.85,Accept,Experimental Usage,StepTactin XT System
PMID:39890807,10.1038/s41598-024-84493-y,Global proteomics and affinity mass spectrometry analysis of human Schwann cells indicates that variation in and loss of neurofibromin (NF1) alters protein expression and cellular and mitochondrial metabolism.,,Mag Strep type3 XT beads (iba Cat. #: 2–4090-002) for Strep-tag purification were washed in 1X Buffer W...,0.9,Accept,Experimental Usage,Mag Strep type3 XT beads (iba Cat. #: 2–4090-002)
PMID:39890807,10.1038/s41598-024-84493-y,Global proteomics and affinity mass spectrometry analysis of human Schwann cells indicates that variation in and loss of neurofibromin (NF1) alters protein expression and cellular and mitochondrial metabolism.,,"Global protein extracts were attained using M-PER™ Mammalian Protein Extraction Reagent (Thermo Fisher Scientific, Cat.# 78501)",0.9,Accept,Experimental Usage,"M-PER™ Mammalian Protein Extraction Reagent (Thermo Fisher Scientific, Cat.# 78501)"
PMID:39890807,10.1038/s41598-024-84493-y,Global proteomics and affinity mass spectrometry analysis of human Schwann cells indicates that variation in and loss of neurofibromin (NF1) alters protein expression and cellular and mitochondrial metabolism.,,"and quantified using Pierce BCA Protein Assay Kit (Thermo Fisher Scientific, Cat.# PI23225)",0.9,Accept,Experimental Usage,"Pierce BCA Protein Assay Kit (Thermo Fisher Scientific, Cat.# PI23225)"
PMID:39890807,10.1038/s41598-024-84493-y,Global proteomics and affinity mass spectrometry analysis of human Schwann cells indicates that variation in and loss of neurofibromin (NF1) alters protein expression and cellular and mitochondrial metabolism.,,"For the global proteomics studies this system ran in-line with a Thermo Q Exactive HFx mass spectrometer, equipped with a Nanospray FlexTM ion source",0.85,Accept,Experimental Usage,Thermo Q Exactive HFx mass spectrometer
PMID:39890807,10.1038/s41598-024-84493-y,Global proteomics and affinity mass spectrometry analysis of human Schwann cells indicates that variation in and loss of neurofibromin (NF1) alters protein expression and cellular and mitochondrial metabolism.,,"for the PPI experiments, the same model of HPLC ran in-line with a Thermo Velos Pro Orbitrap mass spectrometer, equipped with a Nanospray ion source",0.85,Accept,Experimental Usage,Thermo Velos Pro Orbitrap mass spectrometer
PMID:39890807,10.1038/s41598-024-84493-y,Global proteomics and affinity mass spectrometry analysis of human Schwann cells indicates that variation in and loss of neurofibromin (NF1) alters protein expression and cellular and mitochondrial metabolism.,,The cell pellet was then resuspended in MiR05 medium and 750 K cells/ml were added into each chamber of an O2K system (Oroboros Instruments),0.85,Accept,Experimental Usage,O2K system (Oroboros Instruments)
PMID:37520682,10.1016/j.omtn.2023.06.018,Combining nonsense mutation suppression therapy with nonsense-mediated decay inhibition in neurofibromatosis type 1.,,TALENs were designed to flank the region of NF1 in exon 41. Ossabaw minipig fetal fibroblasts isolated from day 38 embryos were transfected with TALENs,0.85,Accept,Experimental Usage,TALENs
PMID:37520682,10.1016/j.omtn.2023.06.018,Combining nonsense mutation suppression therapy with nonsense-mediated decay inhibition in neurofibromatosis type 1.,,"were pulsed for 20 ms at 1,800 V using the Neon Transfection System (Thermo). Resulting cells were plated at low density",0.9,Accept,Experimental Usage,Neon Transfection System (Thermo)
PMID:37520682,10.1016/j.omtn.2023.06.018,Combining nonsense mutation suppression therapy with nonsense-mediated decay inhibition in neurofibromatosis type 1.,,DNA was isolated from harvested tissues using DNeasy blood and tissue kit (Qiagen) according to the manufacturer's protocol.,0.85,Accept,Experimental Usage,DNeasy blood and tissue kit (Qiagen)
PMID:37520682,10.1016/j.omtn.2023.06.018,Combining nonsense mutation suppression therapy with nonsense-mediated decay inhibition in neurofibromatosis type 1.,,Cells were run through a CytoFLEX flow cytometer (Beckman Coulter) using the Cytexpert software according to the manufacturer's protocol.,0.85,Accept,Experimental Usage,CytoFLEX flow cytometer (Beckman Coulter)
PMID:37520682,10.1016/j.omtn.2023.06.018,Combining nonsense mutation suppression therapy with nonsense-mediated decay inhibition in neurofibromatosis type 1.,,Total RNA was extracted from cells and tissues using the RNeasy mini kit (Qiagen) following manufacturer's instructions.,0.85,Accept,Experimental Usage,RNeasy mini kit (Qiagen)
PMID:37520682,10.1016/j.omtn.2023.06.018,Combining nonsense mutation suppression therapy with nonsense-mediated decay inhibition in neurofibromatosis type 1.,,RT-qPCR was performed using the Bio-Rad CFX96 Real-Time System (Bio-Rad) using technical replicates,0.85,Accept,Experimental Usage,Bio-Rad CFX96 Real-Time System
PMID:37520682,10.1016/j.omtn.2023.06.018,Combining nonsense mutation suppression therapy with nonsense-mediated decay inhibition in neurofibromatosis type 1.,,Samples were sequenced on an Illumina NovaSeq 6000 using a 150 paired end flow cell.,0.85,Accept,Experimental Usage,Illumina NovaSeq 6000
PMID:37520682,10.1016/j.omtn.2023.06.018,Combining nonsense mutation suppression therapy with nonsense-mediated decay inhibition in neurofibromatosis type 1.,,The NF1 DLR plasmid was kindly provided by David Bedwell at University of Alabama. The R1497X Renilla-NF1-R1947X-Firefly insert contains 30 nucleotides,0.9,Accept,Experimental Usage,NF1 DLR plasmid
PMID:37520682,10.1016/j.omtn.2023.06.018,Combining nonsense mutation suppression therapy with nonsense-mediated decay inhibition in neurofibromatosis type 1.,,Proliferation was evaluated by the alamarBlue TM cell viability assay (Invitrogen) after indicated days in culture.,0.85,Accept,Experimental Usage,alamarBlue cell viability assay (Invitrogen)
PMID:37520682,10.1016/j.omtn.2023.06.018,Combining nonsense mutation suppression therapy with nonsense-mediated decay inhibition in neurofibromatosis type 1.,,Images were acquired using a Cytation 5 cell imaging reader (BioTek).,0.85,Accept,Experimental Usage,Cytation 5 cell imaging reader (BioTek)
PMID:37520682,10.1016/j.omtn.2023.06.018,Combining nonsense mutation suppression therapy with nonsense-mediated decay inhibition in neurofibromatosis type 1.,,"The DLR assay system (Promega) was used to detect readthrough, according to the manufacturer's instructions.",0.85,Accept,Experimental Usage,DLR assay system (Promega)
PMID:34040258,10.1038/s41586-021-03580-6,NF1 mutation drives neuronal activity-dependent initiation of optic glioma.,,"supplemented with vehicle...NLGN3 (70 nM unless otherwise noted, OriGene TP307955)",0.9,Accept,Experimental Usage,NLGN3 (OriGene TP307955)
PMID:34040258,10.1038/s41586-021-03580-6,NF1 mutation drives neuronal activity-dependent initiation of optic glioma.,,"NLGN3 (70 nM unless otherwise noted, OriGene TP307955), or BDNF (70 nM, PeproTech 450-02)",0.9,Accept,Experimental Usage,BDNF (PeproTech 450-02)
PMID:34040258,10.1038/s41586-021-03580-6,NF1 mutation drives neuronal activity-dependent initiation of optic glioma.,,mice were injected with 100 mg kg−1 GI254023X (Sigma-Aldrich SML0798),0.9,Accept,Experimental Usage,GI254023X (Sigma-Aldrich SML0798)
PMID:34040258,10.1038/s41586-021-03580-6,NF1 mutation drives neuronal activity-dependent initiation of optic glioma.,,mice were gavaged with 120 mg kg−1 entrectinib (MedChem Express HY-12678),0.9,Accept,Experimental Usage,entrectinib (MedChem Express HY-12678)
PMID:34040258,10.1038/s41586-021-03580-6,NF1 mutation drives neuronal activity-dependent initiation of optic glioma.,,3 pl of 1 mM TTX (Tocris 1069) or the same volume of vehicle (PBS),0.9,Accept,Experimental Usage,TTX (Tocris 1069)
PMID:21949590,10.2478/v10134-010-0025-8,ALTERED CALCIUM CURRENTS AND AXONAL GROWTH IN Nf1 HAPLOINSUFFICIENT MICE.,,Glutamate released from wild-type and Nf1 cortical neurons was measured using the Amplex Red glutamic acid/glutsamate oxidase assay kit (Invitrogen),0.9,Accept,Experimental Usage,Amplex Red glutamic acid/glutamate oxidase assay kit
PMID:37164978,10.1038/s41467-023-38432-6,Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities.,,"DNA was extracted from fresh-frozen tumor tissue and normal tissue using the DNeasy Blood and Tissue Kit (Qiagen, USA).",0.85,Accept,Experimental Usage,DNeasy Blood and Tissue Kit
PMID:37164978,10.1038/s41467-023-38432-6,Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities.,,"Total RNA was isolated from tumor using the RNeasy Mini Kit (Qiagen, USA).",0.85,Accept,Experimental Usage,RNeasy Mini Kit
PMID:37164978,10.1038/s41467-023-38432-6,Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities.,,"Methylation profiling was performed on bisulfite-treated DNA using the Illumina Infinium MethylationEPIC BeadChip array (Illumina, San Diego, USA)",0.9,Accept,Experimental Usage,Illumina Infinium MethylationEPIC BeadChip array
PMID:37164978,10.1038/s41467-023-38432-6,Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities.,,Genomic DNA libraries were prepared using Agilent SureSelect Human Exome Library Preparation V5 kit with the Agilent Bravo Automation System,0.9,Accept,Experimental Usage,Agilent SureSelect Human Exome Library Preparation V5 kit
PMID:37164978,10.1038/s41467-023-38432-6,Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities.,,The isolated RNA was processed using the Illumina TruSeq Stranded Total RNA kit with Ribo-Zero Gold Prep kit,0.9,Accept,Experimental Usage,Illumina TruSeq Stranded Total RNA kit
PMID:37164978,10.1038/s41467-023-38432-6,Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities.,,Samples were loaded onto a 10× Chromium controller using the Chromium Single Cell 3' Library & Gel Bead Kit v3 (10× Genomics).,0.9,Accept,Experimental Usage,Chromium Single Cell 3' Library & Gel Bead Kit v3
PMID:37164978,10.1038/s41467-023-38432-6,Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities.,,"read by CellTitre-Glo luminescent cell viability assay in accordance with the manufacturer's instructions (Promega, G7570)",0.85,Accept,Experimental Usage,CellTitre-Glo luminescent cell viability assay
PMID:37164978,10.1038/s41467-023-38432-6,Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities.,,"To generate CRISPR/Cas9-modified ipNF06.2A cell lines, sequences were subcloned into pX330",0.85,Accept,Experimental Usage,pX330
PMID:37164978,10.1038/s41467-023-38432-6,Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities.,,Cells were co-transfected with one pX330 construct and pRNAT-H1.3 (Hygro) control plasmid expressing GFP and hygromycin resistance genes.,0.85,Accept,Experimental Usage,pRNAT-H1.3 (Hygro)
PMID:37164978,10.1038/s41467-023-38432-6,Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities.,,"Cells were treated with sonidegib (NVP-LDE225, Selleck Chemicals) the following day with increasing drug concentrations",0.85,Accept,Experimental Usage,sonidegib (NVP-LDE225)
PMID:25772366,10.1016/j.celrep.2015.02.041,Mouse low-grade gliomas contain cancer stem cells with unique molecular and functional properties.,,Wild-type and Nf1 −/− NSCs were generated from Nf1 flox/flox mouse brains following infection with Ad5-LacZ and Ad5-Cre adenovirus,0.85,Accept,Experimental Usage,Ad5-LacZ
PMID:25772366,10.1016/j.celrep.2015.02.041,Mouse low-grade gliomas contain cancer stem cells with unique molecular and functional properties.,,Wild-type and Nf1 −/− NSCs were generated from Nf1 flox/flox mouse brains following infection with Ad5-LacZ and Ad5-Cre adenovirus,0.85,Accept,Experimental Usage,Ad5-Cre
PMID:25772366,10.1016/j.celrep.2015.02.041,Mouse low-grade gliomas contain cancer stem cells with unique molecular and functional properties.,,"Abcg1 shRNA or control shGFP-containing pLKO.1 plasmid was co-transfected with pMDLg/pRRE, pRSV-REV and pCMV-VSV-G into HEK293T cells",0.85,Accept,Experimental Usage,Abcg1 shRNA
PMID:25772366,10.1016/j.celrep.2015.02.041,Mouse low-grade gliomas contain cancer stem cells with unique molecular and functional properties.,,"Abcg1 shRNA or control shGFP-containing pLKO.1 plasmid was co-transfected with pMDLg/pRRE, pRSV-REV and pCMV-VSV-G",0.85,Accept,Experimental Usage,pLKO.1
PMID:25772366,10.1016/j.celrep.2015.02.041,Mouse low-grade gliomas contain cancer stem cells with unique molecular and functional properties.,,"pLKO.1 plasmid was co-transfected with pMDLg/pRRE, pRSV-REV and pCMV-VSV-G into HEK293T cells using the FuGENEHD transfection reagent",0.8,Accept,Experimental Usage,pMDLg/pRRE
PMID:25772366,10.1016/j.celrep.2015.02.041,Mouse low-grade gliomas contain cancer stem cells with unique molecular and functional properties.,,"pLKO.1 plasmid was co-transfected with pMDLg/pRRE, pRSV-REV and pCMV-VSV-G into HEK293T cells using the FuGENEHD transfection reagent",0.8,Accept,Experimental Usage,pRSV-REV
PMID:25772366,10.1016/j.celrep.2015.02.041,Mouse low-grade gliomas contain cancer stem cells with unique molecular and functional properties.,,"pLKO.1 plasmid was co-transfected with pMDLg/pRRE, pRSV-REV and pCMV-VSV-G into HEK293T cells using the FuGENEHD transfection reagent",0.8,Accept,Experimental Usage,pCMV-VSV-G
PMID:25772366,10.1016/j.celrep.2015.02.041,Mouse low-grade gliomas contain cancer stem cells with unique molecular and functional properties.,,"co-transfected with pMDLg/pRRE, pRSV-REV and pCMV-VSV-G into HEK293T cells using the FuGENEHD transfection reagent (Roche)",0.8,Accept,Experimental Usage,FuGENEHD
PMID:22901811,10.1016/j.cell.2012.06.034,ERK inhibition rescues defects in fate specification of Nf1-deficient neural progenitors and brain abnormalities.,,The control mice used in this study are a pool of phenotypically indistinguishable mice with genotypes of hGFAP-cre-; Nf1 flox/flox,0.85,Accept,Experimental Usage,hGFAP-cre
PMID:22901811,10.1016/j.cell.2012.06.034,ERK inhibition rescues defects in fate specification of Nf1-deficient neural progenitors and brain abnormalities.,,The control mice used in this study are a pool of phenotypically indistinguishable mice with genotypes of hGFAP-cre-; Nf1 flox/flox,0.85,Accept,Experimental Usage,Nf1 flox/flox
PMID:22901811,10.1016/j.cell.2012.06.034,ERK inhibition rescues defects in fate specification of Nf1-deficient neural progenitors and brain abnormalities.,,"For inducible experiments, Nestin-cre ER +; Nf1 flox/+ (tamoxifen+) mice were used as controls while Nestin-cre ER +; Nf1 flox/flox",0.85,Accept,Experimental Usage,Nestin-cre ER
PMID:22901811,10.1016/j.cell.2012.06.034,ERK inhibition rescues defects in fate specification of Nf1-deficient neural progenitors and brain abnormalities.,,Both of inducible strains carry R26 LacZR allele as a reporter,0.8,Accept,Experimental Usage,R26 LacZR
PMID:22901811,10.1016/j.cell.2012.06.034,ERK inhibition rescues defects in fate specification of Nf1-deficient neural progenitors and brain abnormalities.,,"MEK inhibitor (PD0325901, Sigma) was dissolved in DMSO at a concentration of 25mg/ml",0.9,Accept,Experimental Usage,PD0325901
PMID:34464388,10.1371/journal.pmed.1003734,Cell-free DNA ultra-low-pass whole genome sequencing to distinguish malignant peripheral nerve sheath tumor (MPNST) from its benign precursor lesion: A cross-sectional study.,,"...cfDNA was extracted from 2 to 8 mL of plasma using the QIAamp Circulating Nucleic Acid kit (Qiagen, Hilden, Germany)...",0.85,Accept,Experimental Usage,QIAamp Circulating Nucleic Acid kit (Qiagen)
PMID:34464388,10.1371/journal.pmed.1003734,Cell-free DNA ultra-low-pass whole genome sequencing to distinguish malignant peripheral nerve sheath tumor (MPNST) from its benign precursor lesion: A cross-sectional study.,,"...germline DNA extraction using the DNeasy Blood and Tissue kit (Qiagen, Hilden, Germany)...",0.85,Accept,Experimental Usage,DNeasy Blood and Tissue kit (Qiagen)
PMID:34464388,10.1371/journal.pmed.1003734,Cell-free DNA ultra-low-pass whole genome sequencing to distinguish malignant peripheral nerve sheath tumor (MPNST) from its benign precursor lesion: A cross-sectional study.,,"...Sequencing libraries were constructed from cfDNA...using commercial kits per the manufacturers' instructions: TruSeq Nano (Illumina, San Diego, California) for NCI samples...",0.85,Accept,Experimental Usage,TruSeq Nano (Illumina)
PMID:34464388,10.1371/journal.pmed.1003734,Cell-free DNA ultra-low-pass whole genome sequencing to distinguish malignant peripheral nerve sheath tumor (MPNST) from its benign precursor lesion: A cross-sectional study.,,"...and Kapa HyperPrep (Roche, Basel, Switzerland) for WUSTL samples...",0.85,Accept,Experimental Usage,Kapa HyperPrep (Roche)
PMID:38481529,10.3389/fcell.2024.1359561,Generation of heterozygous and homozygous NF1 lines from human-induced pluripotent stem cells using CRISPR/Cas9 to investigate bone defects associated with neurofibromatosis type 1.,,sgRNA1 (5′-TAACTGCGCAACCTTCTTTA-3′) and sgRNA2 (5′-GTTAGCAGTTATAAATAGCC-3′) target the exon 6 of NF1 gene,0.9,Accept,Experimental Usage,sgRNA1 (5′-TAACTGCGCAACCTTCTTTA-3′)
PMID:38481529,10.3389/fcell.2024.1359561,Generation of heterozygous and homozygous NF1 lines from human-induced pluripotent stem cells using CRISPR/Cas9 to investigate bone defects associated with neurofibromatosis type 1.,,sgRNA1 (5′-TAACTGCGCAACCTTCTTTA-3′) and sgRNA2 (5′-GTTAGCAGTTATAAATAGCC-3′) target the exon 6 of NF1 gene,0.9,Accept,Experimental Usage,sgRNA2 (5′-GTTAGCAGTTATAAATAGCC-3′)
PMID:38481529,10.3389/fcell.2024.1359561,Generation of heterozygous and homozygous NF1 lines from human-induced pluripotent stem cells using CRISPR/Cas9 to investigate bone defects associated with neurofibromatosis type 1.,,"100 pmol of Streptococcus pyogenes Cas9 protein (gift from Jean-Paul Concordet, MNHN/CNRS UMR 7196/INSERM U1154)",0.85,Accept,Experimental Usage,Streptococcus pyogenes Cas9 protein
PMID:38481529,10.3389/fcell.2024.1359561,Generation of heterozygous and homozygous NF1 lines from human-induced pluripotent stem cells using CRISPR/Cas9 to investigate bone defects associated with neurofibromatosis type 1.,,using the P3 Primary Cell 4D-Nucleofector X Kit (Lonza) according to the manufacturer's instructions,0.85,Accept,Experimental Usage,P3 Primary Cell 4D-Nucleofector X Kit (Lonza)
PMID:38481529,10.3389/fcell.2024.1359561,Generation of heterozygous and homozygous NF1 lines from human-induced pluripotent stem cells using CRISPR/Cas9 to investigate bone defects associated with neurofibromatosis type 1.,,"PCR products were subcloned using a TOPO™ TA Cloning™ Kit for Sequencing, with One Shot™ TOP10 Chemically Competent E. coli",0.85,Accept,Experimental Usage,TOPO TA Cloning Kit for Sequencing
PMID:40590220,10.1172/JCI188932,A haploinsufficiency restoration strategy corrects neurobehavioral deficits in Nf1+/- mice.,,"GFP-tagged human neurofibromin, transcript variant 1 cDNA (RG220425, Origene)",0.9,Accept,Experimental Usage,GFP-tagged human neurofibromin cDNA RG220425
PMID:40590220,10.1172/JCI188932,A haploinsufficiency restoration strategy corrects neurobehavioral deficits in Nf1+/- mice.,,"Myc-DDK–tagged human FBXW11 transcript variant 3 cDNA (RC218905, Origene)",0.9,Accept,Experimental Usage,Myc-DDK-tagged human FBXW11 cDNA RC218905
PMID:40590220,10.1172/JCI188932,A haploinsufficiency restoration strategy corrects neurobehavioral deficits in Nf1+/- mice.,,"human FBXW11 siRNA (siRNA ID 23487, Ambion)",0.9,Accept,Experimental Usage,human FBXW11 siRNA 23487
PMID:40590220,10.1172/JCI188932,A haploinsufficiency restoration strategy corrects neurobehavioral deficits in Nf1+/- mice.,,"control (GFP; AAV5-CMV-GFP, UNC) or Cre-recombinase fused to GFP (CRE; AAV5-CMV-Cre-GFP, UNC)",0.9,Accept,Experimental Usage,AAV5-CMV-GFP
PMID:40590220,10.1172/JCI188932,A haploinsufficiency restoration strategy corrects neurobehavioral deficits in Nf1+/- mice.,,"control (GFP; AAV5-CMV-GFP, UNC) or Cre-recombinase fused to GFP (CRE; AAV5-CMV-Cre-GFP, UNC)",0.9,Accept,Experimental Usage,AAV5-CMV-Cre-GFP
PMID:21681782,10.1002/ajh.22035,Nf1 mutant mice with p19ARF gene loss develop accelerated hematopoietic disease resembling acute leukemia with a variable phenotype.,,"Recipient C57BL/6J × 129/Sv F1 mice were sublethally irradiated in a Mark 1 Model 30 Cs137 irradiator (J.L. Shepherd & Associates, San Fernando, CA)",0.8,Accept,Experimental Usage,Mark 1 Model 30 Cs137 irradiator
PMID:21681782,10.1002/ajh.22035,Nf1 mutant mice with p19ARF gene loss develop accelerated hematopoietic disease resembling acute leukemia with a variable phenotype.,,"recipient animals were given a series of three 250 μL intraperitoneal injections in five days of polyinosinc-polycytidylic acid (pIpC, Sigma-Aldrich, St. Louis, MO)",0.85,Accept,Experimental Usage,"polyinosinc-polycytidylic acid (pIpC, Sigma-Aldrich)"
PMID:21681782,10.1002/ajh.22035,Nf1 mutant mice with p19ARF gene loss develop accelerated hematopoietic disease resembling acute leukemia with a variable phenotype.,,All flow cytometry was performed on a FACS Calibur (BD).,0.8,Accept,Experimental Usage,FACS Calibur
PMID:21681782,10.1002/ajh.22035,Nf1 mutant mice with p19ARF gene loss develop accelerated hematopoietic disease resembling acute leukemia with a variable phenotype.,,"Peripheral blood was analyzed using a HemaVet Mascot 800 hematology analyzer (CDC Technologies, Oxford, CT).",0.8,Accept,Experimental Usage,HemaVet Mascot 800 hematology analyzer
PMID:23175151,10.1038/bjc.2012.518,MicroRNA profiling of peripheral nerve sheath tumours identifies miR-29c as a tumour suppressor gene involved in tumour progression.,,"Total RNA, including miRNA was extracted using the miRNAeasy kit (Qiagen Ltd, Crawley, West Sussex, UK)",0.9,Accept,Experimental Usage,"miRNAeasy kit (Qiagen Ltd, Crawley, West Sussex, UK)"
PMID:23175151,10.1038/bjc.2012.518,MicroRNA profiling of peripheral nerve sheath tumours identifies miR-29c as a tumour suppressor gene involved in tumour progression.,,Hundred nanogram of total RNA per sample was labelled and hybridised to the Agilent Human miRNA microarray V2 (Agilent Technologies),0.95,Accept,Experimental Usage,Agilent Human miRNA Microarray V2
PMID:23175151,10.1038/bjc.2012.518,MicroRNA profiling of peripheral nerve sheath tumours identifies miR-29c as a tumour suppressor gene involved in tumour progression.,,"MicroRNA expression in each sample, and the cell line, was measured using TaqMan miRNA assays technology (Applied Biosystems Inc., Life Technologies, Foster City, CA, USA)",0.9,Accept,Experimental Usage,"TaqMan miRNA assays (Applied Biosystems Inc., Life Technologies, Foster City, CA, USA)"
PMID:23175151,10.1038/bjc.2012.518,MicroRNA profiling of peripheral nerve sheath tumours identifies miR-29c as a tumour suppressor gene involved in tumour progression.,,Approximately 150–200 ng of the total RNA extracted from each sample was reverse transcribed using Superscript III First-Strand Synthesis kit,0.9,Accept,Experimental Usage,"Superscript III First-Strand Synthesis kit (Invitrogen Ltd/Life Technologies Ltd, Paisley, Scotland, UK)"
PMID:23175151,10.1038/bjc.2012.518,MicroRNA profiling of peripheral nerve sheath tumours identifies miR-29c as a tumour suppressor gene involved in tumour progression.,,"Cell proliferation was assessed using the MTS...assay (CellTiter 96 AQueous Non-Radioactive Cell Proliferation Assay; Promega, Southampton, UK)",0.9,Accept,Experimental Usage,"CellTiter 96 AQueous Non-Radioactive Cell Proliferation Assay (Promega, Southampton, UK)"
PMID:40217315,10.1186/s13073-025-01462-4,A single-cell atlas of Schwannoma across genetic backgrounds and anatomic locations.,,Tumors were mechanically and enzymatically dissociated using a papain-based tumor dissociation kit (Miltenyi Biotec).,0.85,Accept,Experimental Usage,papain-based tumor dissociation kit (Miltenyi Biotec)
PMID:40217315,10.1186/s13073-025-01462-4,A single-cell atlas of Schwannoma across genetic backgrounds and anatomic locations.,,then re-suspended in 1 mL of BSA/HBSS containing 1 mM calcein AM (Life Technologies) and 0.33 mM TO-PRO-3 iodide,0.8,Accept,Experimental Usage,calcein AM (Life Technologies)
PMID:40217315,10.1186/s13073-025-01462-4,A single-cell atlas of Schwannoma across genetic backgrounds and anatomic locations.,,then re-suspended in 1 mL of BSA/HBSS containing 1 mM calcein AM (Life Technologies) and 0.33 mM TO-PRO-3 iodide (Life Technologies),0.8,Accept,Experimental Usage,TO-PRO-3 iodide (Life Technologies)
PMID:40217315,10.1186/s13073-025-01462-4,A single-cell atlas of Schwannoma across genetic backgrounds and anatomic locations.,,"Sorting was performed with the FACS Aria Fusion Special Order System (Becton Dickinson) using 488 nm (calcein AM, 530/30 filter)",0.85,Accept,Experimental Usage,FACS Aria Fusion Special Order System (Becton Dickinson)
PMID:40217315,10.1186/s13073-025-01462-4,A single-cell atlas of Schwannoma across genetic backgrounds and anatomic locations.,,"We sorted individual, viable, immune, and non-immune single cells into 96-well plates containing TCL buffer (QIAGEN) with 1% beta-mercaptoethanol.",0.8,Accept,Experimental Usage,TCL buffer (QIAGEN)
PMID:27999334,10.3390/genes7120133,Hybridization Capture-Based Next-Generation Sequencing to Evaluate Coding Sequence and Deep Intronic Mutations in the NF1 Gene.,,"Extraction of DNA from leukocytes and purification were performed with QIAamp DNA Blood Mini kit (Qiagen, Valencia, CA, USA), according to the manufacturer's instructions.",0.9,Accept,Experimental Usage,QIAamp DNA Blood Mini kit
PMID:27999334,10.3390/genes7120133,Hybridization Capture-Based Next-Generation Sequencing to Evaluate Coding Sequence and Deep Intronic Mutations in the NF1 Gene.,,Capture probe set was designed and synthesized by Thermo Fisher Scientific for the Ion TargetSeq Custom Enrichment kit (Thermo Fisher Scientific) to target all the coding exons,0.9,Accept,Experimental Usage,Ion TargetSeq Custom Enrichment kit
PMID:27999334,10.3390/genes7120133,Hybridization Capture-Based Next-Generation Sequencing to Evaluate Coding Sequence and Deep Intronic Mutations in the NF1 Gene.,,"we size-selected and amplified the library using the IonXpress Plus gDNA Fragment Library kit, Ion Xpress Barcode Adapters and E-Gel Size Select 2% agarose gels",0.9,Accept,Experimental Usage,IonXpress Plus gDNA Fragment Library kit
PMID:29941005,10.1186/s13023-018-0843-1,Increased extracellular matrix deposition during chondrogenic differentiation of dental pulp stem cells from individuals with neurofibromatosis type 1: an in vitro 2D and 3D study.,,"...transported to the culture laboratory in a conical tube containing 5 mL of DMEM-F12 medium (Dulbecco's Modified Eagle Medium Nutrient Mixture F-12; Invitrogen, CA, USA)...",0.85,Accept,Experimental Usage,DMEM-F12 medium
PMID:29941005,10.1186/s13023-018-0843-1,Increased extracellular matrix deposition during chondrogenic differentiation of dental pulp stem cells from individuals with neurofibromatosis type 1: an in vitro 2D and 3D study.,,"...supplemented with 15% ( v /v) fetal bovine serum (FBS) (HyClone™, Utah, USA), 100 U/mL penicillin and 100 μg/mL streptomycin...",0.8,Accept,Experimental Usage,HyClone FBS
PMID:37990867,10.1242/dmm.049861,Neurofibromin 1 mutations impair the function of human induced pluripotent stem cell-derived microglia.,,"cells were tested for mycoplasma using the Promokine Mycoplasma Test Kit I/C (Minerva Biolabs, Berlin, Germany)",0.8,Accept,Experimental Usage,Promokine Mycoplasma Test Kit I/C
PMID:37990867,10.1242/dmm.049861,Neurofibromin 1 mutations impair the function of human induced pluripotent stem cell-derived microglia.,,Cell line identity (short tandem repeat analysis) was performed using the GenePrint 10 System (Promega),0.8,Accept,Experimental Usage,GenePrint 10 System
PMID:37990867,10.1242/dmm.049861,Neurofibromin 1 mutations impair the function of human induced pluripotent stem cell-derived microglia.,,HPCs were generated using the STEMdiff hematopoietic kit (STEMCELL Technologies),0.85,Accept,Experimental Usage,STEMdiff hematopoietic kit
PMID:37990867,10.1242/dmm.049861,Neurofibromin 1 mutations impair the function of human induced pluripotent stem cell-derived microglia.,,"cells were harvested and RNA was isolated with the ReliaPrep RNA tissue kit (Promega, Fitchburg, USA)",0.8,Accept,Experimental Usage,ReliaPrep RNA tissue kit
PMID:37990867,10.1242/dmm.049861,Neurofibromin 1 mutations impair the function of human induced pluripotent stem cell-derived microglia.,,"RNA was reverse transcribed into cDNA using the PrimeScript RT reagent kit (Takara Bio, Kusatsu, Japan)",0.8,Accept,Experimental Usage,PrimeScript RT reagent kit
PMID:37990867,10.1242/dmm.049861,Neurofibromin 1 mutations impair the function of human induced pluripotent stem cell-derived microglia.,,"Cell motility was assessed using the IncuCyte cell migration kit (Sartorius, Göttingen, Germany)",0.85,Accept,Experimental Usage,IncuCyte cell migration kit
PMID:37990867,10.1242/dmm.049861,Neurofibromin 1 mutations impair the function of human induced pluripotent stem cell-derived microglia.,,"cAMP levels in hiMGL cells were determined using the cAMP ELISA kit (Cayman Chemical, Ann Arbor, MI, USA)",0.8,Accept,Experimental Usage,cAMP ELISA kit
PMID:37990867,10.1242/dmm.049861,Neurofibromin 1 mutations impair the function of human induced pluripotent stem cell-derived microglia.,,"The MILLIPLEX MAP human cytokine/chemokine/growth factor panel A – immunology multiplex assay (HCYTA-60K, Merck) was used",0.85,Accept,Experimental Usage,MILLIPLEX MAP human cytokine/chemokine/growth factor panel A
PMID:33436083,10.1186/s13072-020-00380-6,Distinctive epigenomic alterations in NF1-deficient cutaneous and plexiform neurofibromas drive differential MKK/p38 signaling.,,"500 ng of DNA from each sample was bisulfite converted using the Zymo EZ DNA Methylation Kit (Zymo Research, Irvine, CA USA)",0.9,Accept,Experimental Usage,Zymo EZ DNA Methylation Kit
PMID:29847659,10.1167/iovs.17-22588,Neurofibromin Deficiency Induces Endothelial Cell Proliferation and Retinal Neovascularization.,,"Lentiviral vectors expressing NF1 small hairpin (sh) RNA and shCtr were purchased from Sigma (CAT# TRCN000023878, TRCN0000039713, and SHC202)",0.9,Accept,Experimental Usage,NF1 shRNA (TRCN000023878)
PMID:29847659,10.1167/iovs.17-22588,Neurofibromin Deficiency Induces Endothelial Cell Proliferation and Retinal Neovascularization.,,"Lentiviral vectors expressing NF1 small hairpin (sh) RNA and shCtr were purchased from Sigma (CAT# TRCN000023878, TRCN0000039713, and SHC202)",0.9,Accept,Experimental Usage,NF1 shRNA (TRCN0000039713)
PMID:29847659,10.1167/iovs.17-22588,Neurofibromin Deficiency Induces Endothelial Cell Proliferation and Retinal Neovascularization.,,"Lentiviral vectors expressing NF1 small hairpin (sh) RNA and shCtr were purchased from Sigma (CAT# TRCN000023878, TRCN0000039713, and SHC202)",0.85,Accept,Experimental Usage,shCtr (SHC202)
PMID:36890585,10.1186/s40478-023-01525-w,Neurofibromatosis type 1-dependent alterations in mouse microglia function are not cell-intrinsic.,,Global proteome analysis was conducted using isobaric TMTpro 16-plex labeling (Thermo Fisher Scientific),0.85,Accept,Experimental Usage,TMTpro 16-plex
PMID:25549701,,Exome sequencing on malignant meningiomas identified mutations in neurofibromatosis type 2 (NF2) and meningioma 1 (MN1) genes.,,We performed exome sequencing on five malignant meningiomas on the Illumina HiSeq2000 platform using Agilent SureSelect Human All Exon kits.,0.85,Accept,Experimental Usage,Agilent SureSelect Human All Exon kits
PMID:25549701,,Exome sequencing on malignant meningiomas identified mutations in neurofibromatosis type 2 (NF2) and meningioma 1 (MN1) genes.,,"We next designed custom NimbleGen targeted region arrays on five candidate genes, and sequenced four additional malignant meningiomas.",0.85,Accept,Experimental Usage,NimbleGen targeted region arrays
PMID:25549701,,Exome sequencing on malignant meningiomas identified mutations in neurofibromatosis type 2 (NF2) and meningioma 1 (MN1) genes.,,"DNA samples were extracted from the tumor FFPE slides from these patients using QIAamp DNA FFPE kit (Qiagen, Valencia, CA, USA)",0.85,Accept,Experimental Usage,QIAamp DNA FFPE kit
PMID:25549701,,Exome sequencing on malignant meningiomas identified mutations in neurofibromatosis type 2 (NF2) and meningioma 1 (MN1) genes.,,2 μg purified genomic DNA was extracted and randomly fragmented using Covaris E210 to generate DNA fragments around 200 to 300 bp,0.85,Accept,Experimental Usage,Covaris E210
PMID:25549701,,Exome sequencing on malignant meningiomas identified mutations in neurofibromatosis type 2 (NF2) and meningioma 1 (MN1) genes.,,"Next, we purified DNA fragments using AMpure XP beads (Beckman, Brea, CA, USA).",0.85,Accept,Experimental Usage,AMpure XP beads
PMID:27458360,10.3389/fnhum.2016.00334,COMT Val(158)Met Polymorphism Is Associated with Verbal Working Memory in Neurofibromatosis Type 1.,,"Genotyping was performed using a real-time PCR system...using the TaqMan Genotyping Master Mix (Applied Biosystems, Foster City, CA, USA)",0.85,Accept,Experimental Usage,TaqMan Genotyping Master Mix
PMID:36730269,10.1371/journal.pone.0277305,Identification of therapeutic sensitivities in a spheroid drug combination screen of Neurofibromatosis Type I associated High Grade Gliomas.,,"Cell lines were transduced with Incucyte ® Nuclight Red Lentivirus (Sartorius, Gottingen, Germany) such that they will produce an EF1α promoter driven nuclear restricted red fluorescent label",0.9,Accept,Experimental Usage,Incucyte Nuclight Red Lentivirus
PMID:20195187,10.1097/MAO.0b013e3181d2777f,Merlin knockdown in human Schwann cells: clues to vestibular schwannoma tumorigenesis.,,"Small interfering RNA (siRNA) molecules (neurofibromin 2 ON-TARGETplus SMARTpool; Dharmacon, Lafayette, CO) were diluted in Opti-MEM",0.95,Accept,Experimental Usage,"neurofibromin 2 ON-TARGETplus SMARTpool; Dharmacon, Lafayette, CO"
PMID:20195187,10.1097/MAO.0b013e3181d2777f,Merlin knockdown in human Schwann cells: clues to vestibular schwannoma tumorigenesis.,,incubated with Lipofectamine-2000 ™ transfection reagent (Invitrogen) at room temperature for 20 minutes before being dropped onto cells,0.85,Accept,Experimental Usage,Lipofectamine-2000 ™ transfection reagent (Invitrogen)
PMID:20195187,10.1097/MAO.0b013e3181d2777f,Merlin knockdown in human Schwann cells: clues to vestibular schwannoma tumorigenesis.,,"total RNA was harvested with the RNeasy Mini Kit according to manufacturer's instructions (Qiagen Sciences, Germantown, MD)",0.85,Accept,Experimental Usage,"RNeasy Mini Kit (Qiagen Sciences, Germantown, MD)"
PMID:20195187,10.1097/MAO.0b013e3181d2777f,Merlin knockdown in human Schwann cells: clues to vestibular schwannoma tumorigenesis.,,2 μg of RNA was converted to the more stable complimentary deoxyribonucleic acid (cDNA) strands with TaqMan reverse transcription reagents,0.85,Accept,Experimental Usage,"TaqMan reverse transcription reagents (Applied Biosystems, Foster city, CA)"
PMID:20195187,10.1097/MAO.0b013e3181d2777f,Merlin knockdown in human Schwann cells: clues to vestibular schwannoma tumorigenesis.,,Cells were then treated with Zymed ® BrdU Staining Kit (Invitrogen),0.85,Accept,Experimental Usage,Zymed ® BrdU Staining Kit (Invitrogen)
PMID:20195187,10.1097/MAO.0b013e3181d2777f,Merlin knockdown in human Schwann cells: clues to vestibular schwannoma tumorigenesis.,,"The Annexin V-FITC Apoptosis Detection kit (Calbiochem, San Diego, Cat # PF032) was used following the manufacturer's instructions",0.9,Accept,Experimental Usage,"Annexin V-FITC Apoptosis Detection kit (Calbiochem, San Diego, Cat # PF032)"
PMID:18413802,10.1158/1535-7163.MCT-07-0518,Sorafenib inhibits growth and mitogen-activated protein kinase signaling in malignant peripheral nerve sheath cells.,,Viability was assessed using the Cell Counting Kit 8 (CCK8) from Dojindo Molecular Technologies,0.9,Accept,Experimental Usage,Cell Counting Kit 8 (CCK8)
PMID:18413802,10.1158/1535-7163.MCT-07-0518,Sorafenib inhibits growth and mitogen-activated protein kinase signaling in malignant peripheral nerve sheath cells.,,"To determine the activity of Ras the EZ-Detect Ras Activation Kit (cat. 89855 from Pierce, Rockford, IL) was used",0.9,Accept,Experimental Usage,EZ-Detect Ras Activation Kit
PMID:18413802,10.1158/1535-7163.MCT-07-0518,Sorafenib inhibits growth and mitogen-activated protein kinase signaling in malignant peripheral nerve sheath cells.,,"siRNA for either B-Raf: AAAGAATTGGATCTGGATCAT, and C-Raf: TGTGCGAAATGGAATGAGCTT, both from Dharmacon",0.9,Accept,Experimental Usage,B-Raf siRNA
PMID:18413802,10.1158/1535-7163.MCT-07-0518,Sorafenib inhibits growth and mitogen-activated protein kinase signaling in malignant peripheral nerve sheath cells.,,"siRNA for either B-Raf: AAAGAATTGGATCTGGATCAT, and C-Raf: TGTGCGAAATGGAATGAGCTT, both from Dharmacon",0.9,Accept,Experimental Usage,C-Raf siRNA
PMID:18413802,10.1158/1535-7163.MCT-07-0518,Sorafenib inhibits growth and mitogen-activated protein kinase signaling in malignant peripheral nerve sheath cells.,,Cells were then transiently transfected using Lipofectamine RNAiMAX (Invitrogen) mixed with siRNA,0.85,Accept,Experimental Usage,Lipofectamine RNAiMAX
PMID:30274821,10.1016/j.ebiom.2018.09.042,Synergistic effect of Nutlin-3 combined with MG-132 on schwannoma cells through restoration of merlin and p53 tumour suppressors.,,"DNA extraction was performed using the TIANamp Genomic DNA Kit (Tiangen Biotech, Beijing, China).",0.8,Accept,Experimental Usage,TIANamp Genomic DNA Kit
PMID:30274821,10.1016/j.ebiom.2018.09.042,Synergistic effect of Nutlin-3 combined with MG-132 on schwannoma cells through restoration of merlin and p53 tumour suppressors.,,"To identify exonic deletions, we used a Multiplex Ligation-Dependent Probe Amplification Analysis (MLPA) kit (SALSA P044 NF2; MRC-Holland)",0.85,Accept,Experimental Usage,SALSA P044 NF2
PMID:30274821,10.1016/j.ebiom.2018.09.042,Synergistic effect of Nutlin-3 combined with MG-132 on schwannoma cells through restoration of merlin and p53 tumour suppressors.,,"The plasmids HA-tagged NF2 (a gift from Dr. Y. J. LU, Tongji University, China), Flag-tagged P53 (Addgene; #10838)",0.85,Accept,Experimental Usage,HA-tagged NF2 plasmid
PMID:30274821,10.1016/j.ebiom.2018.09.042,Synergistic effect of Nutlin-3 combined with MG-132 on schwannoma cells through restoration of merlin and p53 tumour suppressors.,,Flag-tagged P53 (Addgene; #10838) and a plasmid vector control (ViGene Biosciences) were transfected into cells,0.85,Accept,Experimental Usage,Flag-tagged P53 plasmid
PMID:30274821,10.1016/j.ebiom.2018.09.042,Synergistic effect of Nutlin-3 combined with MG-132 on schwannoma cells through restoration of merlin and p53 tumour suppressors.,,"The nuclear/ cytoplasmic fractions were isolated using the NE-PER Nuclear Cytoplasmic Extraction Reagent kit (#78835, Thermo Scientific).",0.8,Accept,Experimental Usage,NE-PER Nuclear Cytoplasmic Extraction Reagent kit
PMID:30274821,10.1016/j.ebiom.2018.09.042,Synergistic effect of Nutlin-3 combined with MG-132 on schwannoma cells through restoration of merlin and p53 tumour suppressors.,,"Cell viability was determined by Cell Counting Kit-8 (CCK-8) from Dojindo (Kumamoto, Japan).",0.8,Accept,Experimental Usage,Cell Counting Kit-8 (CCK-8)
PMID:20554030,10.1016/j.jneuroim.2010.05.002,CXCL12 alone is insufficient for gliomagenesis in Nf1 mutant mice.,,A second packaging vector (FUW-FLG) encoding a fusion of firefly luciferase and enhanced green fluorescent protein,0.85,Accept,Experimental Usage,FUW-FLG lentiviral vector
PMID:20554030,10.1016/j.jneuroim.2010.05.002,CXCL12 alone is insufficient for gliomagenesis in Nf1 mutant mice.,,Murine CXCL12 cDNA was subcloned into the lentiviral vector,0.85,Accept,Experimental Usage,CXCL12 lentiviral vector
PMID:20554030,10.1016/j.jneuroim.2010.05.002,CXCL12 alone is insufficient for gliomagenesis in Nf1 mutant mice.,,"treatment of Nf1 OPG mice with AMD3100, a CXCR4 antagonist",0.9,Accept,Experimental Usage,AMD3100
PMID:20554030,10.1016/j.jneuroim.2010.05.002,CXCL12 alone is insufficient for gliomagenesis in Nf1 mutant mice.,,"Apoptosis was examined by terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling assay (TUNEL assay, Roche Diagnostics)",0.85,Accept,Experimental Usage,TUNEL assay
PMID:37446790,10.3390/molecules28135128,Icariin Promotes Osteogenic Differentiation in a Cell Model with NF1 Gene Knockout by Activating the cAMP/PKA/CREB Pathway.,,"CRISPR/Cas9 single-vector lentivirus was purchased from GeneChem (Shanghai, China)...An appropriate volume of CRISPR/Cas9 single-vector lentivirus solution",0.85,Accept,Experimental Usage,CRISPR/Cas9 single-vector lentivirus
PMID:37446790,10.3390/molecules28135128,Icariin Promotes Osteogenic Differentiation in a Cell Model with NF1 Gene Knockout by Activating the cAMP/PKA/CREB Pathway.,,H89 was purchased from Sigma-Aldrich...The PKA selective inhibitor H89 significantly impaired the stimulatory effect,0.8,Accept,Experimental Usage,H89
PMID:37446790,10.3390/molecules28135128,Icariin Promotes Osteogenic Differentiation in a Cell Model with NF1 Gene Knockout by Activating the cAMP/PKA/CREB Pathway.,,"genomic DNA was extracted using the QIAamp DNA Mini kit (QIAGEN, Germantown, MD, USA) according to the manufacturer's instructions",0.8,Accept,Experimental Usage,QIAamp DNA Mini kit
PMID:40862755,10.3390/cells14161276,Fibroblasts Attenuate Anti-Tumor Drug Efficacy in Tumor Cells via Paracrine Interactions with Tumor Cells in 3D Plexiform Neurofibroma Cultures.,,Reconstituted basement membrane (rBM; Cultrex TM  with reduced growth factor) and high-concentration collagen I (rat tail) were purchased from Bio-Techne,0.8,Accept,Experimental Usage,Cultrex TM with reduced growth factor
PMID:28831766,10.1007/s12104-017-9768-1,NMR resonance assignments of the EVH1 domain of neurofibromin's recruitment factor Spred1.,,Construction of pET-Spred1(EVH1) encoding the EVH1 domain of human Spred1 (Ser13–Ser130) preceded by a non-native translation initiating methionine...,0.85,Accept,Experimental Usage,pET-Spred1(EVH1)
PMID:28831766,10.1007/s12104-017-9768-1,NMR resonance assignments of the EVH1 domain of neurofibromin's recruitment factor Spred1.,,"The lysate was cleared by centrifugation and loaded onto a cation exchange column (HiTrap SP FF 5 mL, GE Healthcare).",0.8,Accept,Experimental Usage,HiTrap SP FF 5 mL
PMID:28831766,10.1007/s12104-017-9768-1,NMR resonance assignments of the EVH1 domain of neurofibromin's recruitment factor Spred1.,,"loaded onto a size exclusion column (HiLoad 16/60 Superdex 75 prep grade, GE Healthcare) equilibrated in a buffer...",0.8,Accept,Experimental Usage,HiLoad 16/60 Superdex 75 prep grade
PMID:24681606,10.18632/oncotarget.1609,Co-targeting the MAPK and PI3K/AKT/mTOR pathways in two genetically engineered mouse models of schwann cell tumors reduces tumor grade and multiplicity.,,Everolimus (RAD001) inhibits the mTOR and is currently FDA approved for several types of solid tumors... Everolimus and PD-901 were solubilized in DMSO,0.9,Accept,Experimental Usage,Everolimus
PMID:24681606,10.18632/oncotarget.1609,Co-targeting the MAPK and PI3K/AKT/mTOR pathways in two genetically engineered mouse models of schwann cell tumors reduces tumor grade and multiplicity.,,"PD-0325901 (PD-901) inhibits MEK, a component of the MAPK pathway, and is currently in clinical trials... Everolimus and PD-901 were solubilized in DMSO",0.9,Accept,Experimental Usage,PD-0325901
PMID:32107864,10.1002/mgg3.1180,Expanding the Noonan spectrum/RASopathy NGS panel: Benefits of adding NF1 and SPRED1.,,DNA was extracted from peripheral blood samples using PureGene Blood Core Kit B (Qiagen).,0.85,Accept,Experimental Usage,PureGene Blood Core Kit B (Qiagen)
PMID:32107864,10.1002/mgg3.1180,Expanding the Noonan spectrum/RASopathy NGS panel: Benefits of adding NF1 and SPRED1.,,NGS was performed by oligonucleotide hybridization‐based DNA capture (SureSelect; Agilent),0.8,Accept,Experimental Usage,SureSelect (Agilent)
PMID:32107864,10.1002/mgg3.1180,Expanding the Noonan spectrum/RASopathy NGS panel: Benefits of adding NF1 and SPRED1.,,followed by sequencing using the MiSeq‐M01450 instrument (150‐base paired end mode; Illumina),0.85,Accept,Experimental Usage,MiSeq‐M01450 instrument (Illumina)
PMID:32107864,10.1002/mgg3.1180,Expanding the Noonan spectrum/RASopathy NGS panel: Benefits of adding NF1 and SPRED1.,,"Confirmation of CNVs was done using ddPCR as previously described (Ceyhan‐Birsoy et al., 2015)",0.8,Accept,Experimental Usage,ddPCR
PMID:34257279,10.1038/s41467-021-24505-x,Neurofibromin regulates metabolic rate via neuronal mechanisms in Drosophila.,,UAS-Nf1-eGFP transgenes were generated using an Nf1 mini-gene (full-length Nf1 cDNA corresponding to the RF isoform with addition of introns 9 and 10).,0.9,Accept,Development,UAS-Nf1-eGFP
PMID:34257279,10.1038/s41467-021-24505-x,Neurofibromin regulates metabolic rate via neuronal mechanisms in Drosophila.,,The Nf1 RNAi line was obtained from the Vienna Drosophila RNAi Center (VDRC #109637),0.9,Accept,Experimental Usage,VDRC #109637
PMID:34257279,10.1038/s41467-021-24505-x,Neurofibromin regulates metabolic rate via neuronal mechanisms in Drosophila.,,Gal4/+ control crosses consisted of an empty attP control line (VDRC #60100).,0.85,Accept,Experimental Usage,VDRC #60100
PMID:34257279,10.1038/s41467-021-24505-x,Neurofibromin regulates metabolic rate via neuronal mechanisms in Drosophila.,,ERK was activated via expression of ERK with the gain-of-function mutation ERK 56 Sem (UAS-rl Sem).,0.85,Accept,Experimental Usage,UAS-rl Sem
PMID:34257279,10.1038/s41467-021-24505-x,Neurofibromin regulates metabolic rate via neuronal mechanisms in Drosophila.,,The following lines were obtained from the Bloomington Drosophila Stock Center (BDSC): nSyb (BDSC #51635),0.9,Accept,Experimental Usage,BDSC #51635
PMID:34257279,10.1038/s41467-021-24505-x,Neurofibromin regulates metabolic rate via neuronal mechanisms in Drosophila.,,"R57C10 (39171), 69B (1774), tsh-Gal4 (3040), and Oct-TyrR-Gal4 (36494)",0.9,Accept,Experimental Usage,BDSC #39171
PMID:34257279,10.1038/s41467-021-24505-x,Neurofibromin regulates metabolic rate via neuronal mechanisms in Drosophila.,,PCB-Gal4 (fatbody-Gal4) was previously generated by Ronald Kühnlein,0.85,Accept,Experimental Usage,PCB-Gal4
PMID:23685747,10.1038/ng.2641,Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis.,,"...a conditionally expressed SB transposase enzyme (R26-lsl-SB11), a Schwann cell specific Cre-recombinase controlled by the CNP promoter...",0.9,Accept,Experimental Usage,R26-lsl-SB11
PMID:23685747,10.1038/ng.2641,Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis.,,"...a Schwann cell specific Cre-recombinase controlled by the CNP promoter (Cnp-Cre), and a concatomer of oncogenic transposons...",0.9,Accept,Experimental Usage,Cnp-Cre
PMID:23685747,10.1038/ng.2641,Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis.,,...and a concatemer of oncogenic transposons (T2/Onc15). Triple transgenic mice (Cnp-Cre; R26-lsl-SB11; T2/Onc15) undergo insertional mutagenesis...,0.9,Accept,Experimental Usage,T2/Onc15
PMID:23685747,10.1038/ng.2641,Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis.,,"...MPNST predisposing alleles, Cnp-EGFR and conditional Trp53 alleles, were also included...",0.85,Accept,Experimental Usage,Cnp-EGFR
PMID:23685747,10.1038/ng.2641,Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis.,,...shRNA GIPZ lentiviral constructs were purchased from Openbiosystems. Proliferation assays were setup...,0.85,Accept,Experimental Usage,GIPZ lentiviral constructs
PMID:23685747,10.1038/ng.2641,Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis.,,...FOXR2 cDNA (Open Biosystems) was cloned into the Gateway Vector System (Invitrogen) and subcloned into a piggyBac (PB) transposon vector...,0.85,Accept,Experimental Usage,piggyBac transposon vector
PMID:23685747,10.1038/ng.2641,Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis.,,...Cells were transfected with 2ug of FOXR2 or Luciferase PB transposon and 500ng of PB7 transposase plasmid using the NEON transfection system...,0.85,Accept,Experimental Usage,PB7 transposase plasmid
PMID:40025578,10.1186/s40478-025-01965-6,Development of CAR-T cell therapy for NF1/SWN-related nerve sheath tumor treatment.,,"blood DNA of patients listed in Table 2 was extracted using the TIANamp Genomic DNA Kit (DP348, TIANYuan, Beijing, China)",0.9,Accept,Experimental Usage,TIANamp Genomic DNA Kit (DP348)
PMID:40025578,10.1186/s40478-025-01965-6,Development of CAR-T cell therapy for NF1/SWN-related nerve sheath tumor treatment.,,DNA libraries were constructed using the KAPA Library Preparation Kit (Kapa Biosystems Inc.),0.9,Accept,Experimental Usage,KAPA Library Preparation Kit
PMID:40025578,10.1186/s40478-025-01965-6,Development of CAR-T cell therapy for NF1/SWN-related nerve sheath tumor treatment.,,"The tailored Agilent SureSelectXT panel (962 genes including NF1, NF2, SMARCB1 and LZTR1) was employed for DNA capture",0.9,Accept,Experimental Usage,Agilent SureSelectXT panel
PMID:40025578,10.1186/s40478-025-01965-6,Development of CAR-T cell therapy for NF1/SWN-related nerve sheath tumor treatment.,,"P3 Primary Cell 4D-Nucleofector X Kit (V4XP-3032, Lonza), and program EO-115 were used for CAR-T cell electroporation",0.9,Accept,Experimental Usage,P3 Primary Cell 4D-Nucleofector X Kit (V4XP-3032)
PMID:40025578,10.1186/s40478-025-01965-6,Development of CAR-T cell therapy for NF1/SWN-related nerve sheath tumor treatment.,,"After co-culture for indicated time, 10 μl Steady-Glo luciferase substrate (Promega) was added, and 5 min later, luminescence was recorded",0.9,Accept,Experimental Usage,Steady-Glo luciferase substrate (Promega)
PMID:40025578,10.1186/s40478-025-01965-6,Development of CAR-T cell therapy for NF1/SWN-related nerve sheath tumor treatment.,,"After 48–72 h incubation at 37 °C in 5% CO2, Caspase-3 substrate (Biotium, 30029) was added to the wells according to the manufacturers' instruction",0.9,Accept,Experimental Usage,"Caspase-3 substrate (Biotium, 30029)"
PMID:34011935,10.1038/s41419-021-03802-9,Metalloproteinase 1 downregulation in neurofibromatosis 1: Therapeutic potential of antimalarial hydroxychloroquine and chloroquine.,,"Dermal fibroblast cells were cultured with Minimum Essential Eagle's Medium (Sigma-Aldrich, St. Louis, MI, USA)",0.85,Accept,Experimental Usage,Minimum Essential Eagle's Medium
PMID:34011935,10.1038/s41419-021-03802-9,Metalloproteinase 1 downregulation in neurofibromatosis 1: Therapeutic potential of antimalarial hydroxychloroquine and chloroquine.,,"supplied with nonessential amino acid solution (Thermo Fisher Scientific, Waltham, MA, USA)",0.8,Accept,Experimental Usage,nonessential amino acid solution
PMID:34011935,10.1038/s41419-021-03802-9,Metalloproteinase 1 downregulation in neurofibromatosis 1: Therapeutic potential of antimalarial hydroxychloroquine and chloroquine.,,"15% fetal bovine serum (Nichirei Biosciences Inc., Tokyo, Japan)",0.8,Accept,Experimental Usage,fetal bovine serum
PMID:34011935,10.1038/s41419-021-03802-9,Metalloproteinase 1 downregulation in neurofibromatosis 1: Therapeutic potential of antimalarial hydroxychloroquine and chloroquine.,,"CQ and HCQ were purchased from Fujifilm (Osaka, Japan) and Tokyo Chemical Industry, Co., Ltd.",0.9,Accept,Experimental Usage,chloroquine
PMID:34011935,10.1038/s41419-021-03802-9,Metalloproteinase 1 downregulation in neurofibromatosis 1: Therapeutic potential of antimalarial hydroxychloroquine and chloroquine.,,"CQ and HCQ were purchased from Fujifilm (Osaka, Japan) and Tokyo Chemical Industry, Co., Ltd.",0.9,Accept,Experimental Usage,hydroxychloroquine
PMID:34011935,10.1038/s41419-021-03802-9,Metalloproteinase 1 downregulation in neurofibromatosis 1: Therapeutic potential of antimalarial hydroxychloroquine and chloroquine.,,"Bafilomycin A1 (Cayman Chemical, Ann Arbor, MI, USA)",0.85,Accept,Experimental Usage,Bafilomycin A1
PMID:34011935,10.1038/s41419-021-03802-9,Metalloproteinase 1 downregulation in neurofibromatosis 1: Therapeutic potential of antimalarial hydroxychloroquine and chloroquine.,,"U0126 (Cell Signaling Technology, Danvers, MA, USA)",0.85,Accept,Experimental Usage,U0126
PMID:34011935,10.1038/s41419-021-03802-9,Metalloproteinase 1 downregulation in neurofibromatosis 1: Therapeutic potential of antimalarial hydroxychloroquine and chloroquine.,,PD184352 (Sigma-Aldrich),0.85,Accept,Experimental Usage,PD184352
PMID:34011935,10.1038/s41419-021-03802-9,Metalloproteinase 1 downregulation in neurofibromatosis 1: Therapeutic potential of antimalarial hydroxychloroquine and chloroquine.,,"rapamycin (LC Laboratories, Woburn, MA, USA)",0.85,Accept,Experimental Usage,rapamycin
PMID:34011935,10.1038/s41419-021-03802-9,Metalloproteinase 1 downregulation in neurofibromatosis 1: Therapeutic potential of antimalarial hydroxychloroquine and chloroquine.,,Small interfering RNA (siRNA) targeting NF1 (s221793)...were purchased from Thermo Fisher Scientific,0.9,Accept,Experimental Usage,NF1 siRNA (s221793)
PMID:34011935,10.1038/s41419-021-03802-9,Metalloproteinase 1 downregulation in neurofibromatosis 1: Therapeutic potential of antimalarial hydroxychloroquine and chloroquine.,,siRNA targeting...AHR (s1200)...were purchased from Thermo Fisher Scientific,0.9,Accept,Experimental Usage,AHR siRNA (s1200)
PMID:34011935,10.1038/s41419-021-03802-9,Metalloproteinase 1 downregulation in neurofibromatosis 1: Therapeutic potential of antimalarial hydroxychloroquine and chloroquine.,,"DNA was isolated from cultured fibroblast cells...with NucleoSpin Tissue (Qiagen, Hilden, Germany)",0.85,Accept,Experimental Usage,NucleoSpin Tissue
PMID:34011935,10.1038/s41419-021-03802-9,Metalloproteinase 1 downregulation in neurofibromatosis 1: Therapeutic potential of antimalarial hydroxychloroquine and chloroquine.,,"Viable cells were measured using a CCK-8 kit (Dojindo, Tokyo, Japan)",0.85,Accept,Experimental Usage,CCK-8 kit
PMID:41444363,10.1038/s41598-025-32031-9,Focused ultrasound-mediated drug delivery of bevacizumab in treating NF2-related schwannomatosis in an animal model.,,The Postn-Cre transgene was detected by PCR analysis with the following primers: P1 (CAT-TTG- GGC-CAG-CTA-AAC-AT) and P2 (CCC-GGC-AAA-ACA- GGT-AGT-TA),0.9,Accept,Experimental Usage,Postn-Cre transgenic
PMID:41444363,10.1038/s41598-025-32031-9,Focused ultrasound-mediated drug delivery of bevacizumab in treating NF2-related schwannomatosis in an animal model.,,conditional Nf2flox/flox knocking alleles were obtained from the Conway and Clapp labs at Indiana University School of Medicine,0.9,Accept,Experimental Usage,Nf2flox/flox
PMID:41444363,10.1038/s41598-025-32031-9,Focused ultrasound-mediated drug delivery of bevacizumab in treating NF2-related schwannomatosis in an animal model.,,"bevacizumab 5 mg/kg b.w., Avastin® 100 mg/25 ml, Roche, Basel, Switzerland",0.85,Accept,Experimental Usage,Avastin
PMID:41444363,10.1038/s41598-025-32031-9,Focused ultrasound-mediated drug delivery of bevacizumab in treating NF2-related schwannomatosis in an animal model.,,"murine bevacizumab 5 mg/kg b.w. (B20-4.1.1, 100 mg/25 ml, Roche, Basel, Switzerland)",0.85,Accept,Experimental Usage,B20-4.1.1
PMID:41444363,10.1038/s41598-025-32031-9,Focused ultrasound-mediated drug delivery of bevacizumab in treating NF2-related schwannomatosis in an animal model.,,"coupled with IV microbubble administration (0.02 ml/kg, Definity, Lantheus Medical Imaging, USA)",0.8,Accept,Experimental Usage,Definity
PMID:41444363,10.1038/s41598-025-32031-9,Focused ultrasound-mediated drug delivery of bevacizumab in treating NF2-related schwannomatosis in an animal model.,,"IV gadolinium contrast injection (0.1 ml/kg, Gadovist, Bayer Inc.)",0.8,Accept,Experimental Usage,Gadovist
PMID:41036607,10.1158/1535-7163.MCT-24-1053,Pharmacogenomic Synthetic Lethal Screens Reveal Hidden Vulnerabilities and New Therapeutic Approaches for Treatment of NF1-Associated Tumors.,,Mycoplasma detection was routinely performed using the MycoAlert detection kit (Lonza Bioscience),0.8,Accept,Experimental Usage,MycoAlert detection kit (Lonza Bioscience)
PMID:41036607,10.1158/1535-7163.MCT-24-1053,Pharmacogenomic Synthetic Lethal Screens Reveal Hidden Vulnerabilities and New Therapeutic Approaches for Treatment of NF1-Associated Tumors.,,All vectors were introduced via electroporation and performed using the NEON electroporation system (Invitrogen),0.8,Accept,Experimental Usage,NEON electroporation system (Invitrogen)
PMID:41036607,10.1158/1535-7163.MCT-24-1053,Pharmacogenomic Synthetic Lethal Screens Reveal Hidden Vulnerabilities and New Therapeutic Approaches for Treatment of NF1-Associated Tumors.,,RAS–GTP levels were determined in S462-TY in response to drug treatment using the Active Motif RAS GTPase Chemi ELISA Kit (52097),0.85,Accept,Experimental Usage,Active Motif RAS GTPase Chemi ELISA Kit (52097)
PMID:41036607,10.1158/1535-7163.MCT-24-1053,Pharmacogenomic Synthetic Lethal Screens Reveal Hidden Vulnerabilities and New Therapeutic Approaches for Treatment of NF1-Associated Tumors.,,cells were collected and stained for flow cytometry using a propidium iodide kit (Abcam ab139418),0.8,Accept,Experimental Usage,propidium iodide kit (Abcam ab139418)
PMID:41036607,10.1158/1535-7163.MCT-24-1053,Pharmacogenomic Synthetic Lethal Screens Reveal Hidden Vulnerabilities and New Therapeutic Approaches for Treatment of NF1-Associated Tumors.,,before being run through a Beckman Coulter CytoFLEX Flow Cytometer (RRID: SCR_019627),0.85,Accept,Experimental Usage,Beckman Coulter CytoFLEX Flow Cytometer (RRID: SCR_019627)
PMID:41036607,10.1158/1535-7163.MCT-24-1053,Pharmacogenomic Synthetic Lethal Screens Reveal Hidden Vulnerabilities and New Therapeutic Approaches for Treatment of NF1-Associated Tumors.,,RNA quality was assayed via the Agilent Bioanalyzer and sequenced on an Illumina NovaSeq 6000 next-generation sequencer (RRID: SCR_016387),0.85,Accept,Experimental Usage,Illumina NovaSeq 6000 (RRID: SCR_016387)
PMID:30055648,10.1186/s13104-018-3630-0,Testing ATRA and MEK inhibitor PD0325901 effectiveness in a nude mouse model for human MPNST xenografts.,,"Staining was visualized using the ultraView™ Universal Alkaline Phosphatase Red Detection Kit (Ventana, A-PAP method)",0.8,Accept,Experimental Usage,ultraView™ Universal Alkaline Phosphatase Red Detection Kit
PMID:18451155,10.1158/0008-5472.CAN-07-6867,Pten haploinsufficiency accelerates formation of high-grade astrocytomas.,,"we crossed Mut3 (8) or Mut4 males with wild-type (wt), loxP-Pten (Pten f hereafter; ref. 27), p53 f (28)",0.9,Accept,Experimental Usage,loxP-Pten (Pten f)
PMID:18451155,10.1158/0008-5472.CAN-07-6867,Pten haploinsufficiency accelerates formation of high-grade astrocytomas.,,"loxP-Pten (Pten f hereafter; ref. 27), p53 f (28), or p53 f ; Pten f females",0.9,Accept,Experimental Usage,p53 f
PMID:32733557,10.1155/2020/5976465,"Gene Expression, Network Analysis, and Drug Discovery of Neurofibromatosis Type 2-Associated Vestibular Schwannomas Based on Bioinformatics Analysis.",,"Reverse transcription was carried out using SYBR premix EX Taq (Takara, Japan)",0.9,Accept,Experimental Usage,"SYBR premix EX Taq (Takara, Japan)"
PMID:32733557,10.1155/2020/5976465,"Gene Expression, Network Analysis, and Drug Discovery of Neurofibromatosis Type 2-Associated Vestibular Schwannomas Based on Bioinformatics Analysis.",,and SYBR Premix Ex Taq II (Takara) was used for qPCR.,0.9,Accept,Experimental Usage,SYBR Premix Ex Taq II (Takara)
PMID:24980480,10.1186/1479-7364-8-10,Novel age-dependent targets in vestibular schwannomas.,,"Sample RNA was processed in triplicate with serial dilutions of Human Universal Reference RNA (Stratagene, La Jolla, CA, USA)",0.8,Accept,Experimental Usage,Human Universal Reference RNA (Stratagene)
PMID:35511749,10.1158/1535-7163.MCT-21-0947,A High-Throughput Screening Platform Identifies Novel Combination Treatments for Malignant Peripheral Nerve Sheath Tumors.,,We screened a collection of compounds from the NCATS Mechanism Interrogation PlatE (MIPE) library in three MPNST cell lines,0.85,Accept,Experimental Usage,NCATS Mechanism Interrogation PlatE (MIPE) library
PMID:28029918,10.1056/NEJMoa1605943,Activity of Selumetinib in Neurofibromatosis Type 1-Related Plexiform Neurofibromas.,,"We conducted a phase 1 trial of selumetinib (AZD6244 or ARRY-142886), an oral selective inhibitor of MAPK kinase (MEK) 1 and 2, in children who had neurofibromatosis type 1",0.95,Accept,Experimental Usage,selumetinib (AZD6244 or ARRY-142886)
PMID:39061138,10.3390/cancers16142498,A Fibroblast-Derived Secretome Stimulates the Growth and Invasiveness of 3D Plexiform Neurofibroma Spheroids.,,"Reduced growth factor reconstituted basement membrane (rBM; Cultrex TM ) and Collagen I (high concentration; rat tail) were purchased from Bio-Techne (Minneapolis, MN, USA)",0.8,Accept,Experimental Usage,Cultrex TM
PMID:39061138,10.3390/cancers16142498,A Fibroblast-Derived Secretome Stimulates the Growth and Invasiveness of 3D Plexiform Neurofibroma Spheroids.,,"CellTracker TM Orange, CellTrace TM Far red, Hoechst33342, LookOut RT-PCR kits for mycoplasma detection, and Thermo Scientific Three-Step Stain (methylene blue and eosin) were purchased from Thermo Fisher Scientific",0.85,Accept,Experimental Usage,CellTracker TM Orange
PMID:39061138,10.3390/cancers16142498,A Fibroblast-Derived Secretome Stimulates the Growth and Invasiveness of 3D Plexiform Neurofibroma Spheroids.,,"pNF1 cells were transduced with RFP or were labeled with CellTracker TM orange, and fibroblasts were labeled with CellTrace TM Far Red prior to seeding to distinguish each cell type in 3D cocultures.",0.85,Accept,Experimental Usage,CellTrace TM Far Red
PMID:39061138,10.3390/cancers16142498,A Fibroblast-Derived Secretome Stimulates the Growth and Invasiveness of 3D Plexiform Neurofibroma Spheroids.,,"CellTracker TM Orange, CellTrace TM Far red, Hoechst33342, LookOut RT-PCR kits for mycoplasma detection, and Thermo Scientific Three-Step Stain were purchased from Thermo Fisher Scientific",0.85,Accept,Experimental Usage,Hoechst33342
PMID:39061138,10.3390/cancers16142498,A Fibroblast-Derived Secretome Stimulates the Growth and Invasiveness of 3D Plexiform Neurofibroma Spheroids.,,"Human Inflammation Arrays were purchased from Abcam (Cambridge, MA, USA).",0.8,Accept,Experimental Usage,Human Inflammation Arrays
PMID:18636037,10.1097/MAO.0b013e31817f7398,The ErbB inhibitors trastuzumab and erlotinib inhibit growth of vestibular schwannoma xenografts in nude mice: a preliminary study.,,"Two mice received trastuzumab (25 mg/kg in 0.25 ml normal saline i.p., Genentech, South San Francisco, CA) three times per week for two weeks",0.85,Accept,Experimental Usage,trastuzumab
PMID:18636037,10.1097/MAO.0b013e31817f7398,The ErbB inhibitors trastuzumab and erlotinib inhibit growth of vestibular schwannoma xenografts in nude mice: a preliminary study.,,"The second group was gavage fed erlotinib (50 mg/kg, Genentech, South San Francisco, CA), five days a week.",0.85,Accept,Experimental Usage,erlotinib
PMID:26219339,10.18632/oncotarget.4858,A high-throughput kinome screen reveals serum/glucocorticoid-regulated kinase 1 as a therapeutic target for NF2-deficient meningiomas.,,"AZD2014 (provided by AstraZeneca; Wilmington, DE)",0.9,Accept,Experimental Usage,AZD2014
PMID:26219339,10.18632/oncotarget.4858,A high-throughput kinome screen reveals serum/glucocorticoid-regulated kinase 1 as a therapeutic target for NF2-deficient meningiomas.,,"FRAX597 (generously given by Dr. Joseph Kissil, The Scripps Research Institute, Jupiter, FL)",0.9,Accept,Experimental Usage,FRAX597
PMID:26219339,10.18632/oncotarget.4858,A high-throughput kinome screen reveals serum/glucocorticoid-regulated kinase 1 as a therapeutic target for NF2-deficient meningiomas.,,"GSK650394 (Tocris; Minneapolis, MN)",0.85,Accept,Experimental Usage,GSK650394
PMID:26219339,10.18632/oncotarget.4858,A high-throughput kinome screen reveals serum/glucocorticoid-regulated kinase 1 as a therapeutic target for NF2-deficient meningiomas.,,"Torin1 (kindly provided by Dr. David Sabatini, Whitehead Institute/MIT, Cambridge, MA)",0.85,Accept,Experimental Usage,Torin1
PMID:26219339,10.18632/oncotarget.4858,A high-throughput kinome screen reveals serum/glucocorticoid-regulated kinase 1 as a therapeutic target for NF2-deficient meningiomas.,,"high titer lentivirus for 6,091 shRNAs, cloned into the pLKO-puromycin system",0.85,Accept,Experimental Usage,pLKO-puromycin system
PMID:26219339,10.18632/oncotarget.4858,A high-throughput kinome screen reveals serum/glucocorticoid-regulated kinase 1 as a therapeutic target for NF2-deficient meningiomas.,,positive control lentiviral human RHEB-shRNA (TRCN0000010424),0.9,Accept,Experimental Usage,TRCN0000010424
PMID:26219339,10.18632/oncotarget.4858,A high-throughput kinome screen reveals serum/glucocorticoid-regulated kinase 1 as a therapeutic target for NF2-deficient meningiomas.,,pLKO-puro-based shRNAs targeting human SGK1 (TRCN0000194957),0.9,Accept,Experimental Usage,TRCN0000194957
PMID:26219339,10.18632/oncotarget.4858,A high-throughput kinome screen reveals serum/glucocorticoid-regulated kinase 1 as a therapeutic target for NF2-deficient meningiomas.,,human PAK1 (TRCN0000197238),0.9,Accept,Experimental Usage,TRCN0000197238
PMID:26219339,10.18632/oncotarget.4858,A high-throughput kinome screen reveals serum/glucocorticoid-regulated kinase 1 as a therapeutic target for NF2-deficient meningiomas.,,pLKO.1-emptyT (nullT) control (TRCN0000208001),0.9,Accept,Experimental Usage,TRCN0000208001
PMID:26219339,10.18632/oncotarget.4858,A high-throughput kinome screen reveals serum/glucocorticoid-regulated kinase 1 as a therapeutic target for NF2-deficient meningiomas.,,transfected using program U-023 with lenti-CRISPR-NF2_sg1 expressing a single guide RNA targeting human NF2 exon 8,0.9,Accept,Experimental Usage,lenti-CRISPR-NF2_sg1
PMID:26219339,10.18632/oncotarget.4858,A high-throughput kinome screen reveals serum/glucocorticoid-regulated kinase 1 as a therapeutic target for NF2-deficient meningiomas.,,"Cell viability was assessed in 384-well plates using CellTiter-Glo Luminescent Cell Viability Assay (Promega; Madison, WI)",0.85,Accept,Experimental Usage,CellTiter-Glo Luminescent Cell Viability Assay
PMID:15255999,10.1186/1476-4598-3-20,"Molecular profiling of malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1, based on large-scale real-time RT-PCR.",,...performed using an ABI Prism 7700 Sequence Detection System (Perkin-Elmer Applied Biosystems) and either the TaqMan PCR Core REAGENTS Kit or the SYBR Green PCR Core Reagents kit...,0.8,Accept,Experimental Usage,TaqMan PCR Core REAGENTS Kit
PMID:15255999,10.1186/1476-4598-3-20,"Molecular profiling of malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1, based on large-scale real-time RT-PCR.",,...performed using an ABI Prism 7700 Sequence Detection System (Perkin-Elmer Applied Biosystems) and either the TaqMan PCR Core REAGENTS Kit or the SYBR Green PCR Core Reagents kit...,0.8,Accept,Experimental Usage,SYBR Green PCR Core Reagents kit
PMID:15255999,10.1186/1476-4598-3-20,"Molecular profiling of malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1, based on large-scale real-time RT-PCR.",,"...20 units of RNasin RNase inhibitor (Promega, Madison, WI), 10 mM DDT, 100 units of Superscript II RNase H-reverse transcriptase (Invitrogen, Cergy Pontoise, France)...",0.85,Accept,Experimental Usage,Superscript II RNase H-reverse transcriptase
PMID:15255999,10.1186/1476-4598-3-20,"Molecular profiling of malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1, based on large-scale real-time RT-PCR.",,"...containing 1X RT buffer (500 μM each dNTP, 3 mM MgCl2, 75 mM KCl, 50 mM Tris-HCl pH 8.3), 20 units of RNasin RNase inhibitor (Promega, Madison, WI)...",0.8,Accept,Experimental Usage,RNasin RNase inhibitor
PMID:28166733,10.1186/s12864-017-3519-7,A machine learning classifier trained on cancer transcriptomes detects NF1 inactivation signal in glioblastoma.,,"RNA extraction with a mirVana miRNA isolation kit, without phenol, following the standard operating protocol (Thermo Scientific)",0.85,Accept,Experimental Usage,mirVana miRNA isolation kit
PMID:28166733,10.1186/s12864-017-3519-7,A machine learning classifier trained on cancer transcriptomes detects NF1 inactivation signal in glioblastoma.,,immediately processed with a DNA/RNA/Protein Purification Plus kit (Norgen Biotek) following the standard operating protocol,0.85,Accept,Experimental Usage,DNA/RNA/Protein Purification Plus kit
PMID:28166733,10.1186/s12864-017-3519-7,A machine learning classifier trained on cancer transcriptomes detects NF1 inactivation signal in glioblastoma.,,protein sample concentration was determined using a Pierce BCA Protein Assay Kit (Thermo Scientific),0.8,Accept,Experimental Usage,Pierce BCA Protein Assay Kit
PMID:25026211,10.1016/j.ccr.2014.05.001,Merlin/NF2 loss-driven tumorigenesis linked to CRL4(DCAF1)-mediated inhibition of the hippo pathway kinases Lats1 and 2 in the nucleus.,,Nuclear and non-nuclear fractions were prepared using NE-PER Nuclear and Cytoplasmic Extraction Reagents following manufacturer's instructions (Thermo Fisher Scientific).,0.85,Accept,Experimental Usage,NE-PER Nuclear and Cytoplasmic Extraction Reagents
PMID:25026211,10.1016/j.ccr.2014.05.001,Merlin/NF2 loss-driven tumorigenesis linked to CRL4(DCAF1)-mediated inhibition of the hippo pathway kinases Lats1 and 2 in the nucleus.,,plated in 0.34% low melting temperature agarose (FMC Bioproducts) in complete medium at 2×10 4 (Meso-33 cells) or 1.2×10 4 (FC-1801 cells) per well in 24-well Ultra Low Cluster Plates (Costar).,0.8,Accept,Experimental Usage,Ultra Low Cluster Plates (Costar)
PMID:21072183,10.1371/journal.pone.0013791,p21-Activated kinases are required for transformation in a cell-based model of neurofibromatosis type 2.,,A GST-PID (Pak1 amino acids 83–149) or Gst-PID L107F cDNA was subcloned as a BglII/XhoI fragment into the retroviral expression vector,0.9,Accept,Experimental Usage,GST-PID (Pak1 amino acids 83–149)
PMID:21072183,10.1371/journal.pone.0013791,p21-Activated kinases are required for transformation in a cell-based model of neurofibromatosis type 2.,,subcloned as a BglII/XhoI fragment into the retroviral expression vector pBMN-I-GFP,0.85,Accept,Experimental Usage,pBMN-I-GFP
PMID:21072183,10.1371/journal.pone.0013791,p21-Activated kinases are required for transformation in a cell-based model of neurofibromatosis type 2.,,Matrigel invasion chamber (BD Biosciences) were rehydrated in serum-free DMEM medium for 2 hr,0.8,Accept,Experimental Usage,Matrigel invasion chamber
PMID:33032988,10.1158/0008-5472.CAN-20-1365,Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.,,Trametinib and RMC-4550 for in vitro study were purchased from SelleckChem,0.85,Accept,Experimental Usage,Trametinib
PMID:33032988,10.1158/0008-5472.CAN-20-1365,Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.,,SHP099 for in vitro study was purchased from MedChemExpress,0.85,Accept,Experimental Usage,SHP099
PMID:33032988,10.1158/0008-5472.CAN-20-1365,Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.,,Trametinib and RMC-4550 for in vitro study were purchased from SelleckChem,0.85,Accept,Experimental Usage,RMC-4550
PMID:33032988,10.1158/0008-5472.CAN-20-1365,Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.,,"SMARTPool ON-TARGETplus Human PTPN11 siRNA (#L-003947–00-0005, Dharmacon) to knockdown (KD) the expression of...SHP2",0.9,Accept,Experimental Usage,ON-TARGETplus PTPN11 siRNA (#L-003947–00-0005)
PMID:28051113,10.1038/srep39348,"A comprehensive custom panel design for routine hereditary cancer testing: preserving control, improving diagnostics and revealing a complex variation landscape.",,"we developed the I2HCP panel, a custom bait library covering 122 hereditary cancer genes...The I2HCP panel was developed using a training set of hereditary colorectal cancer, hereditary breast and ovarian cancer and neurofibromatosis patients",0.85,Accept,Development,I2HCP panel
PMID:28051113,10.1038/srep39348,"A comprehensive custom panel design for routine hereditary cancer testing: preserving control, improving diagnostics and revealing a complex variation landscape.",,"We used Agilent eArray to design our SureSelect bait library V1 (Agilent, California, USA), covering 106 genes for a total of 0.45 Mb",0.8,Accept,Experimental Usage,SureSelect bait library V1
PMID:28051113,10.1038/srep39348,"A comprehensive custom panel design for routine hereditary cancer testing: preserving control, improving diagnostics and revealing a complex variation landscape.",,The bait library V2 included 122 genes responsible for most of the cancer predisposition syndromes and RASopathies...for a total of 0.5 Mb of targeted DNA,0.8,Accept,Experimental Usage,SureSelect bait library V2
PMID:26904939,10.1016/j.celrep.2016.01.074,Insertional Mutagenesis Identifies a STAT3/Arid1b/β-catenin Pathway Driving Neurofibroma Initiation.,,"β-catenin overexpression lentivirus ΔN90 (Addgene, Cambridge MA) or same backbone control",0.9,Accept,Experimental Usage,"β-catenin overexpression lentivirus ΔN90 (Addgene, Cambridge MA)"
PMID:26904939,10.1016/j.celrep.2016.01.074,Insertional Mutagenesis Identifies a STAT3/Arid1b/β-catenin Pathway Driving Neurofibroma Initiation.,,We infected secondary Nf1 neurofibroma spheres or fl/fl;DhhCre Stat3 DRG/neurofibroma spheres with shRNAs,0.8,Accept,Experimental Usage,"shRNAs (Sigma, St Louis, MO, USA)"
PMID:18974932,10.1007/s11060-008-9721-3,A role for the p53 pathway in the pathology of meningiomas with NF2 loss.,,"PCR products were then digested using the endonuclease BstUI in 30 μl volumes according to the manufacturer's specifications (New England Biolabs, Beverly, CA)",0.85,Accept,Experimental Usage,BstUI
PMID:18974932,10.1007/s11060-008-9721-3,A role for the p53 pathway in the pathology of meningiomas with NF2 loss.,,"0.25 U of Taq polymerase (Qiagen, Valencia, CA). Initial denaturation was carried out at 95°C for 5 min",0.8,Accept,Experimental Usage,Qiagen Taq polymerase
PMID:34010628,10.1016/j.stem.2021.04.029,Stem-like cells drive NF1-associated MPNST functional heterogeneity and tumor progression.,,"The incorporated EdU were stained on top of BrdU staining with Click-iT™ EdU Cell Proliferation Kit for Imaging (ThemoFisher, Cat# C10337)",0.9,Accept,Experimental Usage,Click-iT™ EdU Cell Proliferation Kit for Imaging
PMID:34010628,10.1016/j.stem.2021.04.029,Stem-like cells drive NF1-associated MPNST functional heterogeneity and tumor progression.,,"Mast cells were determined by following the manufacturer's instruction of Eosinophil-mast cell co-staining (Abcam, Cat# ab150665)",0.85,Accept,Experimental Usage,Eosinophil-mast cell co-staining
PMID:34010628,10.1016/j.stem.2021.04.029,Stem-like cells drive NF1-associated MPNST functional heterogeneity and tumor progression.,,The primary tumor was dissected and minced into small tissue blocks and then dissociated by gentleMACS Octo Dissociator (Miltenyi Biotec),0.85,Accept,Experimental Usage,gentleMACS Octo Dissociator
PMID:34010628,10.1016/j.stem.2021.04.029,Stem-like cells drive NF1-associated MPNST functional heterogeneity and tumor progression.,,GFP+ and GFP- cells from the same tumor were analyzed and sorted by the S3e sorter (BioRad) after color compensation,0.85,Accept,Experimental Usage,S3e sorter
PMID:34010628,10.1016/j.stem.2021.04.029,Stem-like cells drive NF1-associated MPNST functional heterogeneity and tumor progression.,,Total RNA was extracted from paired GFP+ and GFP- population from each of the five CGD;BC&DRG allografts by Qiagen Rneasy plus mini kit,0.85,Accept,Experimental Usage,Qiagen Rneasy plus mini kit
PMID:34010628,10.1016/j.stem.2021.04.029,Stem-like cells drive NF1-associated MPNST functional heterogeneity and tumor progression.,,"iScript cDNA synthesis kit (BioRad, Cat# 1708891) for cDNA synthesis",0.85,Accept,Experimental Usage,iScript cDNA synthesis kit
PMID:34010628,10.1016/j.stem.2021.04.029,Stem-like cells drive NF1-associated MPNST functional heterogeneity and tumor progression.,,Single cell capture (target capture 6000 cells/lane) was done using a 10X Chromium controller,0.85,Accept,Experimental Usage,10X Chromium controller
PMID:18242513,10.1016/j.ccr.2008.01.003,The loss of Nf1 transiently promotes self-renewal but not tumorigenesis by neural crest stem cells.,,cells were stained for BrdU using a flow-cytometry kit (BD Pharmingen; cat#559619),0.9,Accept,Experimental Usage,BrdU flow-cytometry kit (BD Pharmingen; cat#559619)
PMID:24386979,10.1186/1471-2407-14-6,"Modulation of Ras signaling alters the toxicity of hydroquinone, a benzene metabolite and component of cigarette smoke.",,Lineage-marker-negative (Lin-) cells were purified through a 0.3-in StemSep negative selection column as per the manufacturer's instructions,0.8,Accept,Experimental Usage,StemSep negative selection column
PMID:24386979,10.1186/1471-2407-14-6,"Modulation of Ras signaling alters the toxicity of hydroquinone, a benzene metabolite and component of cigarette smoke.",,"Colony forming unit granulocyte/macrophage (CFU-GM) progenitors were grown in MethoCult® (StemCell Technologies, Cat #03434)",0.85,Accept,Experimental Usage,MethoCult® M3434
PMID:21216928,10.1158/1535-7163.MCT-10-0654,Interpreting mammalian target of rapamycin and cell growth inhibition in a genetically engineered mouse model of Nf1-deficient astrocytes.,,"Rapamycin (LC Laboratories, catalog number R-5000; Supplementary Fig. S1A)",0.9,Accept,Experimental Usage,"Rapamycin (LC Laboratories, catalog number R-5000)"
PMID:21216928,10.1158/1535-7163.MCT-10-0654,Interpreting mammalian target of rapamycin and cell growth inhibition in a genetically engineered mouse model of Nf1-deficient astrocytes.,,"NVP-BEZ235 (LC Laboratories, catalog number 915019-65-7; Supplementary Fig. S1B)",0.9,Accept,Experimental Usage,"NVP-BEZ235 (LC Laboratories, catalog number 915019-65-7)"
PMID:21216928,10.1158/1535-7163.MCT-10-0654,Interpreting mammalian target of rapamycin and cell growth inhibition in a genetically engineered mouse model of Nf1-deficient astrocytes.,,"and LY294002 (Calbiochem, San Diego CA) were purchased from commercial sources",0.85,Accept,Experimental Usage,LY294002 (Calbiochem)
PMID:25917366,10.1038/mp.2015.48,HCN channels are a novel therapeutic target for cognitive dysfunction in Neurofibromatosis type 1.,,"For interneurons recordings, 0.2% biocytin was included in the intracellular pipette solution for later morphological identification",0.8,Accept,Experimental Usage,biocytin
PMID:25917366,10.1038/mp.2015.48,HCN channels are a novel therapeutic target for cognitive dysfunction in Neurofibromatosis type 1.,,"Furthermore, the HCN channel agonist lamotrigine rescued the electrophysiological and cognitive deficits in two independent Nf1 mouse models",0.85,Accept,Experimental Usage,lamotrigine
PMID:32419643,10.1177/1533033820919759,Long Noncoding RNA WT1-AS Inhibit Cell Malignancy via miR-494-3p in Glioma.,,"Transfections were mediated as per the manufacturer's instruction for lipofectamine 3000 (Invitrogen, Carlsbad, CA, USA)",0.8,Accept,Experimental Usage,lipofectamine 3000
PMID:32419643,10.1177/1533033820919759,Long Noncoding RNA WT1-AS Inhibit Cell Malignancy via miR-494-3p in Glioma.,,The human lncRNA WT1-AS were cloned into plasmid cloning DNA (pcDNA) vector,0.8,Accept,Experimental Usage,pcDNA vector
PMID:32419643,10.1177/1533033820919759,Long Noncoding RNA WT1-AS Inhibit Cell Malignancy via miR-494-3p in Glioma.,,Total cellular RNA was extracted from glioma tissues and cultured cells using the commercially procured TRIzol reagent (Invitrogen),0.8,Accept,Experimental Usage,TRIzol reagent
PMID:32419643,10.1177/1533033820919759,Long Noncoding RNA WT1-AS Inhibit Cell Malignancy via miR-494-3p in Glioma.,,RNA was reverse transcribed in to complementary DNA (cDNA) using the commercial Transcriptor First strand cDNA synthesis kit (Roche Diagnostics),0.8,Accept,Experimental Usage,Transcriptor First strand cDNA synthesis kit
PMID:32419643,10.1177/1533033820919759,Long Noncoding RNA WT1-AS Inhibit Cell Malignancy via miR-494-3p in Glioma.,,The quantitative real time polymerase chain reaction (qRT-PCR) was undertaken using the commercial SYBR premix Extaq II kit (Takara Inc),0.8,Accept,Experimental Usage,SYBR premix Extaq II kit
PMID:32419643,10.1177/1533033820919759,Long Noncoding RNA WT1-AS Inhibit Cell Malignancy via miR-494-3p in Glioma.,,"mirVana qRTPCR miRNA detection kit (Ambion, Austin, Texas) were used to detect WT1-AS and miR-494-3p expression",0.8,Accept,Experimental Usage,mirVana qRTPCR miRNA detection kit
PMID:32419643,10.1177/1533033820919759,Long Noncoding RNA WT1-AS Inhibit Cell Malignancy via miR-494-3p in Glioma.,,"Commercial kits were procured from Dojindo Molecular Technologies (CCK-8 kit, Shanghai, China)",0.8,Accept,Experimental Usage,CCK-8 kit
PMID:32419643,10.1177/1533033820919759,Long Noncoding RNA WT1-AS Inhibit Cell Malignancy via miR-494-3p in Glioma.,,"Commercial kits were procured from Dojindo Molecular Technologies (CCK-8 kit, Shanghai, China) and Ribobio (EdU assay kit, Guangzhou, China)",0.8,Accept,Experimental Usage,EdU assay kit
PMID:32419643,10.1177/1533033820919759,Long Noncoding RNA WT1-AS Inhibit Cell Malignancy via miR-494-3p in Glioma.,,"The WT1-AS sequence including the putative binding sites of miR-494-3p was subcloned and then inserted into the pmirGLO vector (Promega, Madison, Wisconsin)",0.8,Accept,Experimental Usage,pmirGLO vector
PMID:25340526,10.1371/journal.pone.0107760,Nilotinib is more potent than imatinib for treating plexiform neurofibroma in vitro and in vivo.,,"Sequencing libraries were prepared using TruSeq Stranded Total RNA Sample Preparation kit (Illumina, San Diego, CA)",0.8,Accept,Experimental Usage,TruSeq Stranded Total RNA Sample Preparation kit
PMID:25340526,10.1371/journal.pone.0107760,Nilotinib is more potent than imatinib for treating plexiform neurofibroma in vitro and in vivo.,,"mRNA was reverse transcribed using SuperScript III First-Strand Synthesis System for RT-PCR (Invitrogen, Carlsabd, CA)",0.8,Accept,Experimental Usage,SuperScript III First-Strand Synthesis System
PMID:25340526,10.1371/journal.pone.0107760,Nilotinib is more potent than imatinib for treating plexiform neurofibroma in vitro and in vivo.,,"Cytotoxic efficacy of the non-adherent spleen cells was assessed...using the CytoTox 96 Non-Radioactive Cytotoxicity assay (Promega, Fitchburg, WI)",0.85,Accept,Experimental Usage,CytoTox 96 Non-Radioactive Cytotoxicity assay
PMID:29787563,10.1371/journal.pone.0190001,Graph complexity analysis identifies an ETV5 tumor-specific network in human and murine low-grade glioma.,,RNA from primary astrocytes was isolated using the RNeasy Mini Kit (Qiagen) according to the manufacturer's protocol.,0.8,Accept,Experimental Usage,RNeasy Mini Kit (Qiagen)
PMID:28398289,10.1038/sdata.2017.45,A high-throughput molecular data resource for cutaneous neurofibromas.,,"Genomic DNA (gDNA) was extracted from both frozen tumour and blood tissues using the DNeasy mini kit (Qiagen, Valencia, CA, USA) according to the manufacturer's protocol.",0.85,Accept,Experimental Usage,DNeasy mini kit
PMID:28398289,10.1038/sdata.2017.45,A high-throughput molecular data resource for cutaneous neurofibromas.,,"Standard whole genome library prep was done using the NEBNext DNA Library Prep Reagent Set for Illumina (New England BioLabs Inc., Ipswich, MA, USA)",0.85,Accept,Experimental Usage,NEBNext DNA Library Prep Reagent Set for Illumina
PMID:28398289,10.1038/sdata.2017.45,A high-throughput molecular data resource for cutaneous neurofibromas.,,"Accurate quantification for sequencing applications was determined using the qPCR-based KAPA Biosystems Library Quantification Kit (Kapa Biosystems, Inc., Woburn, MA, USA).",0.85,Accept,Experimental Usage,KAPA Biosystems Library Quantification Kit
PMID:28398289,10.1038/sdata.2017.45,A high-throughput molecular data resource for cutaneous neurofibromas.,,"SNP array sample prep was done using the HumanOmni2.5–8 (Illumina, Inc., San Diego, CA, USA) as per manufacturer's recommended protocol",0.85,Accept,Experimental Usage,HumanOmni2.5-8
PMID:28398289,10.1038/sdata.2017.45,A high-throughput molecular data resource for cutaneous neurofibromas.,,"Total RNA containing both mRNA as well as microRNA fractions was extracted from the tissues using the miRNeasy mini kit (Qiagen, Valencia, CA, USA)",0.85,Accept,Experimental Usage,miRNeasy mini kit
PMID:28398289,10.1038/sdata.2017.45,A high-throughput molecular data resource for cutaneous neurofibromas.,,Poly-adenylated RNAs were isolated using NEBNext Magnetic Oligo d(T)25 Beads.,0.85,Accept,Experimental Usage,NEBNext Magnetic Oligo d(T)25 Beads
PMID:28398289,10.1038/sdata.2017.45,A high-throughput molecular data resource for cutaneous neurofibromas.,,"The NEBNext mRNA Library Prep Reagent Set for Illumina (New England BioLabs Inc., Ipswich, MA, USA) was then used to prepare individually bar-coded next-generation sequencing expression libraries",0.85,Accept,Experimental Usage,NEBNext mRNA Library Prep Reagent Set for Illumina
PMID:28398289,10.1038/sdata.2017.45,A high-throughput molecular data resource for cutaneous neurofibromas.,,"Paired-end sequencing (25 million, 50-bp, paired-end reads) was performed using a 200 Cycle TruSeq SBS HS v4 Kit on an Illumina HiSeq2500 sequencer",0.85,Accept,Experimental Usage,TruSeq SBS HS v4 Kit
PMID:29670214,10.1038/s41598-018-24310-5,Restoring functional neurofibromin by protein transduction.,,A synthetic gene (GeneArt) encoding the human full-length NF1 (synNF1) was cloned into the pFastBacHta (Life Technology) vector in frame with the upstream His 6 -tag,0.85,Accept,Experimental Usage,pFastBacHta
PMID:29670214,10.1038/s41598-018-24310-5,Restoring functional neurofibromin by protein transduction.,,"SynNF1 was transduced into fibroblasts using the transduction reagent EndoPorter (GeneTools, LLC)",0.9,Accept,Experimental Usage,EndoPorter
PMID:29670214,10.1038/s41598-018-24310-5,Restoring functional neurofibromin by protein transduction.,,"The human NF1 +/+ fibroblasts KF3 were transfected with 4 siRNAs (FlexiTube, Qiagen, Hilden; Supplementary Table 2)",0.85,Accept,Experimental Usage,FlexiTube siRNAs
PMID:29670214,10.1038/s41598-018-24310-5,Restoring functional neurofibromin by protein transduction.,,As a control the Allstar Negative Control siRNA (Qiagen) was used,0.85,Accept,Experimental Usage,Allstar Negative Control siRNA
PMID:29670214,10.1038/s41598-018-24310-5,Restoring functional neurofibromin by protein transduction.,,"transfected with 4 siRNAs (FlexiTube, Qiagen, Hilden; Supplementary Table 2) designed for silencing the NF1 message using the Lipofectamine RNAiMAX transfection reagent",0.85,Accept,Experimental Usage,Lipofectamine RNAiMAX
PMID:29670214,10.1038/s41598-018-24310-5,Restoring functional neurofibromin by protein transduction.,,For RNA isolation the RNeasy Mini kit (Qiagen) was used,0.8,Accept,Experimental Usage,RNeasy Mini kit
PMID:29670214,10.1038/s41598-018-24310-5,Restoring functional neurofibromin by protein transduction.,,1 µg of the RNA was reverse transcribed into cDNA with the Superscript III kit (Qiagen) using random hexamers,0.8,Accept,Experimental Usage,Superscript III kit
PMID:28256556,10.1038/srep43315,An inflammatory gene signature distinguishes neurofibroma Schwann cells and macrophages from cells in the normal peripheral nervous system.,,"...RNAs were isolated using RNeasy mini kit (QIAGEN, Valencia, CA)...",0.85,Accept,Experimental Usage,RNeasy mini kit (QIAGEN)
PMID:28256556,10.1038/srep43315,An inflammatory gene signature distinguishes neurofibroma Schwann cells and macrophages from cells in the normal peripheral nervous system.,,...PEGylated interferon alpha-2b was purchased at the Cincinnati Children's Hospital (National Drug Code 00085132302) pharmacy...,0.9,Accept,Experimental Usage,PEGylated interferon alpha-2b
PMID:28256556,10.1038/srep43315,An inflammatory gene signature distinguishes neurofibroma Schwann cells and macrophages from cells in the normal peripheral nervous system.,,"...Mouse cytokine protein expressions were quantified using mouse cytokine array (panel A, R&D system, Minneapolis, MN)...",0.85,Accept,Experimental Usage,"mouse cytokine array (panel A, R&D system)"
PMID:28256556,10.1038/srep43315,An inflammatory gene signature distinguishes neurofibroma Schwann cells and macrophages from cells in the normal peripheral nervous system.,,"...We used 24-well Transwells (Corning #3421, New York, NY, 5.0 μm pore size) for migration assays...",0.85,Accept,Experimental Usage,24-well Transwells (Corning #3421)
PMID:20049725,10.1002/emmm.200900027,Integrative genomic analyses of neurofibromatosis tumours identify SOX9 as a biomarker and survival gene.,,we infected MPNST cells at 70–90% confluence with lentiviral particles containing shRNAs targeting SOX9 (Open Biosystems; TRC library),0.9,Accept,Experimental Usage,shRNAs targeting SOX9 (Open Biosystems; TRC library)
PMID:20049725,10.1002/emmm.200900027,Integrative genomic analyses of neurofibromatosis tumours identify SOX9 as a biomarker and survival gene.,,lentiviral particles containing shRNAs targeting SOX9 (Open Biosystems; TRC library) or GFP (Addgene),0.85,Accept,Experimental Usage,GFP (Addgene)
PMID:41564118,10.1371/journal.pone.0340183,Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas.,,"The vector pTYcPPT, containing the elongation factor 1 alpha promoter [22], was used to separately clone hTERT (full length human telomerase reverse transcriptase cDNA) and mCdk4",0.85,Accept,Experimental Usage,pTYcPPT
PMID:41564118,10.1371/journal.pone.0340183,Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas.,,established the first semi-immortalized cNF cell lines through transduction with wild-type human telomerase reverse transcriptase (hTERT) and murine cyclin-dependent kinase 4 (mCdk4) genes,0.9,Accept,Experimental Usage,hTERT
PMID:41564118,10.1371/journal.pone.0340183,Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas.,,established the first semi-immortalized cNF cell lines through transduction with wild-type human telomerase reverse transcriptase (hTERT) and murine cyclin-dependent kinase 4 (mCdk4) genes,0.9,Accept,Experimental Usage,mCdk4
PMID:41564118,10.1371/journal.pone.0340183,Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas.,,"Cell authentication using STR genotyping utilized the Promega GenePrint 10 system, comparing DNA from primary cultures to immortalized cell lines",0.85,Accept,Experimental Usage,Promega GenePrint 10 system
PMID:41564118,10.1371/journal.pone.0340183,Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas.,,"Multiplex Ligation-Dependent Probe Amplification (MLPA) analysis of DNA to detect copy number changes (insertions/deletions) at multiple points in the NF1 gene (P082 kit, MRC Holland)",0.85,Accept,Experimental Usage,P082 kit
PMID:41564118,10.1371/journal.pone.0340183,Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas.,,"DNA was extracted with the PureGene system (Qiagen), and RNA extracted using the DirectZol kit (Zymo Research)",0.8,Accept,Experimental Usage,PureGene system
PMID:41564118,10.1371/journal.pone.0340183,Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas.,,"DNA was extracted with the PureGene system (Qiagen), and RNA extracted using the DirectZol kit (Zymo Research)",0.8,Accept,Experimental Usage,DirectZol kit
PMID:41564118,10.1371/journal.pone.0340183,Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas.,,libraries were prepared following the manufacturer's protocol for Ion AmpliSeq Library Kit 2.0. Individual samples were barcoded during library preparation,0.85,Accept,Experimental Usage,Ion AmpliSeq Library Kit 2.0
PMID:41564118,10.1371/journal.pone.0340183,Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas.,,"For whole exome sequencing (WES), exomes were captured by IDT exome reagent xGen Exome Research Panel V1.0 (Integrated DNA Technologies)",0.85,Accept,Experimental Usage,IDT exome reagent xGen Exome Research Panel V1.0
PMID:41564118,10.1371/journal.pone.0340183,Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas.,,libraries were subsequently constructed with a Kapa Hyper amplified kit (Roche) and sequenced using a NovaSeq 6000 S4 (Illumina),0.8,Accept,Experimental Usage,Kapa Hyper amplified kit
PMID:41564118,10.1371/journal.pone.0340183,Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas.,,"For whole genome sequencing (WGS), libraries were constructed with Kapa Hyper PCR-free kits and sequenced using the NovaSeq 6000 S4",0.8,Accept,Experimental Usage,Kapa Hyper PCR-free kits
PMID:32642733,10.1093/noajnl/vdz061,KIF11 and KIF15 mitotic kinesins are potential therapeutic vulnerabilities for malignant peripheral nerve sheath tumors.,,"A siRNA pool targeting KIF15, KIF23, or a non-targeting control (NTC; siGENOME SMARTpool, Dharmacon)",0.9,Accept,Experimental Usage,siGENOME SMARTpool (Dharmacon)
PMID:32642733,10.1093/noajnl/vdz061,KIF11 and KIF15 mitotic kinesins are potential therapeutic vulnerabilities for malignant peripheral nerve sheath tumors.,,we selected the pX330-U6-Chimeric_BB-CBh-HSpCas0 (Addgene) and the pRGS2 surrogate reporter,0.9,Accept,Experimental Usage,pX330-U6-Chimeric_BB-CBh-HSpCas0 (Addgene)
PMID:32642733,10.1093/noajnl/vdz061,KIF11 and KIF15 mitotic kinesins are potential therapeutic vulnerabilities for malignant peripheral nerve sheath tumors.,,pX330-U6-Chimeric_BB-CBh-HSpCas0 (Addgene) and the pRGS2 surrogate reporter (Labomics) vectors,0.9,Accept,Experimental Usage,pRGS2 surrogate reporter (Labomics)
PMID:32642733,10.1093/noajnl/vdz061,KIF11 and KIF15 mitotic kinesins are potential therapeutic vulnerabilities for malignant peripheral nerve sheath tumors.,,incubated in a dose-dependent manner with either ispinesib (Selleckchem) or ARRY-520,0.9,Accept,Experimental Usage,ispinesib (Selleckchem)
PMID:32642733,10.1093/noajnl/vdz061,KIF11 and KIF15 mitotic kinesins are potential therapeutic vulnerabilities for malignant peripheral nerve sheath tumors.,,"with either ispinesib (Selleckchem) or ARRY-520 (MedChemExpress), which selectively inhibit KIF11",0.9,Accept,Experimental Usage,ARRY-520 (MedChemExpress)
PMID:32642733,10.1093/noajnl/vdz061,KIF11 and KIF15 mitotic kinesins are potential therapeutic vulnerabilities for malignant peripheral nerve sheath tumors.,,Co-targeting KIF11 and BRD4 with ARRY-520 and JQ1 reduced MPNST cell viability,0.85,Accept,Experimental Usage,JQ1
PMID:39881370,10.1186/s13065-024-01353-6,"Spectrophotometric and computational characterization of charge transfer complex of selumetinib with 2,3-dichloro-5,6-dicyano-1,4-benzoquinone and its utilization in developing an innovative green and high throughput microwell assay for analysis of bulk form and pharmaceutical formulation.",,"Koselugo ® capsules (AstraZeneca, Cambridge, UK) with 25 mg of SEL labelled capsules were obtained from the local Saudi market.",0.85,Accept,Experimental Usage,Koselugo capsules
PMID:24882693,10.1016/j.jmb.2014.05.011,Molecular conformation of the full-length tumor suppressor NF2/Merlin--a small-angle neutron scattering study.,,"The human cDNA encoding the full-length Merlin isoform 1 was subcloned into the pET32a vector (EMD Biosciences, Inc)",0.85,Accept,Experimental Usage,pET32a vector
PMID:24882693,10.1016/j.jmb.2014.05.011,Molecular conformation of the full-length tumor suppressor NF2/Merlin--a small-angle neutron scattering study.,,The Merlin(S518D) and Merlin(S518E) mutants were generated with the QuikChange II site-directed mutagenesis kit (Agilent Technologies),0.9,Accept,Experimental Usage,QuikChange II site-directed mutagenesis kit
PMID:24882693,10.1016/j.jmb.2014.05.011,Molecular conformation of the full-length tumor suppressor NF2/Merlin--a small-angle neutron scattering study.,,The supernatant ran through a 5 ml HiTrap Chelating Sepharose™ High Performance (GE healthcare),0.8,Accept,Experimental Usage,HiTrap Chelating Sepharose™ High Performance
PMID:24882693,10.1016/j.jmb.2014.05.011,Molecular conformation of the full-length tumor suppressor NF2/Merlin--a small-angle neutron scattering study.,,Further purification followed by gel filtration chromatography using a Superdex 200 10/300 GL column (GE Healthcare),0.8,Accept,Experimental Usage,Superdex 200 10/300 GL column
PMID:24882693,10.1016/j.jmb.2014.05.011,Molecular conformation of the full-length tumor suppressor NF2/Merlin--a small-angle neutron scattering study.,,"the hydrogel matrix of the CM5 Biosensor chip (GE Life Sciences, NJ) was activated",0.8,Accept,Experimental Usage,CM5 Biosensor chip
PMID:17924978,10.1111/j.1750-3639.2007.00105.x,Natural history of meningioma development in mice reveals: a synergy of Nf2 and p16(Ink4a) mutations.,,direct injection of 3 µL (1 × 10 8 plaque‐forming units) of adCre suspension into the subarachnoidal space on postnatal day 2,0.85,Accept,Experimental Usage,adCre
PMID:25003081,10.3389/fonc.2014.00147,An integrative analysis of meningioma tumors reveals the determinant genes and pathways of malignant transformation.,,Tumor genotyping was performed with the Human Mapping 100K Set platform ( Affymetrix ) and gene-expression data were obtained using GeneChip Human Genome U133 Plus 2.0 Arrays,0.9,Accept,Experimental Usage,Human Mapping 100K Set platform
PMID:25003081,10.3389/fonc.2014.00147,An integrative analysis of meningioma tumors reveals the determinant genes and pathways of malignant transformation.,,gene-expression data were obtained using GeneChip Human Genome U133 Plus 2.0 Arrays ( Affymetrix ),0.9,Accept,Experimental Usage,GeneChip Human Genome U133 Plus 2.0 Arrays
PMID:20551058,10.1158/0008-5472.CAN-09-3769,Cyclic AMP suppression is sufficient to induce gliomagenesis in a mouse model of neurofibromatosis-1.,,A second packaging vector (FUW-FLG) encoding a fusion of firefly luciferase and enhanced green fluorescent protein driven by the human ubiquitin C promoter,0.8,Accept,Experimental Usage,FUW-FLG lentiviral vector
PMID:20551058,10.1158/0008-5472.CAN-09-3769,Cyclic AMP suppression is sufficient to induce gliomagenesis in a mouse model of neurofibromatosis-1.,,Full-length murine PDE4A1 or catalytically inactive PDE4A1-H229Q was cloned into a lentiviral packaging vector that also encodes mCherry fluorescent protein,0.85,Accept,Development,PDE4A1-mCherry lentiviral construct
PMID:20551058,10.1158/0008-5472.CAN-09-3769,Cyclic AMP suppression is sufficient to induce gliomagenesis in a mouse model of neurofibromatosis-1.,,The catalytically inactive PDE4A1-H229Q was generated from full-length murine PDE4A1 using a Quikchange mutagenesis kit,0.8,Accept,Development,PDE4A1-H229Q mutant construct
PMID:41023593,10.1186/s10020-025-01353-9,Selective inhibition of BRAF and CRAF sensitizes NF1-deficient malignant peripheral nerve sheath tumors to MEK inhibitors.,,"Vehicle, trametinib (dosed at 0.075 mg/kg and 0.3 mg/kg, QD- once daily), LXH254 (dosed at 25 mg/kg and 50 mg/kg, BID- twice daily)",0.8,Accept,Experimental Usage,trametinib
PMID:41023593,10.1186/s10020-025-01353-9,Selective inhibition of BRAF and CRAF sensitizes NF1-deficient malignant peripheral nerve sheath tumors to MEK inhibitors.,,"Vehicle, trametinib (dosed at 0.075 mg/kg and 0.3 mg/kg, QD- once daily), LXH254 (dosed at 25 mg/kg and 50 mg/kg, BID- twice daily)",0.8,Accept,Experimental Usage,LXH254
PMID:38127282,10.1158/1078-0432.CCR-23-2548,Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression.,,"Gene expression analysis was conducted on the nCounter Sprint Profiler (NanoString Technologies, Inc.) using the nCounter human PanCancer IO360 probe set",0.9,Accept,Experimental Usage,nCounter human PanCancer IO360 probe set
PMID:38127282,10.1158/1078-0432.CCR-23-2548,Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression.,,"then treated with increasing concentrations of YM155 (MedChemExpress, HY-10194) or LQZ-7I (MedChemExpress, HY-136538)",0.9,Accept,Experimental Usage,"YM155 (MedChemExpress, HY-10194)"
PMID:38127282,10.1158/1078-0432.CCR-23-2548,Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression.,,"then treated with increasing concentrations of YM155 (MedChemExpress, HY-10194) or LQZ-7I (MedChemExpress, HY-136538)",0.9,Accept,Experimental Usage,"LQZ-7I (MedChemExpress, HY-136538)"
PMID:38127282,10.1158/1078-0432.CCR-23-2548,Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression.,,"Human MPNST cell lines were reverse transfected with 10 nM siRNA against CENPF (Santa Cruz Biotechnology, sc-37563)",0.95,Accept,Experimental Usage,"CENPF siRNA (Santa Cruz Biotechnology, sc-37563)"
PMID:38127282,10.1158/1078-0432.CCR-23-2548,Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression.,,"BIRC5 (Santa Cruz Biotechnology, sc-29499) or scrambled control (Santa Cruz Biotechnolgy, sc-37007)",0.95,Accept,Experimental Usage,"BIRC5 siRNA (Santa Cruz Biotechnology, sc-29499)"
PMID:28525381,10.18632/oncotarget.17589,The cell of origin dictates the temporal course of neurofibromatosis-1 (Nf1) low-grade glioma formation.,,"underwent oral gavage with 1mg tamoxifen (Sigma-Aldrich, St. Louis, MO) and 1 mg progesterone",0.8,Accept,Experimental Usage,tamoxifen
PMID:28525381,10.18632/oncotarget.17589,The cell of origin dictates the temporal course of neurofibromatosis-1 (Nf1) low-grade glioma formation.,,"1mg tamoxifen (Sigma-Aldrich, St. Louis, MO) and 1 mg progesterone (Sigma-Aldrich, St. Louis, MO)",0.8,Accept,Experimental Usage,progesterone
PMID:28525381,10.18632/oncotarget.17589,The cell of origin dictates the temporal course of neurofibromatosis-1 (Nf1) low-grade glioma formation.,,"Alexa-Fluor-tagged secondary antibodies (Invitrogen, Grand Island, NY) and DAPI counterstaining",0.8,Accept,Experimental Usage,DAPI
PMID:28525381,10.18632/oncotarget.17589,The cell of origin dictates the temporal course of neurofibromatosis-1 (Nf1) low-grade glioma formation.,,biotinylated secondary antibodies and Vectastain Elite ABC development,0.8,Accept,Experimental Usage,Vectastain Elite ABC
PMID:28525381,10.18632/oncotarget.17589,The cell of origin dictates the temporal course of neurofibromatosis-1 (Nf1) low-grade glioma formation.,,Terminal deoxynucleotide transferase-mediated dUTP nick-end labeling (TUNEL) staining was performed,0.8,Accept,Experimental Usage,TUNEL
PMID:38136356,10.3390/cancers15245811,Drug Responses in Plexiform Neurofibroma Type I (PNF1) Cell Lines Using High-Throughput Data and Combined Effectiveness and Potency.,,"...screen a panel of 1912 small molecules (the MIPE 4.0 library [17]) against immortalized NF1−/−, NF1+/−, and NF1+/+ cell lines...",0.8,Accept,Experimental Usage,MIPE 4.0 library
PMID:40887659,10.1186/s40246-025-00803-z,RENOVO-NF1 accurately predicts NF1 missense variant pathogenicity.,,"Together with NGS, MLPA method was performed to rule out large deletions/duplications in NF1 gene",0.85,Accept,Experimental Usage,MLPA
PMID:32839340,10.1073/pnas.2008391117,Brain-wide structural and functional disruption in mice with oligodendrocyte-specific ,,Inducible Plp-Cre (66) and Nf1 fl/+ (67) mice were maintained on a pure C57BL/6 background and genotyped by PCR,0.9,Accept,Experimental Usage,Plp-Cre
PMID:32839340,10.1073/pnas.2008391117,Brain-wide structural and functional disruption in mice with oligodendrocyte-specific ,,Inducible Plp-Cre (66) and Nf1 fl/+ (67) mice were maintained on a pure C57BL/6 background and genotyped by PCR,0.9,Accept,Experimental Usage,Nf1 fl/+
PMID:25043298,10.1038/onc.2014.185,Oncogenic role of Merlin/NF2 in glioblastoma.,,Merlin knockdown U251-S cells were treated with siRNA SMARTpool (Thermo Scientific) directed to Merlin.,0.85,Accept,Experimental Usage,siRNA SMARTpool (Thermo Scientific)
PMID:25043298,10.1038/onc.2014.185,Oncogenic role of Merlin/NF2 in glioblastoma.,,cells were transfected with pXJ40-HA-Merlin and S518A pXJ40- HA-Merlin and incubated for additional 48 hours,0.9,Accept,Experimental Usage,pXJ40-HA-Merlin
PMID:25043298,10.1038/onc.2014.185,Oncogenic role of Merlin/NF2 in glioblastoma.,,cells were transfected with pXJ40-HA-Merlin and S518A pXJ40- HA-Merlin and incubated for additional 48 hours,0.9,Accept,Experimental Usage,S518A pXJ40-HA-Merlin
PMID:25043298,10.1038/onc.2014.185,Oncogenic role of Merlin/NF2 in glioblastoma.,,Cells were treated with IPA-3 (Sigma-Aldrich) a PAK group1 inhibitor (PAK1/2/3),0.8,Accept,Experimental Usage,IPA-3 (Sigma-Aldrich)
PMID:25043298,10.1038/onc.2014.185,Oncogenic role of Merlin/NF2 in glioblastoma.,,were fractionated using the Q-proteome cell compartment kit (Qiagen) following manufacturer's instructions.,0.85,Accept,Experimental Usage,Q-proteome cell compartment kit (Qiagen)
PMID:25043298,10.1038/onc.2014.185,Oncogenic role of Merlin/NF2 in glioblastoma.,,Co-IP experiments were performed without deviation from Co-IP kit protocol (Thermo Scientific).,0.85,Accept,Experimental Usage,Co-IP kit (Thermo Scientific)
PMID:25043298,10.1038/onc.2014.185,Oncogenic role of Merlin/NF2 in glioblastoma.,,"Total RNA of cultured cells was extracted using the Rneasy Mini Kit (Qiagen, Germantown, MD) following manufacture's instructions.",0.85,Accept,Experimental Usage,Rneasy Mini Kit (Qiagen)
PMID:25043298,10.1038/onc.2014.185,Oncogenic role of Merlin/NF2 in glioblastoma.,,500ng of RNA were reverse-transcribed using the SuperScript™ III first-strand synthesis system for RT-PCR (Life Technologies).,0.85,Accept,Experimental Usage,SuperScript™ III first-strand synthesis system (Life Technologies)
PMID:25043298,10.1038/onc.2014.185,Oncogenic role of Merlin/NF2 in glioblastoma.,,quantitative real-time PCR (Q-PCR) using Power SYBR Green PCR master mix (Life Technologies).,0.85,Accept,Experimental Usage,Power SYBR Green PCR master mix (Life Technologies)
PMID:25043298,10.1038/onc.2014.185,Oncogenic role of Merlin/NF2 in glioblastoma.,,The Vybrant ® MTT cell proliferation assay kit quick protocol (Life Technologies) was employed,0.85,Accept,Experimental Usage,Vybrant® MTT cell proliferation assay kit (Life Technologies)
PMID:36420221,10.1016/j.omtn.2022.10.026,Antisense oligonucleotides targeting exon 11 are able to partially rescue the NF2-related schwannomatosis phenotype ,,Genetic testing was performed using the customized I2HCP panel in blood or tissue when available.,0.85,Accept,Experimental Usage,I2HCP panel
PMID:36420221,10.1016/j.omtn.2022.10.026,Antisense oligonucleotides targeting exon 11 are able to partially rescue the NF2-related schwannomatosis phenotype ,,"The 25-mer-specific PMOs for four patients with splicing variants, and a pair of PMOs to induce exon skipping of exons 4, 8, and 11 of the NF2 gene were designed",0.9,Accept,Experimental Usage,25-mer-specific PMOs
PMID:36420221,10.1016/j.omtn.2022.10.026,Antisense oligonucleotides targeting exon 11 are able to partially rescue the NF2-related schwannomatosis phenotype ,,Endo-Porter (Gene Tools) was used as vehicle to deliver PMOs into cells at 6 μM,0.85,Accept,Experimental Usage,Endo-Porter
PMID:36420221,10.1016/j.omtn.2022.10.026,Antisense oligonucleotides targeting exon 11 are able to partially rescue the NF2-related schwannomatosis phenotype ,,"AClick-iT EdU Alexa Fluor 488 Flow Cytometry Assay Kit (Molecular Probes, Invitrogen) was used, according to the manufacturer's protocol, to determine cell proliferation",0.85,Accept,Experimental Usage,Click-iT EdU Alexa Fluor 488 Flow Cytometry Assay Kit
PMID:36420221,10.1016/j.omtn.2022.10.026,Antisense oligonucleotides targeting exon 11 are able to partially rescue the NF2-related schwannomatosis phenotype ,,Cell viability was assessed using RealTime-Glo MT Cell Viability Assay (Promega) following the manufacturer's instructions,0.85,Accept,Experimental Usage,RealTime-Glo MT Cell Viability Assay
PMID:36420221,10.1016/j.omtn.2022.10.026,Antisense oligonucleotides targeting exon 11 are able to partially rescue the NF2-related schwannomatosis phenotype ,,The NF2 gene was cloned using the Gateway Gene Cloning system (Invitrogen) after treatment to induce the exon-skipping,0.85,Accept,Experimental Usage,Gateway Gene Cloning system
PMID:36420221,10.1016/j.omtn.2022.10.026,Antisense oligonucleotides targeting exon 11 are able to partially rescue the NF2-related schwannomatosis phenotype ,,"The expression vector was transfected into HeLa cells (Lipofectamine LTX with Plus Reagent, Invitrogen)",0.85,Accept,Experimental Usage,Lipofectamine LTX with Plus Reagent
PMID:32438526,10.1002/lary.28671,Effects of Neurod1 Expression on Mouse and Human Schwannoma Cells.,,Periostin-cre (Postn-cre) were crossed with floxed Nf2 gene (Postn-cre;Nf2) as previously described,0.9,Accept,Experimental Usage,Postn-cre
PMID:32438526,10.1002/lary.28671,Effects of Neurod1 Expression on Mouse and Human Schwannoma Cells.,,crossed with a Rosa26 (LSL-Neurod1 R26) line that induces Neurod1 expression via cre-mediated excision of a stop codon,0.85,Accept,Experimental Usage,Rosa26 (LSL-Neurod1 R26)
PMID:32438526,10.1002/lary.28671,Effects of Neurod1 Expression on Mouse and Human Schwannoma Cells.,,we used the following mouse lines: tg(Atoh1-cre); R26 and tg(smo Neurod1-cre) to generate fast and slow growing medulloblastoma,0.9,Accept,Experimental Usage,tg(Atoh1-cre)
PMID:32438526,10.1002/lary.28671,Effects of Neurod1 Expression on Mouse and Human Schwannoma Cells.,,we used the following mouse lines: tg(Atoh1-cre); R26 and tg(smo Neurod1-cre) to generate fast and slow growing medulloblastoma,0.9,Accept,Experimental Usage,tg(smo Neurod1-cre)
PMID:32438526,10.1002/lary.28671,Effects of Neurod1 Expression on Mouse and Human Schwannoma Cells.,,we used the widely available R26 reporter mice to verify that the Postn-cre effectively and exclusively recombines the stop codon,0.85,Accept,Experimental Usage,R26 LacZ reporter mice
PMID:32438526,10.1002/lary.28671,Effects of Neurod1 Expression on Mouse and Human Schwannoma Cells.,,EdU was detected in whole ganglion using the Click-It EdU kit per manufacturer's instructions (Life Technologies),0.9,Accept,Experimental Usage,Click-It EdU kit
PMID:32438526,10.1002/lary.28671,Effects of Neurod1 Expression on Mouse and Human Schwannoma Cells.,,"AdCMVNeuroD1 at 2 × 10^9 pfu/mL, or AdCMVNeuroD1 at 5 × 10^9 pfu/mL (ViraQuest, Inc.) were applied to the culture medium",0.9,Accept,Experimental Usage,AdCMVNeuroD1
PMID:32438526,10.1002/lary.28671,Effects of Neurod1 Expression on Mouse and Human Schwannoma Cells.,,Edu staining was performed using Click-it EdU Alexa Fluor 633 Image Kit (ThermoFisher C10340),0.9,Accept,Experimental Usage,Click-it EdU Alexa Fluor 633 Image Kit
PMID:15240917,10.1155/S1110724304308107,Survival of Human Neurofibroma in Immunodeficient Mice and Initial Results of Therapy With Pirfenidone.,,"After implantation of the tumor grafts, skin was closed with resorbable (Chromic catgut 5/0) suture",0.75,Accept,Experimental Usage,Chromic catgut 5/0
PMID:15240917,10.1155/S1110724304308107,Survival of Human Neurofibroma in Immunodeficient Mice and Initial Results of Therapy With Pirfenidone.,,Tumor implants were secured with a Prolene 8/0 surgical suture,0.75,Accept,Experimental Usage,Prolene 8/0 surgical suture
PMID:21963652,10.1016/j.expneurol.2011.09.005,PET imaging for attention deficit preclinical drug testing in neurofibromatosis-1 mice.,,"[3H]-SCH23390, [3H]-raclopride, [3H]-Win 35428 (PerkinElmer Life and Analytical Sciences; Shelton, CT)",0.85,Accept,Experimental Usage,[3H]-SCH23390
PMID:21963652,10.1016/j.expneurol.2011.09.005,PET imaging for attention deficit preclinical drug testing in neurofibromatosis-1 mice.,,"[3H]-SCH23390, [3H]-raclopride, [3H]-Win 35428 (PerkinElmer Life and Analytical Sciences; Shelton, CT)",0.85,Accept,Experimental Usage,[3H]-raclopride
PMID:21963652,10.1016/j.expneurol.2011.09.005,PET imaging for attention deficit preclinical drug testing in neurofibromatosis-1 mice.,,"[3H]-SCH23390, [3H]-raclopride, [3H]-Win 35428 (PerkinElmer Life and Analytical Sciences; Shelton, CT)",0.85,Accept,Experimental Usage,[3H]-Win 35428
PMID:21963652,10.1016/j.expneurol.2011.09.005,PET imaging for attention deficit preclinical drug testing in neurofibromatosis-1 mice.,,"[3H]-WC-10, and [3H]-a-Dihydrotetrabenazine ([3H]-DTBZ; American Radiolabeled Chemicals; St. Louis, MO)",0.85,Accept,Experimental Usage,[3H]-WC-10
PMID:21963652,10.1016/j.expneurol.2011.09.005,PET imaging for attention deficit preclinical drug testing in neurofibromatosis-1 mice.,,"[3H]-WC-10, and [3H]-a-Dihydrotetrabenazine ([3H]-DTBZ; American Radiolabeled Chemicals; St. Louis, MO)",0.85,Accept,Experimental Usage,[3H]-DTBZ
PMID:21963652,10.1016/j.expneurol.2011.09.005,PET imaging for attention deficit preclinical drug testing in neurofibromatosis-1 mice.,,Mice were injected with ~200μCi of [11C]-raclopride (~2500 Ci/mmol specific activity) via the tail vein,0.85,Accept,Experimental Usage,[11C]-raclopride
PMID:24932921,10.1002/jbmr.2298,Neurofibromin deficiency-associated transcriptional dysregulation suggests a novel therapy for tibial pseudoarthrosis in NF1.,,"Whole-exome capture was performed using either the SeqCap EZ Human Exome Library (Nimblegen, Basel, Switzerland) or TruSeq Exome kit",0.85,Accept,Experimental Usage,SeqCap EZ Human Exome Library
PMID:24932921,10.1002/jbmr.2298,Neurofibromin deficiency-associated transcriptional dysregulation suggests a novel therapy for tibial pseudoarthrosis in NF1.,,"using either the SeqCap EZ Human Exome Library (Nimblegen, Basel, Switzerland) or TruSeq Exome kit (Illumina, San Diego, CA)",0.85,Accept,Experimental Usage,TruSeq Exome kit
PMID:24932921,10.1002/jbmr.2298,Neurofibromin deficiency-associated transcriptional dysregulation suggests a novel therapy for tibial pseudoarthrosis in NF1.,,"When necessary, PCR amplicons were cloned into pcDNA3.1 vector (Life Technologies, CA, USA) to Sanger sequence individual alleles",0.85,Accept,Experimental Usage,pcDNA3.1 vector
PMID:24932921,10.1002/jbmr.2298,Neurofibromin deficiency-associated transcriptional dysregulation suggests a novel therapy for tibial pseudoarthrosis in NF1.,,"re-suspended in Minimum Essential Medium (MEM) Alpha (Life Technologies, CA, USA) supplemented with 10% fetal bovine serum",0.8,Accept,Experimental Usage,Minimum Essential Medium (MEM) Alpha
PMID:39415595,10.1242/dmm.050862,Generation of a zebrafish neurofibromatosis model via inducible knockout of nf2a/b.,,gRNAs targeting zebrafish nf2a/b were validated and cloned in the pU6(x):sgRNA#(x) vectors.,0.85,Accept,Experimental Usage,pU6(x):sgRNA#(x) vectors
PMID:39415595,10.1242/dmm.050862,Generation of a zebrafish neurofibromatosis model via inducible knockout of nf2a/b.,,All four guides were cloned into the final destination vector pGGDestTol2LC-4sgRNA (nf2a/b-4sgRNA).,0.9,Accept,Experimental Usage,pGGDestTol2LC-4sgRNA
PMID:39415595,10.1242/dmm.050862,Generation of a zebrafish neurofibromatosis model via inducible knockout of nf2a/b.,,The pU6(x):nf2a/b-4sgRNA vector and Tol2 transposase mRNA were injected into ABWT one- to two-cell embryos.,0.85,Accept,Experimental Usage,Tol2 transposase mRNA
PMID:39415595,10.1242/dmm.050862,Generation of a zebrafish neurofibromatosis model via inducible knockout of nf2a/b.,,"Then, 10-20 pg Cre recombinase mRNA was injected into the embryo.",0.85,Accept,Experimental Usage,Cre recombinase mRNA
PMID:37246765,10.1093/neuonc/noad097,Ex vivo to in vivo model of malignant peripheral nerve sheath tumors for precision oncology.,,"Patient tumor samples were minced into 2–4 mm sized pieces, dipped in Matrigel (Corning 354234)",0.8,Accept,Experimental Usage,Matrigel (Corning 354234)
PMID:37246765,10.1093/neuonc/noad097,Ex vivo to in vivo model of malignant peripheral nerve sheath tumors for precision oncology.,,"immediately digested using the human Tumor Dissociation Kit (130-095-929, Miltenyi Biotec)",0.85,Accept,Experimental Usage,"human Tumor Dissociation Kit (130-095-929, Miltenyi Biotec)"
PMID:37246765,10.1093/neuonc/noad097,Ex vivo to in vivo model of malignant peripheral nerve sheath tumors for precision oncology.,,in combination with the GentleMACS Octo Dissociator (Miltenyi Biotec),0.8,Accept,Experimental Usage,GentleMACS Octo Dissociator (Miltenyi Biotec)
PMID:37246765,10.1093/neuonc/noad097,Ex vivo to in vivo model of malignant peripheral nerve sheath tumors for precision oncology.,,"Dead cells were removed from the digested PDX using a Dead Cell Removal Kit (130-090-101, Miltenyi Biotec)",0.8,Accept,Experimental Usage,"Dead Cell Removal Kit (130-090-101, Miltenyi Biotec)"
PMID:37246765,10.1093/neuonc/noad097,Ex vivo to in vivo model of malignant peripheral nerve sheath tumors for precision oncology.,,"Murine cells were removed from the dead cell depleted fraction using a Mouse Cell Depletion Kit (130-104-694, Miltenyi Biotec)",0.8,Accept,Experimental Usage,"Mouse Cell Depletion Kit (130-104-694, Miltenyi Biotec)"
PMID:37246765,10.1093/neuonc/noad097,Ex vivo to in vivo model of malignant peripheral nerve sheath tumors for precision oncology.,,"100 mM mirdametinib (S1036, Selleckchem) and 100 mM olaparib (S1060, Selleckchem)",0.8,Accept,Experimental Usage,"mirdametinib (S1036, Selleckchem)"
PMID:37246765,10.1093/neuonc/noad097,Ex vivo to in vivo model of malignant peripheral nerve sheath tumors for precision oncology.,,"100 mM olaparib (S1060, Selleckchem) dissolved in DMSO",0.8,Accept,Experimental Usage,"olaparib (S1060, Selleckchem)"
PMID:37246765,10.1093/neuonc/noad097,Ex vivo to in vivo model of malignant peripheral nerve sheath tumors for precision oncology.,,A Zeiss Axio Observer was used to image z-positions at 50 μm intervals,0.8,Accept,Experimental Usage,Zeiss Axio Observer
PMID:41591566,10.1007/s00401-026-02979-7,FAP expression as a marker of malignant transformation enabling in vivo characterization in peripheral nerve sheath tumors: a multimodal and translational study.,,"Ventana BenchMark ULTRA platform using the iVIEW DAB detection system (Roche, Mannheim, Germany)",0.8,Accept,Experimental Usage,iVIEW DAB detection system
PMID:41591566,10.1007/s00401-026-02979-7,FAP expression as a marker of malignant transformation enabling in vivo characterization in peripheral nerve sheath tumors: a multimodal and translational study.,,"RNA fusion profiling was performed using the TruSight RNA Pan-Cancer Panel (Illumina, San Diego, CA, US)",0.9,Accept,Experimental Usage,TruSight RNA Pan-Cancer Panel (Illumina)
PMID:41591566,10.1007/s00401-026-02979-7,FAP expression as a marker of malignant transformation enabling in vivo characterization in peripheral nerve sheath tumors: a multimodal and translational study.,,"Furthermore, Illumina EPIC DNA methylation profiling was performed with application of the Heidelberg sarcoma classifier",0.85,Accept,Experimental Usage,Illumina EPIC DNA methylation profiling
PMID:41591566,10.1007/s00401-026-02979-7,FAP expression as a marker of malignant transformation enabling in vivo characterization in peripheral nerve sheath tumors: a multimodal and translational study.,,spatial transcriptomics data from eight peripheral nerve lesions profiled by the 10× Genomics Visium platform,0.9,Accept,Experimental Usage,10× Genomics Visium platform
PMID:41591566,10.1007/s00401-026-02979-7,FAP expression as a marker of malignant transformation enabling in vivo characterization in peripheral nerve sheath tumors: a multimodal and translational study.,,"After administration of 179 MBq [68 Ga]Ga-LNTH-1363S, (FAP-directed radiotracer; mass dose, 90 ug)",0.85,Accept,Experimental Usage,[68Ga]Ga-LNTH-1363S
PMID:41591566,10.1007/s00401-026-02979-7,FAP expression as a marker of malignant transformation enabling in vivo characterization in peripheral nerve sheath tumors: a multimodal and translational study.,,"After administration of 179 MBq [68 Ga]Ga-LNTH-1363S, (FAP-directed radiotracer; mass dose, 90 ug) or 167 MBq of [18 F]FDG",0.85,Accept,Experimental Usage,[18F]FDG
PMID:24375753,10.1002/ana.24093,Sex Is a major determinant of neuronal dysfunction in neurofibromatosis type 1.,,"Ras activation (Millipore), cAMP (New East Biosciences), TUNEL (Roche Diagnostics), and dopamine (Rocky Mountain Diagnostics) measurements were determined following manufacturer's protocols",0.8,Accept,Experimental Usage,Ras activation (Millipore)
PMID:24375753,10.1002/ana.24093,Sex Is a major determinant of neuronal dysfunction in neurofibromatosis type 1.,,"Ras activation (Millipore), cAMP (New East Biosciences), TUNEL (Roche Diagnostics), and dopamine (Rocky Mountain Diagnostics) measurements were determined following manufacturer's protocols",0.8,Accept,Experimental Usage,cAMP (New East Biosciences)
PMID:24375753,10.1002/ana.24093,Sex Is a major determinant of neuronal dysfunction in neurofibromatosis type 1.,,"Ras activation (Millipore), cAMP (New East Biosciences), TUNEL (Roche Diagnostics), and dopamine (Rocky Mountain Diagnostics) measurements were determined following manufacturer's protocols",0.8,Accept,Experimental Usage,TUNEL (Roche Diagnostics)
PMID:24375753,10.1002/ana.24093,Sex Is a major determinant of neuronal dysfunction in neurofibromatosis type 1.,,"Ras activation (Millipore), cAMP (New East Biosciences), TUNEL (Roche Diagnostics), and dopamine (Rocky Mountain Diagnostics) measurements were determined following manufacturer's protocols",0.8,Accept,Experimental Usage,dopamine (Rocky Mountain Diagnostics)
PMID:25043591,10.1002/jbmr.2316,Combined MEK inhibition and BMP2 treatment promotes osteoblast differentiation and bone healing in Nf1Osx -/- mice.,,"containing either Ad5-CMV-GFP or Ad5-CMV-cre (Vector development lab, Baylor College of Medicine)",0.9,Accept,Experimental Usage,Ad5-CMV-GFP
PMID:25043591,10.1002/jbmr.2316,Combined MEK inhibition and BMP2 treatment promotes osteoblast differentiation and bone healing in Nf1Osx -/- mice.,,"containing either Ad5-CMV-GFP or Ad5-CMV-cre (Vector development lab, Baylor College of Medicine)",0.9,Accept,Experimental Usage,Ad5-CMV-cre
PMID:25043591,10.1002/jbmr.2316,Combined MEK inhibition and BMP2 treatment promotes osteoblast differentiation and bone healing in Nf1Osx -/- mice.,,Nf1osx (-/-) mice receiving Trametinib (a MEK inhibitor) and BMP2 released locally at the fracture site,0.85,Accept,Experimental Usage,Trametinib
PMID:24371224,10.1158/0008-5472.CAN-13-2062,Tumor suppressor alterations cooperate to drive aggressive mesotheliomas with enriched cancer stem cells via a p53-miR-34a-c-Met axis.,,MM cells in log growth phase were treated with vehicle control or c-Met inhibitors SU-11274 (5 μM) or SGX2943 (5 μM Calbiochem) for 24 h...,0.85,Accept,Experimental Usage,SU-11274
PMID:24371224,10.1158/0008-5472.CAN-13-2062,Tumor suppressor alterations cooperate to drive aggressive mesotheliomas with enriched cancer stem cells via a p53-miR-34a-c-Met axis.,,MM cells in log growth phase were treated with vehicle control or c-Met inhibitors SU-11274 (5 μM) or SGX2943 (5 μM Calbiochem) for 24 h...,0.85,Accept,Experimental Usage,SGX2943 (Calbiochem)
PMID:24371224,10.1158/0008-5472.CAN-13-2062,Tumor suppressor alterations cooperate to drive aggressive mesotheliomas with enriched cancer stem cells via a p53-miR-34a-c-Met axis.,,Cells were nucleofected with siRNA against Tp53 or miR34a (Dharmacon) using Amaxa Nucleofection Kit R and program T20...,0.9,Accept,Experimental Usage,siRNA against Tp53 (Dharmacon)
PMID:24371224,10.1158/0008-5472.CAN-13-2062,Tumor suppressor alterations cooperate to drive aggressive mesotheliomas with enriched cancer stem cells via a p53-miR-34a-c-Met axis.,,Cells were nucleofected with siRNA against Tp53 or miR34a (Dharmacon) using Amaxa Nucleofection Kit R and program T20...,0.9,Accept,Experimental Usage,siRNA against miR34a (Dharmacon)
PMID:34782607,10.1038/s41525-021-00258-w,Pathogenic neurofibromatosis type 1 (NF1) RNA splicing resolved by targeted RNAseq.,,White blood cells were isolated using ficoll (Sigma-Aldrich) from fresh whole blood,0.85,Accept,Experimental Usage,ficoll (Sigma-Aldrich)
PMID:34782607,10.1038/s41525-021-00258-w,Pathogenic neurofibromatosis type 1 (NF1) RNA splicing resolved by targeted RNAseq.,,short term-culture in a complete medium consisting of RPMI 1640 supplemented with 12.5% FCS,0.8,Accept,Experimental Usage,RPMI 1640
PMID:34782607,10.1038/s41525-021-00258-w,Pathogenic neurofibromatosis type 1 (NF1) RNA splicing resolved by targeted RNAseq.,,Lymphocyte growth was stimulated with 50 µl/ml PHA (Gibco) and 10 units/ml of IL-2,0.85,Accept,Experimental Usage,PHA (Gibco)
PMID:34782607,10.1038/s41525-021-00258-w,Pathogenic neurofibromatosis type 1 (NF1) RNA splicing resolved by targeted RNAseq.,,one part was treated with 200 µg/ml of puromycin (Sigma-Aldrich) as an inhibitor of nonsense mediated RNA decay,0.85,Accept,Experimental Usage,puromycin (Sigma-Aldrich)
PMID:34782607,10.1038/s41525-021-00258-w,Pathogenic neurofibromatosis type 1 (NF1) RNA splicing resolved by targeted RNAseq.,,These validation samples were enriched for NF1 RNA using NuGEN SPET for RNA,0.9,Accept,Experimental Usage,NuGEN SPET for RNA
PMID:34782607,10.1038/s41525-021-00258-w,Pathogenic neurofibromatosis type 1 (NF1) RNA splicing resolved by targeted RNAseq.,,for NF1/SPRED1 using Agilent SureSelect RNA Target Enrichment,0.9,Accept,Experimental Usage,Agilent SureSelect RNA Target Enrichment
PMID:34782607,10.1038/s41525-021-00258-w,Pathogenic neurofibromatosis type 1 (NF1) RNA splicing resolved by targeted RNAseq.,,Total RNA was purified and DNAseI treated using RNeasy Plus micro columns (Qiagen),0.85,Accept,Experimental Usage,RNeasy Plus micro columns (Qiagen)
PMID:34782607,10.1038/s41525-021-00258-w,Pathogenic neurofibromatosis type 1 (NF1) RNA splicing resolved by targeted RNAseq.,,Paired-end sequencing (2x150bp) was performed on a NextSeq500 instrument (Illumina),0.85,Accept,Experimental Usage,NextSeq500 instrument (Illumina)
PMID:39669605,10.1016/j.gimo.2024.101816,Next-generation variant exon screening: Moving forward in routine genetic disease investigations.,,ES was performed by standard procedures using the IGT-T192V1 Plus panel (Integrated DNA Technologies) to capture selected targets. This panel covers a 41.97 Mb target region,0.8,Accept,Experimental Usage,IGT-T192V1 Plus panel
PMID:39669605,10.1016/j.gimo.2024.101816,Next-generation variant exon screening: Moving forward in routine genetic disease investigations.,,"A total of 50 ng of genomic DNA purified from peripheral blood (Qiagen DNA Blood Midi/Mini kit, Qiagen GmbH) was fragmented in Tagmentation Buffer 1",0.75,Accept,Experimental Usage,Qiagen DNA Blood Midi/Mini kit
PMID:39669605,10.1016/j.gimo.2024.101816,Next-generation variant exon screening: Moving forward in routine genetic disease investigations.,,"The modified fragments were then ligated with barcoded adapters (Fast DNA Library Prep Set CW3045M, CWBIO Inc). After purification with XP beads",0.75,Accept,Experimental Usage,Fast DNA Library Prep Set CW3045M
PMID:19144871,10.3181/0809-RM-275,Identification of erythrocyte p55/MPP1 as a binding partner of NF2 tumor suppressor protein/Merlin.,,The cDNA fragments were cloned in pMAL-c2X vector (New England Biolabs) for the expression of recombinant proteins as MBP fusions,0.85,Accept,Experimental Usage,pMAL-c2X vector
PMID:23071067,10.1158/0008-5472.CAN-12-1728,Genetically mediated Nf1 loss in mice promotes diverse radiation-induced tumors modeling second malignant neoplasms.,,genomic DNA was isolated and subjected to whole genome amplification according to manufacturers instructions using the REPLI-g FFPE kit (Qiagen).,0.9,Accept,Experimental Usage,REPLI-g FFPE kit (Qiagen)
PMID:28392281,10.1016/j.expneurol.2017.04.001,Human stem cell modeling in neurofibromatosis type 1 (NF1).,,"The first vectors used to generate iPSCs were gamma retroviruses, specifically murine leukemia retroviruses, chosen for their favorable long-term transgene expression",0.8,Accept,Experimental Usage,murine leukemia retroviruses
PMID:28392281,10.1016/j.expneurol.2017.04.001,Human stem cell modeling in neurofibromatosis type 1 (NF1).,,excisable lentiviral vectors have been developed using Cre/loxP technology,0.85,Accept,Experimental Usage,Cre/loxP technology
PMID:28392281,10.1016/j.expneurol.2017.04.001,Human stem cell modeling in neurofibromatosis type 1 (NF1).,,"human fibroblasts have been successfully reprogrammed after a single transfection with oriP/EBNA1 (Epstein-Barr nuclear antigen-1)-based episomal vectors expressing OCT4, SOX2, MYC, KLF4, NANOG, LIN28",0.9,Accept,Experimental Usage,oriP/EBNA1 (Epstein-Barr nuclear antigen-1)-based episomal vectors
PMID:16835260,10.1093/hmg/ddl165,Nf1+/- mast cells induce neurofibroma like phenotypes through secreted TGF-beta signaling.,,a virus expressing the full-length NF1 GTPase-activating related domain (NF1 GRD) and pac (MSCV-NF1 GRD-pac),0.9,Accept,Experimental Usage,MSCV-NF1 GRD-pac
PMID:16835260,10.1093/hmg/ddl165,Nf1+/- mast cells induce neurofibroma like phenotypes through secreted TGF-beta signaling.,,a virus expressing a GAP-inactive mutant of the NF1 GRD that harbors a known human mutation in the arginine finger loop (R1276P) (25) and pac (MSCV-1276P NF1 GRD-pac),0.9,Accept,Experimental Usage,MSCV-1276P NF1 GRD-pac
PMID:16835260,10.1093/hmg/ddl165,Nf1+/- mast cells induce neurofibroma like phenotypes through secreted TGF-beta signaling.,,a virus expressing the selectable marker gene alone (MSCV-pac),0.85,Accept,Experimental Usage,MSCV-pac
PMID:16835260,10.1093/hmg/ddl165,Nf1+/- mast cells induce neurofibroma like phenotypes through secreted TGF-beta signaling.,,"c-abl siRNA oligonucleotides (Cat. no. sc-29844) were purchased from Santa Cruz Biotechnology, Inc.",0.85,Accept,Experimental Usage,c-abl siRNA oligonucleotides
PMID:16835260,10.1093/hmg/ddl165,Nf1+/- mast cells induce neurofibroma like phenotypes through secreted TGF-beta signaling.,,"p21 ras activation was subsequently determined using a p21 ras activation pulldown assay kit (Upstate Biotechnology, Lake Placid, NY, USA)",0.8,Accept,Experimental Usage,p21 ras activation pulldown assay kit
PMID:36241865,10.1038/s12276-022-00850-9,Transplanting neurofibromatosis-1 gene knockout neural stem cells improve functional recovery in rats with spinal cord injury by enhancing the mTORC2 pathway.,,"control lentivirus (LV-vector), NF-1 sgRNA-CAS9 lentivirus (LV-NF-1), Rictor sgRNA-CAS9 lentivirus (LV-Rictor)",0.8,Accept,Experimental Usage,LV-vector
PMID:36241865,10.1038/s12276-022-00850-9,Transplanting neurofibromatosis-1 gene knockout neural stem cells improve functional recovery in rats with spinal cord injury by enhancing the mTORC2 pathway.,,"NF-1 sgRNA-CAS9 lentivirus (LV-NF-1), Rictor sgRNA-CAS9 lentivirus (LV-Rictor), and NF-1 sgRNA-CAS9 lentivirus + Rictor sgRNA-CAS9 lentivirus",0.85,Accept,Experimental Usage,LV-NF-1
PMID:36241865,10.1038/s12276-022-00850-9,Transplanting neurofibromatosis-1 gene knockout neural stem cells improve functional recovery in rats with spinal cord injury by enhancing the mTORC2 pathway.,,"Rictor sgRNA-CAS9 lentivirus (LV-Rictor), and NF-1 sgRNA-CAS9 lentivirus + Rictor sgRNA-CAS9 lentivirus (LV-NF-1+LV-Rictor)",0.8,Accept,Experimental Usage,LV-Rictor
PMID:36241865,10.1038/s12276-022-00850-9,Transplanting neurofibromatosis-1 gene knockout neural stem cells improve functional recovery in rats with spinal cord injury by enhancing the mTORC2 pathway.,,The lentiviral vectors (LV) carrying the CRISPR/CAS9 system and a sequence that knocked out NF-1 or Rictor were constructed by GeneChem Company,0.85,Accept,Experimental Usage,CRISPR/CAS9 system
PMID:36241865,10.1038/s12276-022-00850-9,Transplanting neurofibromatosis-1 gene knockout neural stem cells improve functional recovery in rats with spinal cord injury by enhancing the mTORC2 pathway.,,"The TUNEL assay was conducted by using the TUNEL kit (Roche, Reinach, Switzerland)",0.8,Accept,Experimental Usage,TUNEL kit
PMID:36241865,10.1038/s12276-022-00850-9,Transplanting neurofibromatosis-1 gene knockout neural stem cells improve functional recovery in rats with spinal cord injury by enhancing the mTORC2 pathway.,,"The cell bodies of neurons projecting to the spinal cord caudal to the transplanted area were labeled with Fluorogold (FG; Biotium, San Francisco, USA)",0.8,Accept,Experimental Usage,Fluorogold
PMID:24817309,10.1371/journal.pone.0097320,Nf2/Merlin controls spinal cord neural progenitor function in a Rac1/ErbB2-dependent manner.,,"Terminal deoxynucleotidyltransferase-mediated dUTP-biotin nick end labeling (TUNEL; Roche, Indianapolis IN)-immunoreactive cells",0.85,Accept,Experimental Usage,TUNEL
PMID:24817309,10.1371/journal.pone.0097320,Nf2/Merlin controls spinal cord neural progenitor function in a Rac1/ErbB2-dependent manner.,,"Pharmacologic inhibitor experiments used 10 4 cells per well (NSC23766, 10 µM; AG825, 10 µM; Sigma, St. Louis MO)",0.8,Accept,Experimental Usage,NSC23766
PMID:24817309,10.1371/journal.pone.0097320,Nf2/Merlin controls spinal cord neural progenitor function in a Rac1/ErbB2-dependent manner.,,"Pharmacologic inhibitor experiments used 10 4 cells per well (NSC23766, 10 µM; AG825, 10 µM; Sigma, St. Louis MO)",0.8,Accept,Experimental Usage,AG825
PMID:24817309,10.1371/journal.pone.0097320,Nf2/Merlin controls spinal cord neural progenitor function in a Rac1/ErbB2-dependent manner.,,"Active Rac1 (Rac1-GTP) was determined by PAK1-PBD affinity chromatography (Rac1 activation Assay Kit, Millipore, Bedford MA)",0.85,Accept,Experimental Usage,Rac1 activation Assay Kit
PMID:24817309,10.1371/journal.pone.0097320,Nf2/Merlin controls spinal cord neural progenitor function in a Rac1/ErbB2-dependent manner.,,Murine stem cell virus (MSCV) infection was employed to express human WT or mutant (L64P patient mutation) merlin,0.8,Accept,Experimental Usage,MSCV
PMID:24817309,10.1371/journal.pone.0097320,Nf2/Merlin controls spinal cord neural progenitor function in a Rac1/ErbB2-dependent manner.,,PLKO virus was used as an empty vector control.,0.8,Accept,Experimental Usage,PLKO virus
PMID:25535838,10.7554/eLife.05151,Transient inhibition of the ERK pathway prevents cerebellar developmental defects and improves long-term motor functions in murine models of neurofibromatosis type 1.,,"MEK inhibitor (MEKi, PD0325901, Sigma-Aldrich, St. Louis, MO) was dissolved in DMSO at a concentration of 25 mg/ml",0.95,Accept,Experimental Usage,PD0325901
PMID:25535838,10.7554/eLife.05151,Transient inhibition of the ERK pathway prevents cerebellar developmental defects and improves long-term motor functions in murine models of neurofibromatosis type 1.,,"For hybridization, an 800 bp Math1 antisense probe was made from a plasmid pLA1-HindIII containing 600 bp of the Math1-coding region",0.9,Accept,Experimental Usage,Math1 antisense probe
PMID:25535838,10.7554/eLife.05151,Transient inhibition of the ERK pathway prevents cerebellar developmental defects and improves long-term motor functions in murine models of neurofibromatosis type 1.,,The Zic1 antisense probe was a 690-bp XhoI–SalI segment from the mouse Zic1 cDNA,0.9,Accept,Experimental Usage,Zic1 antisense probe
PMID:25535838,10.7554/eLife.05151,Transient inhibition of the ERK pathway prevents cerebellar developmental defects and improves long-term motor functions in murine models of neurofibromatosis type 1.,,Rapamycin (Millipore) was dissolved in 100% sterile-filtered ethanol at a concentration of 10 mg/ml,0.9,Accept,Experimental Usage,Rapamycin
PMID:40507334,10.3390/cancers17111852,Development of a Novel Biomarker Platform for Profiling Key Protein-Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs.,,"Human MCL-1-glutathione-S-transferase (GST) and BCL-XL-GST fusion proteins were cloned into the pGEX 4T-1 expression plasmid (available from Addgene, Watertown, MA, USA).",0.85,Accept,Experimental Usage,pGEX 4T-1 expression plasmid
PMID:40507334,10.3390/cancers17111852,Development of a Novel Biomarker Platform for Profiling Key Protein-Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs.,,"MCF7 cells (1 × 10 6) were transfected with 1 µg of a 12:1 DNA ratio of the pCMV-T7-(FZ) SpCas9-BPNLS(SV40)-3xFLAG-P2A-Puro-R plasmid (modified from RTW3027, Addgene #139987)",0.85,Accept,Experimental Usage,pCMV-T7-(FZ) SpCas9-BPNLS(SV40)-3xFLAG-P2A-Puro-R plasmid
PMID:40507334,10.3390/cancers17111852,Development of a Novel Biomarker Platform for Profiling Key Protein-Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs.,,"MCF7 breast cancer cells were transfected in 6-well plates with ON-TARGETplus SMARTpool siRNA against BIM (BCL2L11; Dharmacon, Cat#SO-2704885G, Layfayette, CO, USA)",0.85,Accept,Experimental Usage,ON-TARGETplus SMARTpool siRNA against BIM
PMID:40507334,10.3390/cancers17111852,Development of a Novel Biomarker Platform for Profiling Key Protein-Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs.,,"Similar transfection was carried out using siRNA against BCL-XL (ON-TARGETplus Human BCL2L1 siRNA SMARTpool, Dharmacon, (Lafayette, CO, USA) Cat#SO-2702960G)",0.85,Accept,Experimental Usage,ON-TARGETplus Human BCL2L1 siRNA SMARTpool
PMID:41001593,10.1080/23723556.2025.2561292,Loss of Schwann cell's normal rhythmic core clock gene expression and gain of rhythmic expression of oncogenic driver genes in malignant NF1-associated peripheral nerve sheath tumor.,,"10 ng mRNA per sample was transcribed into cDNA with AmpliSeq for Illumina Library Prep (Illumina, San Diego, USA)",0.85,Accept,Experimental Usage,AmpliSeq for Illumina Library Prep
PMID:41001593,10.1080/23723556.2025.2561292,Loss of Schwann cell's normal rhythmic core clock gene expression and gain of rhythmic expression of oncogenic driver genes in malignant NF1-associated peripheral nerve sheath tumor.,,Transcript level of the following genes were analyzed using an Illumina custom panel,0.85,Accept,Experimental Usage,Illumina custom panel
PMID:41001593,10.1080/23723556.2025.2561292,Loss of Schwann cell's normal rhythmic core clock gene expression and gain of rhythmic expression of oncogenic driver genes in malignant NF1-associated peripheral nerve sheath tumor.,,"2 µg RNA was transcribed into cDNA using the RevertAid First Strand cDNA Synthesis Kit (Thermo Fisher Scientific, Waltham, USA)",0.85,Accept,Experimental Usage,RevertAid First Strand cDNA Synthesis Kit
PMID:26190969,10.3389/fncel.2015.00234,"In vivo synaptic transmission and morphology in mouse models of Tuberous sclerosis, Fragile X syndrome, Neurofibromatosis type 1, and Costello syndrome.",,"Tsc1 animals were obtained by crossing the +/- Tsc1 line (f/+ Meikle et al., 2005) once with CAGG-Cre mice to obtain germ-line deletion",0.8,Accept,Experimental Usage,CAGG-Cre mice
PMID:26190969,10.3389/fncel.2015.00234,"In vivo synaptic transmission and morphology in mouse models of Tuberous sclerosis, Fragile X syndrome, Neurofibromatosis type 1, and Costello syndrome.",,"we electroporated the afferent fibers to the calyx of Held with Alexa Fluor 594-labeled dextrans (10,000 MW; Invitrogen)",0.85,Accept,Experimental Usage,Alexa Fluor 594-labeled dextrans
PMID:39409151,10.3390/ijms251910822,Proof of Concept for Genome Profiling of the Neurofibroma/Sarcoma Sequence in Neurofibromatosis Type 1.,,"The gDNA was purified starting from formalin-fixed paraffin-embedded (FFPE) samples obtained at surgical resection, using the Magcore DNA FFPE One-Step Kit (Code 405).",0.85,Accept,Experimental Usage,Magcore DNA FFPE One-Step Kit (Code 405)
PMID:39409151,10.3390/ijms251910822,Proof of Concept for Genome Profiling of the Neurofibroma/Sarcoma Sequence in Neurofibromatosis Type 1.,,Fragmented gDNAs were tested for size distribution and concentration using an Agilent Tapestation 4200 and Qubit dsDNA High Sensitivity kit.,0.85,Accept,Experimental Usage,Qubit dsDNA High Sensitivity kit
PMID:39409151,10.3390/ijms251910822,Proof of Concept for Genome Profiling of the Neurofibroma/Sarcoma Sequence in Neurofibromatosis Type 1.,,"The NGS library was executed using the Agilent Sure Select XT HS2 all exon v8 kit (Agilent, Santa Clara, CA, USA), following the manufacturer's instructions.",0.9,Accept,Experimental Usage,Agilent Sure Select XT HS2 all exon v8 kit
PMID:32948135,10.1186/s12885-020-07397-w,Anti-cancer agent 3-bromopyruvate reduces growth of MPNST and inhibits metabolic pathways in a representative in-vitro model.,,"Viability of MPNST cell lines S462, NSF1, and T265 in response to increasing doses (0-120 μM) of 3-BrPA was analyzed by CellTiter-Blue® assay",0.8,Accept,Experimental Usage,CellTiter-Blue® assay
PMID:32948135,10.1186/s12885-020-07397-w,Anti-cancer agent 3-bromopyruvate reduces growth of MPNST and inhibits metabolic pathways in a representative in-vitro model.,,"reactive oxygen species (ROS) production (dihydroethidium assay), nicotinamide adenine dinucleotide dehydrogenase activity",0.8,Accept,Experimental Usage,dihydroethidium assay
PMID:32948135,10.1186/s12885-020-07397-w,Anti-cancer agent 3-bromopyruvate reduces growth of MPNST and inhibits metabolic pathways in a representative in-vitro model.,,nicotinamide adenine dinucleotide dehydrogenase activity (NADH-TR assay) and lactate production (lactate assay),0.8,Accept,Experimental Usage,NADH-TR assay
PMID:32948135,10.1186/s12885-020-07397-w,Anti-cancer agent 3-bromopyruvate reduces growth of MPNST and inhibits metabolic pathways in a representative in-vitro model.,,nicotinamide adenine dinucleotide dehydrogenase activity (NADH-TR assay) and lactate production (lactate assay),0.8,Accept,Experimental Usage,lactate assay
PMID:32948135,10.1186/s12885-020-07397-w,Anti-cancer agent 3-bromopyruvate reduces growth of MPNST and inhibits metabolic pathways in a representative in-vitro model.,,Mouse fibroblast B8 cells...which were stably transfected with plasmid pSG5 vector and encoding PSME3 cDNA,0.85,Accept,Experimental Usage,pSG5 vector
PMID:32948135,10.1186/s12885-020-07397-w,Anti-cancer agent 3-bromopyruvate reduces growth of MPNST and inhibits metabolic pathways in a representative in-vitro model.,,The detection of L(+)-lactate in cell culture media was performed with Lactate Assay Kit (Sigma-Aldrich),0.9,Accept,Experimental Usage,Lactate Assay Kit (Sigma-Aldrich)
PMID:25639352,10.1002/jbmr.2447,Neural Crest-Specific TSC1 Deletion in Mice Leads to Sclerotic Craniofacial Bone Lesion.,,"treated with ProLong® Gold Antifade Reagent with DAPI (Life Technologies, P36931)",0.9,Accept,Experimental Usage,"ProLong Gold Antifade Reagent with DAPI (Life Technologies, P36931)"
PMID:25639352,10.1002/jbmr.2447,Neural Crest-Specific TSC1 Deletion in Mice Leads to Sclerotic Craniofacial Bone Lesion.,,using fluorescein di-β-D-galactopyranoside (FluoReporter LacZ Flow Cytometry Kit; Molecular Probes),0.9,Accept,Experimental Usage,FluoReporter LacZ Flow Cytometry Kit (Molecular Probes)
PMID:18188004,10.4161/epi.3.1.5469,Real-time PCR analysis of candidate imprinted genes on mouse chromosome 11 shows balanced expression from the maternal and paternal chromosomes and strain-specific variation in expression levels.,,"The tissue was weighed and 100 mg was homogenized in Trizol Reagent (Invitrogen, Carlsbad, CA) using an Omni power homogenizer",0.8,Accept,Experimental Usage,Trizol Reagent
PMID:18188004,10.4161/epi.3.1.5469,Real-time PCR analysis of candidate imprinted genes on mouse chromosome 11 shows balanced expression from the maternal and paternal chromosomes and strain-specific variation in expression levels.,,"100 mg was homogenized in Trizol Reagent (Invitrogen, Carlsbad, CA) using an Omni power homogenizer (Omni International, Marietta, GA).",0.8,Accept,Experimental Usage,Omni power homogenizer
PMID:18188004,10.4161/epi.3.1.5469,Real-time PCR analysis of candidate imprinted genes on mouse chromosome 11 shows balanced expression from the maternal and paternal chromosomes and strain-specific variation in expression levels.,,"The isolated total RNA was quantified using a NanoDrop (NanoDrop Technologies, Wilmington, DE).",0.8,Accept,Experimental Usage,NanoDrop
PMID:18188004,10.4161/epi.3.1.5469,Real-time PCR analysis of candidate imprinted genes on mouse chromosome 11 shows balanced expression from the maternal and paternal chromosomes and strain-specific variation in expression levels.,,"Prior to cDNA synthesis the total RNA was DNased-treated with DNAfree (Ambion, Austin, TX) following the manufacturer's protocol.",0.8,Accept,Experimental Usage,DNAfree
PMID:18188004,10.4161/epi.3.1.5469,Real-time PCR analysis of candidate imprinted genes on mouse chromosome 11 shows balanced expression from the maternal and paternal chromosomes and strain-specific variation in expression levels.,,"The cDNA was synthesized using Superscript II First-Strand Synthesis System for RT-PCR (Invitrogen, Carlsbad, CA).",0.85,Accept,Experimental Usage,Superscript II First-Strand Synthesis System for RT-PCR
PMID:18769552,10.1155/2008/849156,Frequent EGFR Positivity and Overexpression in High-Grade Areas of Human MPNSTs.,,"and anti-Ki-67 (Mib1 Dako, final dilution 1/50), staining was revealed with LSAB kit (Dako).",0.85,Accept,Experimental Usage,LSAB kit (Dako)
PMID:18769552,10.1155/2008/849156,Frequent EGFR Positivity and Overexpression in High-Grade Areas of Human MPNSTs.,,"For anti-Survivin (12C4, Dako, final dilution 1/100) staining was revealed with CSAII (Dako), according to manufacturer's instruction.",0.85,Accept,Experimental Usage,CSAII (Dako)
PMID:18769552,10.1155/2008/849156,Frequent EGFR Positivity and Overexpression in High-Grade Areas of Human MPNSTs.,,EGFR specific sequence probe (LSI EGFR) and control chromosome enumeration probe 7 (CEP7) were used according to the manufacturers' recommended protocol (Vysis-Abbott Molecular Diagnostics,0.9,Accept,Experimental Usage,"LSI EGFR probe (Vysis-Abbott Molecular Diagnostics, Baar, Switzerland)"
PMID:18769552,10.1155/2008/849156,Frequent EGFR Positivity and Overexpression in High-Grade Areas of Human MPNSTs.,,EGFR specific sequence probe (LSI EGFR) and control chromosome enumeration probe 7 (CEP7) were used according to the manufacturers' recommended protocol (Vysis-Abbott Molecular Diagnostics,0.9,Accept,Experimental Usage,"CEP7 probe (Vysis-Abbott Molecular Diagnostics, Baar, Switzerland)"
PMID:18769552,10.1155/2008/849156,Frequent EGFR Positivity and Overexpression in High-Grade Areas of Human MPNSTs.,,The DNA probes and the sections of tissues were denatured at 85°C for 5 minutes using a HYBrite instrument.,0.8,Accept,Experimental Usage,HYBrite instrument
PMID:18769552,10.1155/2008/849156,Frequent EGFR Positivity and Overexpression in High-Grade Areas of Human MPNSTs.,,"real-time quantitative RT-PCR using the ABI Prism 7700 sequence detection system (Applied Biosystems, Foster City, Calif, USA) have been described in detail elsewhere",0.9,Accept,Experimental Usage,"ABI Prism 7700 sequence detection system (Applied Biosystems, Foster City, Calif, USA)"
PMID:34573290,10.3390/genes12091308,Performance Evaluation of SpliceAI for the Prediction of Splicing of ,,"DNA was extracted using a Wizard Genomic DNA Purification Kit (Promega, Madison, WI, USA) according to the manufacturer's instructions",0.85,Accept,Experimental Usage,Wizard Genomic DNA Purification Kit (Promega)
PMID:34573290,10.3390/genes12091308,Performance Evaluation of SpliceAI for the Prediction of Splicing of ,,1 µg of samples were reverse transcribed using Thermo Scientific RevertAid First Strand cDNA Synthesis Kit (Thermo Fisher Scientific),0.85,Accept,Experimental Usage,Thermo Scientific RevertAid First Strand cDNA Synthesis Kit
PMID:34573290,10.3390/genes12091308,Performance Evaluation of SpliceAI for the Prediction of Splicing of ,,Cyclic sequencing was performed using the BigDye Terminator v3.1 Cycle Sequencing Kit (Applied Biosystems),0.85,Accept,Experimental Usage,BigDye Terminator v3.1 Cycle Sequencing Kit (Applied Biosystems)
PMID:22811580,10.1158/1078-0432.CCR-12-1072,Ras-driven transcriptome analysis identifies aurora kinase A as a potential malignant peripheral nerve sheath tumor therapeutic target.,,Total RNA was isolated from cells using the RNeasy kit (Qiagen),0.85,Accept,Experimental Usage,RNeasy kit
PMID:22811580,10.1158/1078-0432.CCR-12-1072,Ras-driven transcriptome analysis identifies aurora kinase A as a potential malignant peripheral nerve sheath tumor therapeutic target.,,"used as a template for cDNA synthesis (High-Capacity cDNA archive kit, Applied Biosystems)",0.85,Accept,Experimental Usage,High-Capacity cDNA archive kit
PMID:22811580,10.1158/1078-0432.CCR-12-1072,Ras-driven transcriptome analysis identifies aurora kinase A as a potential malignant peripheral nerve sheath tumor therapeutic target.,,"an AURKA selective inhibitor, MLN8237, stabilized tumor volume and significantly increased survival",0.9,Accept,Experimental Usage,MLN8237
PMID:22811580,10.1158/1078-0432.CCR-12-1072,Ras-driven transcriptome analysis identifies aurora kinase A as a potential malignant peripheral nerve sheath tumor therapeutic target.,,MTS assay using Cell titer 96 proliferation kit (Promega),0.85,Accept,Experimental Usage,Cell titer 96 proliferation kit
PMID:26657314,10.1371/journal.pone.0144620,Immortalized Human Schwann Cell Lines Derived From Tumors of Schwannomatosis Patients.,,Cells were immortalized using pLenti-SV40 from ABM (catalog number G203) according to manufacturer's instructions.,0.95,Accept,Experimental Usage,pLenti-SV40 from ABM (catalog number G203)
PMID:26657314,10.1371/journal.pone.0144620,Immortalized Human Schwann Cell Lines Derived From Tumors of Schwannomatosis Patients.,,The cell pellet was suspended in 1mL of the human Schwann cell medium (Sciencell).,0.9,Accept,Experimental Usage,human Schwann cell medium (Sciencell)
PMID:26657314,10.1371/journal.pone.0144620,Immortalized Human Schwann Cell Lines Derived From Tumors of Schwannomatosis Patients.,,Tumor tissues were homogenized using the polytron PT1300 tissue homogenizer followed by additional homogenization using a Qiashredder spin column (Qiagen).,0.85,Accept,Experimental Usage,Qiashredder spin column (Qiagen)
PMID:26657314,10.1371/journal.pone.0144620,Immortalized Human Schwann Cell Lines Derived From Tumors of Schwannomatosis Patients.,,RNA DNA and protein were extracted using the Allprep extraction kit (Qiagen).,0.85,Accept,Experimental Usage,Allprep extraction kit (Qiagen)
PMID:26657314,10.1371/journal.pone.0144620,Immortalized Human Schwann Cell Lines Derived From Tumors of Schwannomatosis Patients.,,"RNA from cells in culture was extracted using Trizol, followed by clean up with RNeasy RNA extraction kit (Qiagen).",0.85,Accept,Experimental Usage,RNeasy RNA extraction kit (Qiagen)
PMID:26657314,10.1371/journal.pone.0144620,Immortalized Human Schwann Cell Lines Derived From Tumors of Schwannomatosis Patients.,,1ug of total RNA was converted to cDNA using the Quantitect Reverse Transcription kit (Qiagen).,0.85,Accept,Experimental Usage,Quantitect Reverse Transcription kit (Qiagen)
PMID:26657314,10.1371/journal.pone.0144620,Immortalized Human Schwann Cell Lines Derived From Tumors of Schwannomatosis Patients.,,"One microliter of each tumor, cell line, and normal primary human Schwann cell cDNA, was used for real-time qRT-PCR using QuantiTect SYBR Green PCR kit (Qiagen).",0.85,Accept,Experimental Usage,QuantiTect SYBR Green PCR kit (Qiagen)
PMID:21980365,10.1371/journal.pone.0024917,The haploinsufficient hematopoietic microenvironment is critical to the pathological fracture repair in murine models of neurofibromatosis type 1.,,cultured in mouse MesenCult basal medium containing MesenCult Supplement (Stem Cell Technologies Inc.),0.8,Accept,Experimental Usage,MesenCult basal medium
PMID:22916147,10.1371/journal.pone.0042682,Applying microsatellite multiplex PCR analysis (MMPA) for determining allele copy-number status and percentage of normal cells within tumors.,,DNA from blood was isolated either by the Wizard Genomic DNA purification kit (Promega) according to the manufacturer's instructions,0.85,Accept,Experimental Usage,Wizard Genomic DNA purification kit (Promega)
PMID:22916147,10.1371/journal.pone.0042682,Applying microsatellite multiplex PCR analysis (MMPA) for determining allele copy-number status and percentage of normal cells within tumors.,,DNA from skin or neurofibromas was extracted using the Gentra Puregene Kit (Qiagen) following manufacturer's instructions,0.85,Accept,Experimental Usage,Gentra Puregene Kit (Qiagen)
PMID:22916147,10.1371/journal.pone.0042682,Applying microsatellite multiplex PCR analysis (MMPA) for determining allele copy-number status and percentage of normal cells within tumors.,,"For an accurate quantification of DNA concentration, samples were further quantified using Quant-iT PicoGreen reagent (Invitrogen)",0.85,Accept,Experimental Usage,Quant-iT PicoGreen reagent (Invitrogen)
PMID:22916147,10.1371/journal.pone.0042682,Applying microsatellite multiplex PCR analysis (MMPA) for determining allele copy-number status and percentage of normal cells within tumors.,,"We used a Multiplex PCR Kit (Qiagen) with which we obtained good global microsatellite amplification, providing good peak heights",0.85,Accept,Experimental Usage,Multiplex PCR Kit (Qiagen)
PMID:22916147,10.1371/journal.pone.0042682,Applying microsatellite multiplex PCR analysis (MMPA) for determining allele copy-number status and percentage of normal cells within tumors.,,"SNP-array data generated in a previous study (Illumina Infinium SNP-array, Human660W-Quad beadchip ∼660000 SNPs)",0.85,Accept,Experimental Usage,"Illumina Infinium SNP-array, Human660W-Quad beadchip"
PMID:24786638,10.1016/j.ygyno.2014.04.044,Analyses of merlin/NF2 connection to FAK inhibitor responsiveness in serous ovarian cancer.,,"...small molecule FAK inhibitor (PF-271, also termed VS-6062) from 0.1 to 1 μM for 72 h...PF-271 was synthesized as described",0.9,Accept,Experimental Usage,PF-271
PMID:24786638,10.1016/j.ygyno.2014.04.044,Analyses of merlin/NF2 connection to FAK inhibitor responsiveness in serous ovarian cancer.,,"...small molecule FAK inhibitor (PF-271, also termed VS-6062) from 0.1 to 1 μM for 72 h",0.9,Accept,Experimental Usage,VS-6062
PMID:24786638,10.1016/j.ygyno.2014.04.044,Analyses of merlin/NF2 connection to FAK inhibitor responsiveness in serous ovarian cancer.,,NF2 shRNA lentivirus plasmids (Clone IDs: 000268.x-47s1c1 and 000268.x-2467s1c1) and pLKO.1-puro non-target shRNA control plasmid (SHC016) were from Mission-Sigma,0.95,Accept,Experimental Usage,NF2 shRNA lentivirus plasmids (Clone IDs: 000268.x-47s1c1 and 000268.x-2467s1c1)
PMID:24786638,10.1016/j.ygyno.2014.04.044,Analyses of merlin/NF2 connection to FAK inhibitor responsiveness in serous ovarian cancer.,,NF2 shRNA lentivirus plasmids (Clone IDs: 000268.x-47s1c1 and 000268.x-2467s1c1) and pLKO.1-puro non-target shRNA control plasmid (SHC016) were from Mission-Sigma,0.95,Accept,Experimental Usage,pLKO.1-puro non-target shRNA control plasmid (SHC016)
PMID:24786638,10.1016/j.ygyno.2014.04.044,Analyses of merlin/NF2 connection to FAK inhibitor responsiveness in serous ovarian cancer.,,"The coding sequence for fluorescent mCherry protein (pmCherry-C1, Clontech) was subcloned into the lentiviral expression vector",0.9,Accept,Experimental Usage,pmCherry-C1
PMID:24786638,10.1016/j.ygyno.2014.04.044,Analyses of merlin/NF2 connection to FAK inhibitor responsiveness in serous ovarian cancer.,,"The coding sequence for fluorescent mCherry protein (pmCherry-C1, Clontech) was subcloned into the lentiviral expression vector (pCDH-CMVMSC1, System Biosciences)",0.9,Accept,Experimental Usage,pCDH-CMVMSC1
PMID:20739432,10.1158/1078-0432.CCR-10-0613,Gene expression analysis identifies potential biomarkers of neurofibromatosis type 1 including adrenomedullin.,,We used total RNA as a template to synthesize double-stranded cDNA using an oligo(dT) primer with SuperScript II reverse transcriptase (Invitrogen).,0.85,Accept,Experimental Usage,SuperScript II reverse transcriptase
PMID:20739432,10.1158/1078-0432.CCR-10-0613,Gene expression analysis identifies potential biomarkers of neurofibromatosis type 1 including adrenomedullin.,,Amplification was conducted in SYBR Green Master Mix (Applied Biosystems).,0.85,Accept,Experimental Usage,SYBR Green Master Mix
PMID:20739432,10.1158/1078-0432.CCR-10-0613,Gene expression analysis identifies potential biomarkers of neurofibromatosis type 1 including adrenomedullin.,,We conducted ELISA assays on serum-free conditioned medium and human serum using an ADM detection kit (Phoenix Pharmaceuticals),0.9,Accept,Experimental Usage,ADM detection kit (Phoenix Pharmaceuticals)
PMID:20739432,10.1158/1078-0432.CCR-10-0613,Gene expression analysis identifies potential biomarkers of neurofibromatosis type 1 including adrenomedullin.,,and Human HGF ELISA kit (R&D Systems) following the manufacturer's suggested protocol.,0.9,Accept,Experimental Usage,Human HGF ELISA kit (R&D Systems)
PMID:20739432,10.1158/1078-0432.CCR-10-0613,Gene expression analysis identifies potential biomarkers of neurofibromatosis type 1 including adrenomedullin.,,"Cells (4 × 10 4 ) in serum-free DMEM were plated on the upper chamber of a 24-well Transwell plate with 8-μm pore membranes (Costar, Corning, Inc.).",0.85,Accept,Experimental Usage,"Transwell plate with 8-μm pore membranes (Costar, Corning, Inc.)"
PMID:20739432,10.1158/1078-0432.CCR-10-0613,Gene expression analysis identifies potential biomarkers of neurofibromatosis type 1 including adrenomedullin.,,plated (4 × 10 5  cells/mL) in wells of 96-well plates coated with Matrigel (BD Biosciences),0.85,Accept,Experimental Usage,Matrigel (BD Biosciences)
PMID:24997609,10.1038/nm.3583,"Asfotase-α improves bone growth, mineralization and strength in mouse models of neurofibromatosis type-1.",,"sALP-FcD10 (Asfotase Alfa, Alexion Pharmaceuticals) was described previously. Briefly, mineral-targeting recombinant tissue nonspecific alkaline phosphatase",0.95,Accept,Experimental Usage,"sALP-FcD10 (Asfotase Alfa, Alexion Pharmaceuticals)"
PMID:24997609,10.1038/nm.3583,"Asfotase-α improves bone growth, mineralization and strength in mouse models of neurofibromatosis type-1.",,"cells were incubated in complete culture medium containing either Ad5-CMV-GFP or Ad5-CMV-cre (Vector development lab, Baylor College of Medicine)",0.9,Accept,Experimental Usage,Ad5-CMV-GFP
PMID:24997609,10.1038/nm.3583,"Asfotase-α improves bone growth, mineralization and strength in mouse models of neurofibromatosis type-1.",,"cells were incubated in complete culture medium containing either Ad5-CMV-GFP or Ad5-CMV-cre (Vector development lab, Baylor College of Medicine)",0.9,Accept,Experimental Usage,Ad5-CMV-cre
PMID:24997609,10.1038/nm.3583,"Asfotase-α improves bone growth, mineralization and strength in mouse models of neurofibromatosis type-1.",,"Vitamin D, phosphate and calcium concentration in mouse serum was determined using a 25OH-Vitamin-D ELISA Assay kit (Eagle Biosciences, cat# VID31-K01)",0.9,Accept,Experimental Usage,"25OH-Vitamin-D ELISA Assay kit (Eagle Biosciences, cat# VID31-K01)"
PMID:24997609,10.1038/nm.3583,"Asfotase-α improves bone growth, mineralization and strength in mouse models of neurofibromatosis type-1.",,"phosphate and calcium concentration in mouse serum was determined using...a Phosphate Assay kit (BioVision, cat # k410–500)",0.9,Accept,Experimental Usage,"Phosphate Assay kit (BioVision, cat # k410–500)"
PMID:24997609,10.1038/nm.3583,"Asfotase-α improves bone growth, mineralization and strength in mouse models of neurofibromatosis type-1.",,"calcium concentration in mouse serum was determined using...a Calcium Assay kit (BioVision, cat# k380–250)",0.9,Accept,Experimental Usage,"Calcium Assay kit (BioVision, cat# k380–250)"
PMID:39620202,10.1093/noajnl/vdae188,Multiomic analyses reveal new targets of polycomb repressor complex 2 in Schwann lineage cells and malignant peripheral nerve sheath tumors.,,RNA was extracted using the RNeasy Mini Kit (Qiagen) and sent to the University of Minnesota Genomics Center,0.85,Accept,Experimental Usage,RNeasy Mini Kit
PMID:39620202,10.1093/noajnl/vdae188,Multiomic analyses reveal new targets of polycomb repressor complex 2 in Schwann lineage cells and malignant peripheral nerve sheath tumors.,,RNA was extracted using the PureLink RNA Mini Kit (Invitrogen). cDNA was synthesized using the SuperScript IV First Strand Synthesis Kit,0.85,Accept,Experimental Usage,PureLink RNA Mini Kit
PMID:39620202,10.1093/noajnl/vdae188,Multiomic analyses reveal new targets of polycomb repressor complex 2 in Schwann lineage cells and malignant peripheral nerve sheath tumors.,,cDNA was synthesized using the SuperScript IV First Strand Synthesis Kit (Invitrogen),0.85,Accept,Experimental Usage,SuperScript IV First Strand Synthesis Kit
PMID:39620202,10.1093/noajnl/vdae188,Multiomic analyses reveal new targets of polycomb repressor complex 2 in Schwann lineage cells and malignant peripheral nerve sheath tumors.,,All treatments used SMARTpool ON-TARGETplus Human short interfering RNA (siRNA) (Dharmacon),0.9,Accept,Experimental Usage,SMARTpool ON-TARGETplus Human short interfering RNA
PMID:39620202,10.1093/noajnl/vdae188,Multiomic analyses reveal new targets of polycomb repressor complex 2 in Schwann lineage cells and malignant peripheral nerve sheath tumors.,,"cells were treated with 1 µM EZH2 methyltransferase inhibitor (Selleck Chemicals, GSK126) for 10 days",0.85,Accept,Experimental Usage,GSK126
PMID:39620202,10.1093/noajnl/vdae188,Multiomic analyses reveal new targets of polycomb repressor complex 2 in Schwann lineage cells and malignant peripheral nerve sheath tumors.,,"MPNST cell lines (wild-type and GOF) were treated with γ-secretase inhibitor, nirogacestat (Selleckchem, S8018)",0.85,Accept,Experimental Usage,nirogacestat
PMID:39620202,10.1093/noajnl/vdae188,Multiomic analyses reveal new targets of polycomb repressor complex 2 in Schwann lineage cells and malignant peripheral nerve sheath tumors.,,"treated with γ-secretase inhibitor, nirogacestat (Selleckchem, S8018), and mirdametinib (Selleckchem, S1036)",0.85,Accept,Experimental Usage,mirdametinib
PMID:39620202,10.1093/noajnl/vdae188,Multiomic analyses reveal new targets of polycomb repressor complex 2 in Schwann lineage cells and malignant peripheral nerve sheath tumors.,,The 96-well plate was stained with alamarBlue (Invitrogen) to determine proliferation on day 3,0.8,Accept,Experimental Usage,alamarBlue
PMID:39620202,10.1093/noajnl/vdae188,Multiomic analyses reveal new targets of polycomb repressor complex 2 in Schwann lineage cells and malignant peripheral nerve sheath tumors.,,cells were stained with the Dead Cell Apoptosis Kit with Annexin V Alexa Fluor™ 488 & Propidium Iodide following the manufacturer's protocol (Invitrogen),0.85,Accept,Experimental Usage,Dead Cell Apoptosis Kit with Annexin V Alexa Fluor™ 488 & Propidium Iodide
PMID:39620202,10.1093/noajnl/vdae188,Multiomic analyses reveal new targets of polycomb repressor complex 2 in Schwann lineage cells and malignant peripheral nerve sheath tumors.,,Cells were also stained with Vybrant™ DyeCycle™ Violet Stain following the manufacturer's protocol (Invitrogen),0.85,Accept,Experimental Usage,Vybrant™ DyeCycle™ Violet Stain
PMID:39016685,10.1242/jcs.262343,Chemical genetic screens reveal defective lysosomal trafficking as synthetic lethal with NF1 loss.,,cells were transfected with lentiCRISPRv2 (# 52961 Addgene) and gRNA at a 3:1 ratio using Lipofectamine 2000,0.9,Accept,Experimental Usage,lentiCRISPRv2
PMID:39016685,10.1242/jcs.262343,Chemical genetic screens reveal defective lysosomal trafficking as synthetic lethal with NF1 loss.,,Y102 was originally purchased from Maybridge (NRB04162SC). Subsequent stocks of Y102...were synthesized by Enamine,0.85,Accept,Experimental Usage,Y102
PMID:39016685,10.1242/jcs.262343,Chemical genetic screens reveal defective lysosomal trafficking as synthetic lethal with NF1 loss.,,LC-MS/MS analysis was performed on an Orbitrap Fusion Tribrid mass spectrometer (Thermo Fisher Scientific),0.85,Accept,Experimental Usage,Orbitrap Fusion
PMID:39016685,10.1242/jcs.262343,Chemical genetic screens reveal defective lysosomal trafficking as synthetic lethal with NF1 loss.,,Each temperature treatment was differentially labeled using TMT-10-plex reagent (Thermo Fisher Scientific),0.85,Accept,Experimental Usage,TMT-10-plex reagent
PMID:21157378,10.1097/NEN.0b013e3182032d37,Neurofibromatosis-1 heterozygosity increases microglia in a spatially and temporally restricted pattern relevant to mouse optic glioma formation and growth.,,"Amplification was performed in 96 well plates in a real-time sequence detection system instrument (Bio-Rad CFX96 Real-Time System, Hercules, CA)",0.9,Accept,Experimental Usage,Bio-Rad CFX96 Real-Time System
PMID:21157378,10.1097/NEN.0b013e3182032d37,Neurofibromatosis-1 heterozygosity increases microglia in a spatially and temporally restricted pattern relevant to mouse optic glioma formation and growth.,,"cDNA was synthesized from total RNA samples using the Omniscript kit (Qiagen, Alameda, CA)",0.9,Accept,Experimental Usage,"Omniscript kit (Qiagen, Alameda, CA)"
PMID:25877069,10.1007/s11626-015-9885-z,Establishment of immortalized murine mesothelial cells and a novel mesothelioma cell line.,,"The transfer plasmid pCMV/TO SV40 was obtained from Addgene (# 22298). Primary cells were seeded at a density of 10,000 cells/cm 2",0.9,Accept,Experimental Usage,pCMV/TO SV40
PMID:33574490,10.1038/s41598-021-83152-w,Using antisense oligonucleotides for the physiological modulation of the alternative splicing of NF1 exon 23a during PC12 neuronal differentiation.,,We designed antisense Phosphorodiamidate Morpholino Oligomers (PMOs) to modulate E23a alternative splicing at physiological conditions,0.9,Accept,Experimental Usage,Phosphorodiamidate Morpholino Oligomers (PMOs)
PMID:21697395,10.1158/1535-7163.MCT-11-0309,Discovery of a small molecule targeting IRA2 deletion in budding yeast and neurofibromin loss in malignant peripheral nerve sheath tumor cells.,,erg6Δ and erg6Δ ira2Δ were generated using standard one-step PCR-based gene deletion methods,0.85,Accept,Development,erg6Δ
PMID:21697395,10.1158/1535-7163.MCT-11-0309,Discovery of a small molecule targeting IRA2 deletion in budding yeast and neurofibromin loss in malignant peripheral nerve sheath tumor cells.,,erg6Δ and erg6Δ ira2Δ were generated using standard one-step PCR-based gene deletion methods,0.85,Accept,Development,erg6Δ ira2Δ
PMID:21697395,10.1158/1535-7163.MCT-11-0309,Discovery of a small molecule targeting IRA2 deletion in budding yeast and neurofibromin loss in malignant peripheral nerve sheath tumor cells.,,The YEp13-NAB3 plasmid was generated from a suppressing YEp13 plasmid containing genomic DNA of chromosome XVI,0.9,Accept,Development,YEp13-NAB3
PMID:21697395,10.1158/1535-7163.MCT-11-0309,Discovery of a small molecule targeting IRA2 deletion in budding yeast and neurofibromin loss in malignant peripheral nerve sheath tumor cells.,,"nab3Δ nab3-3 was obtained from Dr. M. Swanson, and nab3–11 was a gift from Dr. J. Corden",0.85,Accept,Experimental Usage,nab3Δ nab3-3
PMID:21697395,10.1158/1535-7163.MCT-11-0309,Discovery of a small molecule targeting IRA2 deletion in budding yeast and neurofibromin loss in malignant peripheral nerve sheath tumor cells.,,"nab3Δ nab3-3 was obtained from Dr. M. Swanson, and nab3–11 was a gift from Dr. J. Corden",0.85,Accept,Experimental Usage,nab3–11
PMID:21697395,10.1158/1535-7163.MCT-11-0309,Discovery of a small molecule targeting IRA2 deletion in budding yeast and neurofibromin loss in malignant peripheral nerve sheath tumor cells.,,The ctk1Δ::KANMX allele was backcrossed to the Σ1278b background from the Open Biosystems yeast deletion collection,0.85,Accept,Experimental Usage,ctk1Δ::KANMX
PMID:21697395,10.1158/1535-7163.MCT-11-0309,Discovery of a small molecule targeting IRA2 deletion in budding yeast and neurofibromin loss in malignant peripheral nerve sheath tumor cells.,,STS26T and T265 cells were routinely maintained in DMEM high-glucose medium (Invitrogen 11965-092) with 10% FBS,0.8,Accept,Experimental Usage,DMEM high-glucose medium (Invitrogen 11965-092)
PMID:21697395,10.1158/1535-7163.MCT-11-0309,Discovery of a small molecule targeting IRA2 deletion in budding yeast and neurofibromin loss in malignant peripheral nerve sheath tumor cells.,,maintained in DMEM high-glucose medium (Invitrogen 11965-092) with 10% FBS (Invitrogen 26140-079) and 1% penicillin/streptomycin,0.8,Accept,Experimental Usage,FBS (Invitrogen 26140-079)
PMID:21697395,10.1158/1535-7163.MCT-11-0309,Discovery of a small molecule targeting IRA2 deletion in budding yeast and neurofibromin loss in malignant peripheral nerve sheath tumor cells.,,with 10% FBS (Invitrogen 26140-079) and 1% penicillin/streptomycin (Invitrogen 15070-063),0.8,Accept,Experimental Usage,penicillin/streptomycin (Invitrogen 15070-063)
PMID:21697395,10.1158/1535-7163.MCT-11-0309,Discovery of a small molecule targeting IRA2 deletion in budding yeast and neurofibromin loss in malignant peripheral nerve sheath tumor cells.,,RNA was extracted from 5–10 × 10^6 cells with TriReagent (MRC TR-118) per manufacturers instruction,0.8,Accept,Experimental Usage,TriReagent (MRC TR-118)
PMID:21697395,10.1158/1535-7163.MCT-11-0309,Discovery of a small molecule targeting IRA2 deletion in budding yeast and neurofibromin loss in malignant peripheral nerve sheath tumor cells.,,RNA was treated with DNAse I (Roche 04716728001) according to manufacturers instructions,0.8,Accept,Experimental Usage,DNAse I (Roche 04716728001)
PMID:21697395,10.1158/1535-7163.MCT-11-0309,Discovery of a small molecule targeting IRA2 deletion in budding yeast and neurofibromin loss in malignant peripheral nerve sheath tumor cells.,,200 ng of DNAse-I-treated RNA was used in a reverse transcription using Invitrogen SuperScript III Reverse Transcriptase (Invitrogen 18080-044),0.8,Accept,Experimental Usage,SuperScript III Reverse Transcriptase (Invitrogen 18080-044)
PMID:18632626,10.1158/0008-5472.CAN-08-0190,Merlin is a potent inhibitor of glioma growth.,,Wild-type merlin and the merlin mutants together with their COOH terminal v5-epitope tags were cloned into the retroviral expression vector pQCXIP (BD Bioscience),0.85,Accept,Experimental Usage,pQCXIP (BD Bioscience)
PMID:18632626,10.1158/0008-5472.CAN-08-0190,Merlin is a potent inhibitor of glioma growth.,,the merlin mutants were generated using the QuikChange mutagenesis kits (Stratagene),0.85,Accept,Experimental Usage,QuikChange mutagenesis kits (Stratagene)
PMID:18632626,10.1158/0008-5472.CAN-08-0190,Merlin is a potent inhibitor of glioma growth.,,"5-Bromo-2'-deoxy-uridine (BrdUrd) cell proliferation kit (Roche), Apoptag kit (Chemicon), and RhoA pull-down kit (Cytoskeleton, Inc.) were also used",0.8,Accept,Experimental Usage,5-Bromo-2'-deoxy-uridine (BrdUrd) cell proliferation kit (Roche)
PMID:18632626,10.1158/0008-5472.CAN-08-0190,Merlin is a potent inhibitor of glioma growth.,,"5-Bromo-2'-deoxy-uridine (BrdUrd) cell proliferation kit (Roche), Apoptag kit (Chemicon), and RhoA pull-down kit (Cytoskeleton, Inc.)",0.8,Accept,Experimental Usage,Apoptag kit (Chemicon)
PMID:18632626,10.1158/0008-5472.CAN-08-0190,Merlin is a potent inhibitor of glioma growth.,,"Apoptag kit (Chemicon), and RhoA pull-down kit (Cytoskeleton, Inc.) were also used",0.8,Accept,Experimental Usage,"RhoA pull-down kit (Cytoskeleton, Inc.)"
PMID:18632626,10.1158/0008-5472.CAN-08-0190,Merlin is a potent inhibitor of glioma growth.,,"To compare gene expression profiles, we used human U133v2 gene chips (Affymetrix) and the probes derived from three independently transduced",0.85,Accept,Experimental Usage,human U133v2 gene chips (Affymetrix)
PMID:18632626,10.1158/0008-5472.CAN-08-0190,Merlin is a potent inhibitor of glioma growth.,,"we used the β-catenin–responsive luciferase reporter construct (TopFlash, Addgene), which contains T-cell factor/lymphocyte enhancer factor (TCF/LEF) binding sites",0.85,Accept,Experimental Usage,TopFlash (Addgene)
PMID:37817770,10.3389/fonc.2023.1253659,Single-cell RNA sequencing of neurofibromas reveals a tumor microenvironment favorable for neural regeneration and immune suppression in a neurofibromatosis type 1 porcine model.,,"...digested with a Tumor Dissociation Kit (Cat #130-095-929; Miltenyi Biotec, Gaithersburg, MD, USA)...",0.9,Accept,Experimental Usage,Tumor Dissociation Kit (Cat #130-095-929; Miltenyi Biotec)
PMID:37817770,10.3389/fonc.2023.1253659,Single-cell RNA sequencing of neurofibromas reveals a tumor microenvironment favorable for neural regeneration and immune suppression in a neurofibromatosis type 1 porcine model.,,"...Libraries were constructed according to the Chromium Single Cell 3' Reagent Kit v3.1 user guide (10x Genomics, Pleasanton, CA)...",0.9,Accept,Experimental Usage,Chromium Single Cell 3' Reagent Kit v3.1
PMID:16524466,10.1186/1471-2202-7-22,Cognitive dysfunction in NF1 knock-out mice may result from altered vesicular trafficking of APP/DRD3 complex.,,"Genotyping was performed through a series of PCR reactions containing one microliter (approximately 100 ng) of sample DNA, 10 pM of primers, 1× PCR buffer, 2.25 mM MgCl 2 , 10 mM of each dNTP, and 1 unit of Taq Gold polymerase.",0.85,Accept,Experimental Usage,Taq Gold polymerase
PMID:16524466,10.1186/1471-2202-7-22,Cognitive dysfunction in NF1 knock-out mice may result from altered vesicular trafficking of APP/DRD3 complex.,,Total RNA was isolated from each 40 mg tissue sample using Stratagene RTPCR Mini-prep kit (the average yield was 15 μg RNA/40 mg tissue).,0.85,Accept,Experimental Usage,Stratagene RTPCR Mini-prep kit
PMID:16524466,10.1186/1471-2202-7-22,Cognitive dysfunction in NF1 knock-out mice may result from altered vesicular trafficking of APP/DRD3 complex.,,"Extracted RNA was subsequently cleaned using the Qiagen Mini kit protocol, and the purified RNA was analyzed through agarose gel electrophoresis to insure quality.",0.85,Accept,Experimental Usage,Qiagen Mini kit
PMID:16524466,10.1186/1471-2202-7-22,Cognitive dysfunction in NF1 knock-out mice may result from altered vesicular trafficking of APP/DRD3 complex.,,Total RNA was extracted from ~20 mg of hippocampus from 3 Nf1 +/- and 3 wild type mice using the Absolutely RNA Miniprep Kit (Stratagene).,0.85,Accept,Experimental Usage,Absolutely RNA Miniprep Kit (Stratagene)
PMID:16524466,10.1186/1471-2202-7-22,Cognitive dysfunction in NF1 knock-out mice may result from altered vesicular trafficking of APP/DRD3 complex.,,"Reverse transcription reactions were done using 3 μg of total RNA from hippocampus, oligo dT primers, and the Super Script III First Strand cDNA synthesis kit (Invitrogen).",0.85,Accept,Experimental Usage,Super Script III First Strand cDNA synthesis kit (Invitrogen)
PMID:16524466,10.1186/1471-2202-7-22,Cognitive dysfunction in NF1 knock-out mice may result from altered vesicular trafficking of APP/DRD3 complex.,,Resulting cDNA was amplified on the Chromo4 Four-Color Real-Time System (MJ Research) using the DyNAmo HS SYBR Green qPCR Kit (Finnzymes),0.85,Accept,Experimental Usage,DyNAmo HS SYBR Green qPCR Kit (Finnzymes)
PMID:26549023,10.1038/onc.2015.404,"The scaffold protein KSR1, a novel therapeutic target for the treatment of Merlin-deficient tumors.",,"Plasmids pcDNA3-pyo-mKSR1 wild-type, S443A and 4xA ( 11 , 22 ), pcDNA3.2-V5-Merlin-S518A/D ( 5 ) were described previously",0.9,Accept,Experimental Usage,pcDNA3-pyo-mKSR1 wild-type
PMID:26549023,10.1038/onc.2015.404,"The scaffold protein KSR1, a novel therapeutic target for the treatment of Merlin-deficient tumors.",,"Plasmids pcDNA3-pyo-mKSR1 wild-type, S443A and 4xA ( 11 , 22 ), pcDNA3.2-V5-Merlin-S518A/D ( 5 ) were described previously",0.9,Accept,Experimental Usage,pcDNA3-pyo-mKSR1 S443A
PMID:26549023,10.1038/onc.2015.404,"The scaffold protein KSR1, a novel therapeutic target for the treatment of Merlin-deficient tumors.",,"Plasmids pcDNA3-pyo-mKSR1 wild-type, S443A and 4xA ( 11 , 22 ), pcDNA3.2-V5-Merlin-S518A/D ( 5 ) were described previously",0.9,Accept,Experimental Usage,pcDNA3-pyo-mKSR1 4xA
PMID:26549023,10.1038/onc.2015.404,"The scaffold protein KSR1, a novel therapeutic target for the treatment of Merlin-deficient tumors.",,"Plasmids pcDNA3-pyo-mKSR1 wild-type, S443A and 4xA ( 11 , 22 ), pcDNA3.2-V5-Merlin-S518A/D ( 5 ) were described previously",0.9,Accept,Experimental Usage,pcDNA3.2-V5-Merlin-S518A/D
PMID:26549023,10.1038/onc.2015.404,"The scaffold protein KSR1, a novel therapeutic target for the treatment of Merlin-deficient tumors.",,All transfections for schwannoma cells were carried out with Lipofectamine ™ 2000 (Invitrogen),0.85,Accept,Experimental Usage,Lipofectamine 2000
PMID:26549023,10.1038/onc.2015.404,"The scaffold protein KSR1, a novel therapeutic target for the treatment of Merlin-deficient tumors.",,Fugene® 6 (Roche) was used for transfection of HEK293T cells,0.85,Accept,Experimental Usage,Fugene 6
PMID:26549023,10.1038/onc.2015.404,"The scaffold protein KSR1, a novel therapeutic target for the treatment of Merlin-deficient tumors.",,A set of pLKO.1-shRNA plasmid encoding a short hairpin RNA (shRNA) with scrambled sequence or sequences targeting human KSR1,0.85,Accept,Experimental Usage,pLKO.1-shRNA
PMID:26549023,10.1038/onc.2015.404,"The scaffold protein KSR1, a novel therapeutic target for the treatment of Merlin-deficient tumors.",,"Two shRNA clones, TRCN0000006226 and TRCN0000006229, were chosen for lentivirus production",0.9,Accept,Experimental Usage,TRCN0000006226
PMID:26549023,10.1038/onc.2015.404,"The scaffold protein KSR1, a novel therapeutic target for the treatment of Merlin-deficient tumors.",,"Two shRNA clones, TRCN0000006226 and TRCN0000006229, were chosen for lentivirus production",0.9,Accept,Experimental Usage,TRCN0000006229
PMID:26549023,10.1038/onc.2015.404,"The scaffold protein KSR1, a novel therapeutic target for the treatment of Merlin-deficient tumors.",,Cell apoptosis was determined with the Caspase-Glo ®3/7 Assay kit (Promega) according to the manufacture's instruction,0.85,Accept,Experimental Usage,Caspase-Glo 3/7 Assay kit
PMID:33413690,10.1186/s40478-020-01103-4,Human cutaneous neurofibroma matrisome revealed by single-cell RNA sequencing.,,"RNA extraction was performed using the TRIzol reagent, reverse transcription was performed using iScript Select cDNA synthesis kit",0.85,Accept,Experimental Usage,TRIzol reagent
PMID:33413690,10.1186/s40478-020-01103-4,Human cutaneous neurofibroma matrisome revealed by single-cell RNA sequencing.,,"reverse transcription was performed using iScript Select cDNA synthesis kit, and qPCR was performed on a Bio-Rad FX96 apparatus",0.85,Accept,Experimental Usage,iScript Select cDNA synthesis kit
PMID:33413690,10.1186/s40478-020-01103-4,Human cutaneous neurofibroma matrisome revealed by single-cell RNA sequencing.,,qPCR was performed on a Bio-Rad FX96 apparatus using Bio-Rad iSCRIPT master mix and the following qPCR primers,0.85,Accept,Experimental Usage,Bio-Rad iSCRIPT master mix
PMID:33413690,10.1186/s40478-020-01103-4,Human cutaneous neurofibroma matrisome revealed by single-cell RNA sequencing.,,incubated with a premixture of avidin and biotin (following Vecta Stain Elite ABC kit procedure) rinsed again in PBS,0.85,Accept,Experimental Usage,Vecta Stain Elite ABC kit
PMID:33413690,10.1186/s40478-020-01103-4,Human cutaneous neurofibroma matrisome revealed by single-cell RNA sequencing.,,"Based on the whole skin dissociation kit (Miltenyi Biotec, Cat. No. 130-101-540), human skin was harvested and immediately immersed",0.95,Accept,Experimental Usage,"whole skin dissociation kit (Miltenyi Biotec, Cat. No. 130-101-540)"
PMID:30713041,10.1016/j.stemcr.2019.01.001,Reprogramming Captures the Genetic and Tumorigenic Properties of Neurofibromatosis Type 1 Plexiform Neurofibromas.,,"For non-integrative reprogramming, a Cytotune-iPS 2.0 Sendai Reprogramming Kit (Thermo Fisher Scientific) was used according to the manufacturer's protocol.",0.9,Accept,Experimental Usage,Cytotune-iPS 2.0 Sendai Reprogramming Kit
PMID:30713041,10.1016/j.stemcr.2019.01.001,Reprogramming Captures the Genetic and Tumorigenic Properties of Neurofibromatosis Type 1 Plexiform Neurofibromas.,,iPSC established lines were grown on dishes coated with growth factor-reduced Matrigel (BD Biosciences) in mTESR1 medium (STEMCELL Technologies).,0.85,Accept,Experimental Usage,mTESR1 medium
PMID:30713041,10.1016/j.stemcr.2019.01.001,Reprogramming Captures the Genetic and Tumorigenic Properties of Neurofibromatosis Type 1 Plexiform Neurofibromas.,,iPSC established lines were grown on dishes coated with growth factor-reduced Matrigel (BD Biosciences) in mTESR1 medium,0.85,Accept,Experimental Usage,growth factor-reduced Matrigel
PMID:30713041,10.1016/j.stemcr.2019.01.001,Reprogramming Captures the Genetic and Tumorigenic Properties of Neurofibromatosis Type 1 Plexiform Neurofibromas.,,hESC medium without activin and supplemented with 2 μM CHIR9902 (STEMCELL Technologies) and 20 μM SB432542,0.8,Accept,Experimental Usage,CHIR9902
PMID:30713041,10.1016/j.stemcr.2019.01.001,Reprogramming Captures the Genetic and Tumorigenic Properties of Neurofibromatosis Type 1 Plexiform Neurofibromas.,,supplemented with 2 μM CHIR9902 (STEMCELL Technologies) and 20 μM SB432542 (STEMCELL Technologies),0.8,Accept,Experimental Usage,SB432542
PMID:30713041,10.1016/j.stemcr.2019.01.001,Reprogramming Captures the Genetic and Tumorigenic Properties of Neurofibromatosis Type 1 Plexiform Neurofibromas.,,NCs were maintained in this medium and split with Accutase (Thermo Fischer Scientific) when necessary.,0.8,Accept,Experimental Usage,Accutase
PMID:30713041,10.1016/j.stemcr.2019.01.001,Reprogramming Captures the Genetic and Tumorigenic Properties of Neurofibromatosis Type 1 Plexiform Neurofibromas.,,"digested with 160 U/mL collagenase type 1 and 0.8 U/mL dispase (Worthington, Lakewood, NJ) for 16 h at 37°C",0.75,Accept,Experimental Usage,collagenase type 1
PMID:30713041,10.1016/j.stemcr.2019.01.001,Reprogramming Captures the Genetic and Tumorigenic Properties of Neurofibromatosis Type 1 Plexiform Neurofibromas.,,"digested with 160 U/mL collagenase type 1 and 0.8 U/mL dispase (Worthington, Lakewood, NJ)",0.75,Accept,Experimental Usage,dispase
PMID:25433207,10.1016/j.ydbio.2014.11.017,Nf2-Yap signaling controls the expansion of DRG progenitors and glia during DRG development.,,"Ngn1 probe was provided by Andy Groves (Baylor College of Medicine Houston, TX)",0.85,Accept,Experimental Usage,Ngn1 probe
PMID:25433207,10.1016/j.ydbio.2014.11.017,Nf2-Yap signaling controls the expansion of DRG progenitors and glia during DRG development.,,"Ngn2 and TrkB probes were provided by Qiufu Ma (Harvard Medical School, Boston, MA)",0.85,Accept,Experimental Usage,Ngn2 probe
PMID:25433207,10.1016/j.ydbio.2014.11.017,Nf2-Yap signaling controls the expansion of DRG progenitors and glia during DRG development.,,"Ngn2 and TrkB probes were provided by Qiufu Ma (Harvard Medical School, Boston, MA)",0.85,Accept,Experimental Usage,TrkB probe
PMID:25433207,10.1016/j.ydbio.2014.11.017,Nf2-Yap signaling controls the expansion of DRG progenitors and glia during DRG development.,,"A probe specific for the TrkC tyrosine kinase domain was designed based on Fagan et al., 1996",0.85,Accept,Experimental Usage,TrkC probe
PMID:40587782,10.1073/pnas.2506823122,"A transcriptomic, proteomic, and functional genetic atlas dissects neurofibromin function in the peripheral nervous system.",,"Lentivirus containing pMH0001 (UCOE-SFFV-dCas9-BFP-KRAB, #85969, Addgene) was produced from transfected HEK293T cells",0.95,Accept,Experimental Usage,"pMH0001 (UCOE-SFFV-dCas9-BFP-KRAB, #85969, Addgene)"
PMID:40587782,10.1073/pnas.2506823122,"A transcriptomic, proteomic, and functional genetic atlas dissects neurofibromin function in the peripheral nervous system.",,"transfected HEK293T cells with packaging vectors (pMD2.G #12259, Addgene, and pCMV-dR8.91, Trono Lab)",0.9,Accept,Experimental Usage,"pMD2.G #12259, Addgene"
PMID:40587782,10.1073/pnas.2506823122,"A transcriptomic, proteomic, and functional genetic atlas dissects neurofibromin function in the peripheral nervous system.",,"packaging vectors (pMD2.G #12259, Addgene, and pCMV-dR8.91, Trono Lab)",0.85,Accept,Experimental Usage,pCMV-dR8.91
PMID:40587782,10.1073/pnas.2506823122,"A transcriptomic, proteomic, and functional genetic atlas dissects neurofibromin function in the peripheral nervous system.",,"individually cloning single-guide RNA protospacer sequences into the pCRISPRia-v2 vector (#84832, Addgene)",0.95,Accept,Experimental Usage,"pCRISPRia-v2 vector (#84832, Addgene)"
PMID:40587782,10.1073/pnas.2506823122,"A transcriptomic, proteomic, and functional genetic atlas dissects neurofibromin function in the peripheral nervous system.",,"Viability assays were carried out with the CellTiter 96 Non-Radioactive Cell Proliferation Assay (#G410, Promega)",0.9,Accept,Experimental Usage,"CellTiter 96 Non-Radioactive Cell Proliferation Assay (#G410, Promega)"
PMID:40587782,10.1073/pnas.2506823122,"A transcriptomic, proteomic, and functional genetic atlas dissects neurofibromin function in the peripheral nervous system.",,"RNA were isolated from cell using the All-Prep Universal Kit (#80224, QIAGEN)",0.9,Accept,Experimental Usage,"All-Prep Universal Kit (#80224, QIAGEN)"
PMID:40587782,10.1073/pnas.2506823122,"A transcriptomic, proteomic, and functional genetic atlas dissects neurofibromin function in the peripheral nervous system.",,"BioAnalyzer 2100 using the RNA 6000 Nano Kit (#5067-1511, Agilent Technologies)",0.9,Accept,Experimental Usage,"RNA 6000 Nano Kit (#5067-1511, Agilent Technologies)"
PMID:40587782,10.1073/pnas.2506823122,"A transcriptomic, proteomic, and functional genetic atlas dissects neurofibromin function in the peripheral nervous system.",,"Library preparation was performed using the TruSeq RNA Library Prep Kit v2 (#RS-122-2001, Illumina)",0.9,Accept,Experimental Usage,"TruSeq RNA Library Prep Kit v2 (#RS-122-2001, Illumina)"
PMID:40587782,10.1073/pnas.2506823122,"A transcriptomic, proteomic, and functional genetic atlas dissects neurofibromin function in the peripheral nervous system.",,"RNA was extracted from cell lines using the RNeasy Mini Kit (#74106, QIAGEN)",0.9,Accept,Experimental Usage,"RNeasy Mini Kit (#74106, QIAGEN)"
PMID:40587782,10.1073/pnas.2506823122,"A transcriptomic, proteomic, and functional genetic atlas dissects neurofibromin function in the peripheral nervous system.",,"complementary DNA (cDNA) was synthesized from RNA using iScript cDNA Synthesis kit (#1708891, Bio-Rad)",0.9,Accept,Experimental Usage,"iScript cDNA Synthesis kit (#1708891, Bio-Rad)"
PMID:40587782,10.1073/pnas.2506823122,"A transcriptomic, proteomic, and functional genetic atlas dissects neurofibromin function in the peripheral nervous system.",,"Real-time QPCR was performed using PowerUp SYBR Green Master Mix (#A25918, Thermo Fisher Scientific)",0.9,Accept,Experimental Usage,"PowerUp SYBR Green Master Mix (#A25918, Thermo Fisher Scientific)"
PMID:40587782,10.1073/pnas.2506823122,"A transcriptomic, proteomic, and functional genetic atlas dissects neurofibromin function in the peripheral nervous system.",,"Phosphoenrichment was performed on peptides using PTMScan® Phospho-Enrichment IMAC Fe-NTA Magnetic Beads (Cell Signaling Technology, #20432)",0.9,Accept,Experimental Usage,"PTMScan® Phospho-Enrichment IMAC Fe-NTA Magnetic Beads (Cell Signaling Technology, #20432)"
PMID:40587782,10.1073/pnas.2506823122,"A transcriptomic, proteomic, and functional genetic atlas dissects neurofibromin function in the peripheral nervous system.",,"Streptavidin magnetic beads (ThermoFisher, #88816) were washed 2× with RIPA buffer",0.9,Accept,Experimental Usage,"Streptavidin magnetic beads (ThermoFisher, #88816)"
PMID:32443592,10.3390/ijms21103569,C-Fiber Loss as a Possible Cause of Neuropathic Pain in Schwannomatosis.,,"Sanger sequencing of the PCR products was performed using the BigDye Terminator Cycle Sequencing Kit (ABI, Life Technologies, Foster City, CA, USA)",0.85,Accept,Experimental Usage,BigDye Terminator Cycle Sequencing Kit
PMID:32443592,10.3390/ijms21103569,C-Fiber Loss as a Possible Cause of Neuropathic Pain in Schwannomatosis.,,"Rearrangments involving the NF2 gene were investigated by MLPA (SALSA MLPA P044 NF2 probemix, MRC Holland, Amsterdam, The Netherlands)",0.9,Accept,Experimental Usage,SALSA MLPA P044 NF2 probemix
PMID:32443592,10.3390/ijms21103569,C-Fiber Loss as a Possible Cause of Neuropathic Pain in Schwannomatosis.,,"followed by addition of the chromogen Metal Enhanced DAB Substrate Kit (Thermo Scientific, #34065, Bremen, Germany) according to manufacturer's instructions",0.8,Accept,Experimental Usage,Metal Enhanced DAB Substrate Kit
PMID:28065690,10.1016/j.biochi.2017.01.001,Medium throughput biochemical compound screening identifies novel agents for pharmacotherapy of neurofibromatosis type 1.,,"The ICCB Known Bioactives library (Enzo Life Sciences, USA, BML-2840-0100) was used for the screening",0.85,Accept,Experimental Usage,ICCB Known Bioactives library
PMID:28065690,10.1016/j.biochi.2017.01.001,Medium throughput biochemical compound screening identifies novel agents for pharmacotherapy of neurofibromatosis type 1.,,"Cell viability was evaluated seventy-two hours after addition of drugs using alamarBlue fluorescent assay (Life Technologies, USA)",0.8,Accept,Experimental Usage,alamarBlue fluorescent assay
PMID:30290804,10.1186/s12929-018-0474-9,Genetic diagnosis of neurofibromatosis type 1: targeted next- generation sequencing with Multiple Ligation-Dependent Probe Amplification analysis.,,Genomic DNA of each patient was then prepared using the PUREGENE DNA purification kit from GENTRA using standard protein precipitation procedures.,0.85,Accept,Experimental Usage,PUREGENE DNA purification kit
PMID:30290804,10.1186/s12929-018-0474-9,Genetic diagnosis of neurofibromatosis type 1: targeted next- generation sequencing with Multiple Ligation-Dependent Probe Amplification analysis.,,"Following the purification and size selection using AMPure beads (Beckman Coulter, Brea, CA, USA), the size distribution of the DNA fragments was analyzed",0.85,Accept,Experimental Usage,AMPure beads
PMID:30290804,10.1186/s12929-018-0474-9,Genetic diagnosis of neurofibromatosis type 1: targeted next- generation sequencing with Multiple Ligation-Dependent Probe Amplification analysis.,,Enriched ISPs were prepared for sequencing using the Ion PGM 200 Sequencing Kit v2.0 and were loaded on an Ion 316 chip v2 or Ion 318 chip v2.,0.85,Accept,Experimental Usage,Ion PGM 200 Sequencing Kit v2.0
PMID:30290804,10.1186/s12929-018-0474-9,Genetic diagnosis of neurofibromatosis type 1: targeted next- generation sequencing with Multiple Ligation-Dependent Probe Amplification analysis.,,PCR products were sequenced using the Big Dye Terminator cycle sequencing kit (Life Technologies) according to the manufacturer's cycling conditions,0.85,Accept,Experimental Usage,Big Dye Terminator cycle sequencing kit
PMID:30290804,10.1186/s12929-018-0474-9,Genetic diagnosis of neurofibromatosis type 1: targeted next- generation sequencing with Multiple Ligation-Dependent Probe Amplification analysis.,,"We used SALSA P081/P082 NF1 MLPA kit (MRC Holland, Amsterdam, The Netherlands) to confirm and identify single and multiple exon deletions/duplications",0.95,Accept,Experimental Usage,SALSA P081/P082 NF1 MLPA kit
PMID:24848258,10.1126/scitranslmed.3008639,Merlin deficiency predicts FAK inhibitor sensitivity: a synthetic lethal relationship.,,"...low Merlin expression predicts for increased sensitivity of MPM cells to a FAK inhibitor, VS-4718, in vitro and in tumor xenograft models...",0.85,Accept,Experimental Usage,VS-4718
PMID:24848258,10.1126/scitranslmed.3008639,Merlin deficiency predicts FAK inhibitor sensitivity: a synthetic lethal relationship.,,"The pMXs-NF2-IRES-GFP construct was generated by inserting NF2 cDNA (Open Biosystems, MHS1011-202832561) into pMXs-IRES-GFP retroviral vector...",0.9,Accept,Experimental Usage,pMXs-NF2-IRES-GFP
PMID:24848258,10.1126/scitranslmed.3008639,Merlin deficiency predicts FAK inhibitor sensitivity: a synthetic lethal relationship.,,"...inserting NF2 cDNA (Open Biosystems, MHS1011-202832561) into pMXs-IRES-GFP retroviral vector...",0.95,Accept,Experimental Usage,"NF2 cDNA (Open Biosystems, MHS1011-202832561)"
PMID:24848258,10.1126/scitranslmed.3008639,Merlin deficiency predicts FAK inhibitor sensitivity: a synthetic lethal relationship.,,"...inserting NF2 cDNA (Open Biosystems, MHS1011-202832561) into pMXs-IRES-GFP retroviral vector (Cell Biolabs)...",0.9,Accept,Experimental Usage,pMXs-IRES-GFP retroviral vector (Cell Biolabs)
PMID:24848258,10.1126/scitranslmed.3008639,Merlin deficiency predicts FAK inhibitor sensitivity: a synthetic lethal relationship.,,"A mix of four individual PTK2 siRNAs (ON-TARGETplus PTK2 siRNA; Dharmacon, Thermo Scientific) was used for depletion of FAK...",0.9,Accept,Experimental Usage,"ON-TARGETplus PTK2 siRNA (Dharmacon, Thermo Scientific)"
PMID:24848258,10.1126/scitranslmed.3008639,Merlin deficiency predicts FAK inhibitor sensitivity: a synthetic lethal relationship.,,siGENOME Non-Targeting siRNA #1was used as a negative control.,0.85,Accept,Experimental Usage,siGENOME Non-Targeting siRNA #1
PMID:24848258,10.1126/scitranslmed.3008639,Merlin deficiency predicts FAK inhibitor sensitivity: a synthetic lethal relationship.,,...was used for depletion of FAK in mesothelioma cell lines using DharmaFECT reagent as described...,0.8,Accept,Experimental Usage,DharmaFECT reagent
PMID:33279959,10.1093/brain/awaa404,"Stepwise crosstalk between aberrant Nf1, Tp53 and Rb signalling pathways induces gliomagenesis in zebrafish.",,"Cas9 mRNA was produced by in vitro transcription from a pCS2 Cas9 vector (Jao et al., 2013) using a mMESSAGE mMACHINE SP6 kit",0.85,Accept,Experimental Usage,pCS2 Cas9 vector
PMID:33279959,10.1093/brain/awaa404,"Stepwise crosstalk between aberrant Nf1, Tp53 and Rb signalling pathways induces gliomagenesis in zebrafish.",,"Cas9 mRNA was produced by in vitro transcription from a pCS2 Cas9 vector using a mMESSAGE mMACHINE SP6 kit (Invitrogen, Thermo Fisher Scientific)",0.8,Accept,Experimental Usage,mMESSAGE mMACHINE SP6 kit
PMID:33279959,10.1093/brain/awaa404,"Stepwise crosstalk between aberrant Nf1, Tp53 and Rb signalling pathways induces gliomagenesis in zebrafish.",,gRNAs were transcribed using the MAXIscript T7 kit (Thermo Fisher Scientific),0.8,Accept,Experimental Usage,MAXIscript T7 kit
PMID:33279959,10.1093/brain/awaa404,"Stepwise crosstalk between aberrant Nf1, Tp53 and Rb signalling pathways induces gliomagenesis in zebrafish.",,synthesized from linearized vectors using mMESSAGE mMACHINE T7 Kit (Invitrogen),0.8,Accept,Experimental Usage,mMESSAGE mMACHINE T7 Kit
PMID:33279959,10.1093/brain/awaa404,"Stepwise crosstalk between aberrant Nf1, Tp53 and Rb signalling pathways induces gliomagenesis in zebrafish.",,All mRNA transcripts were purified using MicroElute RNA Clean-Up kit (Omega Bio-Tek),0.8,Accept,Experimental Usage,MicroElute RNA Clean-Up kit
PMID:33279959,10.1093/brain/awaa404,"Stepwise crosstalk between aberrant Nf1, Tp53 and Rb signalling pathways induces gliomagenesis in zebrafish.",,The quality and concentration of RNA were analysed by electrophoresis and NanoDrop 2000 spectrophotometer (Thermo Fisher Scientific),0.8,Accept,Experimental Usage,NanoDrop 2000 spectrophotometer
PMID:33279959,10.1093/brain/awaa404,"Stepwise crosstalk between aberrant Nf1, Tp53 and Rb signalling pathways induces gliomagenesis in zebrafish.",,The in vitro efficiencies of the gRNAs were examined using a gRNA Activity Detection kit (ViewSolid Biotech),0.8,Accept,Experimental Usage,gRNA Activity Detection kit
PMID:33279959,10.1093/brain/awaa404,"Stepwise crosstalk between aberrant Nf1, Tp53 and Rb signalling pathways induces gliomagenesis in zebrafish.",,"CRISPR/Cas9 skeleton vector (Cas9-T2A-mCherry) from the Tol2 kit (Kwan et al., 2007)",0.85,Accept,Experimental Usage,Cas9-T2A-mCherry
PMID:33279959,10.1093/brain/awaa404,"Stepwise crosstalk between aberrant Nf1, Tp53 and Rb signalling pathways induces gliomagenesis in zebrafish.",,"respectively including gfap:Cas9-T2A-mCherry,U6:gRNA(nf1a), gfap:Cas9-T2A-mCherry,U6:gRNA(tp53), and gfap:Cas9-T2A-mCherry,U6:gRNA(rb1) vectors",0.9,Accept,Development,"gfap:Cas9-T2A-mCherry,U6:gRNA(nf1a)"
PMID:33279959,10.1093/brain/awaa404,"Stepwise crosstalk between aberrant Nf1, Tp53 and Rb signalling pathways induces gliomagenesis in zebrafish.",,"respectively including gfap:Cas9-T2A-mCherry,U6:gRNA(nf1a), gfap:Cas9-T2A-mCherry,U6:gRNA(tp53), and gfap:Cas9-T2A-mCherry,U6:gRNA(rb1) vectors",0.9,Accept,Development,"gfap:Cas9-T2A-mCherry,U6:gRNA(tp53)"
PMID:33279959,10.1093/brain/awaa404,"Stepwise crosstalk between aberrant Nf1, Tp53 and Rb signalling pathways induces gliomagenesis in zebrafish.",,"respectively including gfap:Cas9-T2A-mCherry,U6:gRNA(nf1a), gfap:Cas9-T2A-mCherry,U6:gRNA(tp53), and gfap:Cas9-T2A-mCherry,U6:gRNA(rb1) vectors",0.9,Accept,Development,"gfap:Cas9-T2A-mCherry,U6:gRNA(rb1)"
PMID:33279959,10.1093/brain/awaa404,"Stepwise crosstalk between aberrant Nf1, Tp53 and Rb signalling pathways induces gliomagenesis in zebrafish.",,2 ml of PCR products was cloned into the pMD-19T vector (Takara Bio) for DNA sequencing,0.8,Accept,Experimental Usage,pMD-19T vector
PMID:33279959,10.1093/brain/awaa404,"Stepwise crosstalk between aberrant Nf1, Tp53 and Rb signalling pathways induces gliomagenesis in zebrafish.",,reverse-transcribed by qRT-PCR assay using QuantiTect SYBR Green PCR kit (Qiagen),0.8,Accept,Experimental Usage,QuantiTect SYBR Green PCR kit
PMID:33279959,10.1093/brain/awaa404,"Stepwise crosstalk between aberrant Nf1, Tp53 and Rb signalling pathways induces gliomagenesis in zebrafish.",,amplified by 7300 Real-time PCR System (Applied Biosystems),0.8,Accept,Experimental Usage,7300 Real-time PCR System
PMID:33279959,10.1093/brain/awaa404,"Stepwise crosstalk between aberrant Nf1, Tp53 and Rb signalling pathways induces gliomagenesis in zebrafish.",,visualized using a SuperSignal West Pico Substrate Kit (Thermo Fisher Scientific),0.8,Accept,Experimental Usage,SuperSignal West Pico Substrate Kit
PMID:33279959,10.1093/brain/awaa404,"Stepwise crosstalk between aberrant Nf1, Tp53 and Rb signalling pathways induces gliomagenesis in zebrafish.",,The motor capabilities of the larvae in different groups were evaluated using a behavioural tracking system (Noldus),0.8,Accept,Experimental Usage,Noldus behavioural tracking system
PMID:19041782,10.1016/j.stem.2008.10.003,Nf1 mutation expands an EGFR-dependent peripheral nerve progenitor that confers neurofibroma tumorigenic potential.,,"For EGFR inhibition experiments, erlotinib (Genentech; San Francisco, CA), was dissolved in DMSO, added at 3 μM",0.85,Accept,Experimental Usage,erlotinib (Genentech)
PMID:19041782,10.1016/j.stem.2008.10.003,Nf1 mutation expands an EGFR-dependent peripheral nerve progenitor that confers neurofibroma tumorigenic potential.,,The monoclonal antibody Cetuximab was also used at 5 μg/ml (ImClone),0.85,Accept,Experimental Usage,Cetuximab (ImClone)
PMID:19041782,10.1016/j.stem.2008.10.003,Nf1 mutation expands an EGFR-dependent peripheral nerve progenitor that confers neurofibroma tumorigenic potential.,,We produced lentivirus particles encoding GFP by transient co-transfection of 293T cells,0.8,Accept,Experimental Usage,lentiviral eGFP
PMID:38900740,10.1371/journal.pone.0301040,Revisiting the NPcis mouse model: A new tool to model plexiform neurofibroma.,,"For immunohistochemistry, the Vecta Stain Elite ABC kit (Vectorlabs, PK-6100) was used according to the manufacturer's protocol",0.9,Accept,Experimental Usage,"Vecta Stain Elite ABC kit (Vectorlabs, PK-6100)"
PMID:38900740,10.1371/journal.pone.0301040,Revisiting the NPcis mouse model: A new tool to model plexiform neurofibroma.,,cDNA from RNA extracted from FFPE (formalin-fixed paraffin-embedded) histology slides based on the RNeasy FFPE kit (Qiagen; 73504),0.9,Accept,Experimental Usage,RNeasy FFPE kit (Qiagen; 73504)
PMID:38900740,10.1371/journal.pone.0301040,Revisiting the NPcis mouse model: A new tool to model plexiform neurofibroma.,,150 ng from each sample were submitted to a reverse transcription reaction using Roche Transcriptor ™ and N6 random primers,0.85,Accept,Experimental Usage,Roche Transcriptor
PMID:38900740,10.1371/journal.pone.0301040,Revisiting the NPcis mouse model: A new tool to model plexiform neurofibroma.,,"in the 2X SyBr Green mix buffer (Quantabio, 95054-02K) under the following cycling conditions",0.9,Accept,Experimental Usage,"2X SyBr Green mix buffer (Quantabio, 95054-02K)"
PMID:32245042,10.3390/genes11030331,Kinome Profiling of NF1-Related MPNSTs in Response to Kinase Inhibition and Doxorubicin Reveals Therapeutic Vulnerabilities.,,Respective doses across all treatment combinations were capmatinib (30 mg/kg twice daily vial oral gavage)...Capmatinib and trametinib were obtained from Novartis,0.9,Accept,Experimental Usage,capmatinib
PMID:32245042,10.3390/genes11030331,Kinome Profiling of NF1-Related MPNSTs in Response to Kinase Inhibition and Doxorubicin Reveals Therapeutic Vulnerabilities.,,trametinib (1 mg/kg daily via oral gavage)...Capmatinib and trametinib were obtained from Novartis,0.9,Accept,Experimental Usage,trametinib
PMID:32245042,10.3390/genes11030331,Kinome Profiling of NF1-Related MPNSTs in Response to Kinase Inhibition and Doxorubicin Reveals Therapeutic Vulnerabilities.,,doxorubicin (1 mg/kg once via subcutaneous injection)...Doxorubicin was obtained from LC Laboratories,0.85,Accept,Experimental Usage,doxorubicin
PMID:29137242,10.18632/oncotarget.18301,Immune profiling of NF1-associated tumors reveals histologic subtype distinctions and heterogeneity: implications for immunotherapy.,,"All cell lines used in this study were found to be free of mycoplasma using MycoAlert™ Mycoplasma Detection Kit (LT07-318, Lonza Inc. Allendale, NJ)",0.85,Accept,Experimental Usage,"MycoAlert™ Mycoplasma Detection Kit (LT07-318, Lonza Inc.)"
PMID:29662612,10.18632/oncotarget.19335,Exploiting mitochondrial and metabolic homeostasis as a vulnerability in NF1 deficient cells.,,"Yeast (MDW320, Table 3) were transformed with 1 μg of the S. cerevisiae AB320 genomic library in YEp13 (ATCC 37323)",0.85,Accept,Experimental Usage,MDW320
PMID:29662612,10.18632/oncotarget.19335,Exploiting mitochondrial and metabolic homeostasis as a vulnerability in NF1 deficient cells.,,"Yeast (MDW320, Table 3) were transformed with 1 μg of the S. cerevisiae AB320 genomic library in YEp13 (ATCC 37323) or empty vector (YEp13)",0.85,Accept,Experimental Usage,S. cerevisiae AB320 genomic library in YEp13 (ATCC 37323)
PMID:29662612,10.18632/oncotarget.19335,Exploiting mitochondrial and metabolic homeostasis as a vulnerability in NF1 deficient cells.,,"Cells were transfected with siRNA targeting RIPK1 (Sigma, SASI_Hs01_00071803), or a non-targeting control (Sigma, Universal Control #1)",0.9,Accept,Experimental Usage,"siRNA targeting RIPK1 (Sigma, SASI_Hs01_00071803)"
PMID:26066488,10.1371/journal.pone.0129099,A Systematic Assessment of Accuracy in Detecting Somatic Mosaic Variants by Deep Amplicon Sequencing: Application to NF2 Gene.,,"Library preparation was performed using the TruSeq Custom Amplicon Library Preparation Kit v1.5 (Illumina, San Diego, CA, USA)",0.9,Accept,Experimental Usage,TruSeq Custom Amplicon Library Preparation Kit v1.5
PMID:26066488,10.1371/journal.pone.0129099,A Systematic Assessment of Accuracy in Detecting Somatic Mosaic Variants by Deep Amplicon Sequencing: Application to NF2 Gene.,,"sequenced on the Illumina MiSeq Sequencer (Illumina, San Diego, CA, USA) with MiSeq Reagent Kit v2 (2X150 cycles)",0.9,Accept,Experimental Usage,MiSeq Reagent Kit v2
PMID:26066488,10.1371/journal.pone.0129099,A Systematic Assessment of Accuracy in Detecting Somatic Mosaic Variants by Deep Amplicon Sequencing: Application to NF2 Gene.,,"0.5U HotStarTaq Plus (Qiagen, Hilden, Germany) and 100 ng of genomic DNA",0.85,Accept,Experimental Usage,HotStarTaq Plus
PMID:26066488,10.1371/journal.pone.0129099,A Systematic Assessment of Accuracy in Detecting Somatic Mosaic Variants by Deep Amplicon Sequencing: Application to NF2 Gene.,,"SYTOs 9 (Invitrogen, Eugene, Oregon, USA) was used as the intercalating dye in HRMA",0.85,Accept,Experimental Usage,SYTOs 9
PMID:26066488,10.1371/journal.pone.0129099,A Systematic Assessment of Accuracy in Detecting Somatic Mosaic Variants by Deep Amplicon Sequencing: Application to NF2 Gene.,,Sequencing analysis was performed on both strands using the BigDye Terminator v1.1 Cycle Sequencing Kit (Life Technologies Applied Biosystems),0.9,Accept,Experimental Usage,BigDye Terminator v1.1 Cycle Sequencing Kit
PMID:26066488,10.1371/journal.pone.0129099,A Systematic Assessment of Accuracy in Detecting Somatic Mosaic Variants by Deep Amplicon Sequencing: Application to NF2 Gene.,,"analyzed by Multiplex Ligation-Dependent Probe Amplification (MLPA), using NF2 and/or 22q11 MLPA test kits (MRC-Holland, P044_B1 and P324_A2)",0.9,Accept,Experimental Usage,NF2 MLPA test kit P044_B1
PMID:26066488,10.1371/journal.pone.0129099,A Systematic Assessment of Accuracy in Detecting Somatic Mosaic Variants by Deep Amplicon Sequencing: Application to NF2 Gene.,,"analyzed by Multiplex Ligation-Dependent Probe Amplification (MLPA), using NF2 and/or 22q11 MLPA test kits (MRC-Holland, P044_B1 and P324_A2)",0.9,Accept,Experimental Usage,22q11 MLPA test kit P324_A2
PMID:26066488,10.1371/journal.pone.0129099,A Systematic Assessment of Accuracy in Detecting Somatic Mosaic Variants by Deep Amplicon Sequencing: Application to NF2 Gene.,,"PCR and COLD-PCR products were purified using HiYieldGel/PCR DNA Fragments Extraction Kit (RBCBioscience, New Taipei City, Taiwan)",0.85,Accept,Experimental Usage,HiYieldGel/PCR DNA Fragments Extraction Kit
PMID:19306381,10.1002/glia.20866,Neuregulin-1 beta and neuregulin-1 alpha differentially affect the migration and invasion of malignant peripheral nerve sheath tumor cells.,,"PD168393 , PD98059, U0126, LY294002, wortmannin, PP2, SU6656, SP600125 and Y-27632 were purchased from Calbiochem",0.8,Accept,Experimental Usage,PD168393
PMID:19306381,10.1002/glia.20866,Neuregulin-1 beta and neuregulin-1 alpha differentially affect the migration and invasion of malignant peripheral nerve sheath tumor cells.,,"PD168393 , PD98059, U0126, LY294002, wortmannin, PP2, SU6656, SP600125 and Y-27632 were purchased from Calbiochem",0.8,Accept,Experimental Usage,PD98059
PMID:19306381,10.1002/glia.20866,Neuregulin-1 beta and neuregulin-1 alpha differentially affect the migration and invasion of malignant peripheral nerve sheath tumor cells.,,"PD168393 , PD98059, U0126, LY294002, wortmannin, PP2, SU6656, SP600125 and Y-27632 were purchased from Calbiochem",0.8,Accept,Experimental Usage,U0126
PMID:19306381,10.1002/glia.20866,Neuregulin-1 beta and neuregulin-1 alpha differentially affect the migration and invasion of malignant peripheral nerve sheath tumor cells.,,"PD168393 , PD98059, U0126, LY294002, wortmannin, PP2, SU6656, SP600125 and Y-27632 were purchased from Calbiochem",0.8,Accept,Experimental Usage,LY294002
PMID:19306381,10.1002/glia.20866,Neuregulin-1 beta and neuregulin-1 alpha differentially affect the migration and invasion of malignant peripheral nerve sheath tumor cells.,,"PD168393 , PD98059, U0126, LY294002, wortmannin, PP2, SU6656, SP600125 and Y-27632 were purchased from Calbiochem",0.8,Accept,Experimental Usage,wortmannin
PMID:19306381,10.1002/glia.20866,Neuregulin-1 beta and neuregulin-1 alpha differentially affect the migration and invasion of malignant peripheral nerve sheath tumor cells.,,"PD168393 , PD98059, U0126, LY294002, wortmannin, PP2, SU6656, SP600125 and Y-27632 were purchased from Calbiochem",0.8,Accept,Experimental Usage,PP2
PMID:19306381,10.1002/glia.20866,Neuregulin-1 beta and neuregulin-1 alpha differentially affect the migration and invasion of malignant peripheral nerve sheath tumor cells.,,"PD168393 , PD98059, U0126, LY294002, wortmannin, PP2, SU6656, SP600125 and Y-27632 were purchased from Calbiochem",0.8,Accept,Experimental Usage,SU6656
PMID:19306381,10.1002/glia.20866,Neuregulin-1 beta and neuregulin-1 alpha differentially affect the migration and invasion of malignant peripheral nerve sheath tumor cells.,,"PD168393 , PD98059, U0126, LY294002, wortmannin, PP2, SU6656, SP600125 and Y-27632 were purchased from Calbiochem",0.8,Accept,Experimental Usage,SP600125
PMID:19306381,10.1002/glia.20866,Neuregulin-1 beta and neuregulin-1 alpha differentially affect the migration and invasion of malignant peripheral nerve sheath tumor cells.,,"PD168393 , PD98059, U0126, LY294002, wortmannin, PP2, SU6656, SP600125 and Y-27632 were purchased from Calbiochem",0.8,Accept,Experimental Usage,Y-27632
PMID:24686726,10.1038/oncsis.2014.10,Activation of Sonic hedgehog signaling in neural progenitor cells promotes glioma development in the zebrafish optic pathway.,,"to create the construct pKrt5:Gal4VP16;14×UAS-smoa1-EGFP using the LR Clonase II Plus Enzyme mix (Invitrogen, Carlsbad, CA, USA)",0.95,Accept,Development,pKrt5:Gal4VP16;14×UAS-smoa1-EGFP
PMID:18931645,10.1097/MAO.0b013e31818b6cea,Bioluminescent imaging of intracranial vestibular schwannoma xenografts in NOD/SCID mice.,,"Lentiviruses were generated by cotransfection of 293T cells with 3 plasmids: gag-pol, env, and pHR-SIN-CSGW dlNotI-luciferase (provided by Galanis Lab)",0.85,Accept,Experimental Usage,pHR-SIN-CSGW dlNotI-luciferase
PMID:18931645,10.1097/MAO.0b013e31818b6cea,Bioluminescent imaging of intracranial vestibular schwannoma xenografts in NOD/SCID mice.,,Male mouse whole genomic DNA was extracted from several mouse spleens using the Qiagen DNeasy Blood & Tissue Kit,0.8,Accept,Experimental Usage,Qiagen DNeasy Blood & Tissue Kit
PMID:18931645,10.1097/MAO.0b013e31818b6cea,Bioluminescent imaging of intracranial vestibular schwannoma xenografts in NOD/SCID mice.,,The extracted DNA was quantified and then labeled using the Nick Translation Kit and Spectrum Green deoxyuridine 5-triphosphate (Abbott Molecular),0.8,Accept,Experimental Usage,Nick Translation Kit
PMID:41616055,10.1126/sciadv.ady8382,Inhibition of focal adhesion kinase impairs tumor formation and preserves hearing in a murine model of NF2-related schwannomatosis.,,VS-4718 (PND-1186 and HY-13917) and selumetinib (AZD6244 and HY-50706) were purchased from MedChemExpress,0.9,Accept,Experimental Usage,VS-4718
PMID:41616055,10.1126/sciadv.ady8382,Inhibition of focal adhesion kinase impairs tumor formation and preserves hearing in a murine model of NF2-related schwannomatosis.,,VS-4718 (PND-1186 and HY-13917) and selumetinib (AZD6244 and HY-50706) were purchased from MedChemExpress,0.9,Accept,Experimental Usage,selumetinib
PMID:41616055,10.1126/sciadv.ady8382,Inhibition of focal adhesion kinase impairs tumor formation and preserves hearing in a murine model of NF2-related schwannomatosis.,,The 02.3 cell line was transfected with equal amounts of a CRISPR-Cas9 KO plasmid pool targeting NF2 and a homology-directed repair (HDR) plasmid pool purchased from Santa Cruz Biotechnology (sc-400504 and sc-400504-HDR),0.9,Accept,Experimental Usage,CRISPR-Cas9 KO plasmid pool
PMID:41616055,10.1126/sciadv.ady8382,Inhibition of focal adhesion kinase impairs tumor formation and preserves hearing in a murine model of NF2-related schwannomatosis.,,"Cells were then treated with increasing concentrations of defactinib (MedChemExpress, HY-12289)",0.9,Accept,Experimental Usage,defactinib
PMID:41616055,10.1126/sciadv.ady8382,Inhibition of focal adhesion kinase impairs tumor formation and preserves hearing in a murine model of NF2-related schwannomatosis.,,"defactinib (MedChemExpress, HY-12289) or FAK PROTAC Degrader 1 (MedChemExpress, HY-119932)",0.9,Accept,Experimental Usage,FAK PROTAC Degrader 1
PMID:29590612,10.1016/j.celrep.2018.03.014,A Conserved Circadian Function for the Neurofibromatosis 1 Gene.,,"Nf1, P1 Nf1, and UAS- P2 Nf1 lines were reported (Williams et al., 2001) and were outcrossed into an iso31 background for 7 generations.",0.85,Accept,Experimental Usage,Nf1 P1 Nf1
PMID:29590612,10.1016/j.celrep.2018.03.014,A Conserved Circadian Function for the Neurofibromatosis 1 Gene.,,"Nf1, P1 Nf1, and UAS- P2 Nf1 lines were reported (Williams et al., 2001) and were outcrossed into an iso31 background for 7 generations.",0.85,Accept,Experimental Usage,UAS-P2 Nf1
PMID:29590612,10.1016/j.celrep.2018.03.014,A Conserved Circadian Function for the Neurofibromatosis 1 Gene.,,"Nf1, P1 Nf1, and UAS- P2 Nf1 lines were reported (Williams et al., 2001) and were outcrossed into an iso31 background for 7 generations.",0.8,Accept,Experimental Usage,iso31
PMID:29590612,10.1016/j.celrep.2018.03.014,A Conserved Circadian Function for the Neurofibromatosis 1 Gene.,,Bloomington line Df27352 was used as an SIFa deficiency allele (2R:60C2;60D14) tested in transheterozygotes with SIFa CRISPR alleles.,0.85,Accept,Experimental Usage,Df27352
PMID:29590612,10.1016/j.celrep.2018.03.014,A Conserved Circadian Function for the Neurofibromatosis 1 Gene.,,CaLexA flies were a gift from J. Wang.,0.85,Accept,Experimental Usage,CaLexA flies
PMID:29590612,10.1016/j.celrep.2018.03.014,A Conserved Circadian Function for the Neurofibromatosis 1 Gene.,,UAS-RedStinger flies were obtained from the Bloomington Drosophila Stock Center.,0.85,Accept,Experimental Usage,UAS-RedStinger flies
PMID:29590612,10.1016/j.celrep.2018.03.014,A Conserved Circadian Function for the Neurofibromatosis 1 Gene.,,nsyb-GS construct was generated using Gateway cloning (Invitrogen) and the construct was targeted to the PhiC31-attP2 landing site,0.9,Accept,Development,Nsyb-GS
PMID:29590612,10.1016/j.celrep.2018.03.014,A Conserved Circadian Function for the Neurofibromatosis 1 Gene.,,Tandem SIFa-targeting guide RNA sequences flanking the SIFa coding region were introduced into pCFD4 (Addgene plasmid 49411),0.85,Accept,Experimental Usage,pCFD4
PMID:29590612,10.1016/j.celrep.2018.03.014,A Conserved Circadian Function for the Neurofibromatosis 1 Gene.,,infected with adenovirus type 5 containing β-galactosidase (Ad5-LacZ) or Cre recombinase (Ad5-Cre),0.85,Accept,Experimental Usage,Ad5-LacZ
PMID:29590612,10.1016/j.celrep.2018.03.014,A Conserved Circadian Function for the Neurofibromatosis 1 Gene.,,infected with adenovirus type 5 containing β-galactosidase (Ad5-LacZ) or Cre recombinase (Ad5-Cre),0.85,Accept,Experimental Usage,Ad5-Cre
PMID:29590612,10.1016/j.celrep.2018.03.014,A Conserved Circadian Function for the Neurofibromatosis 1 Gene.,,4 μM Cal 520 acetoxymethyl ester (AM) (Abcam ab171868) in Hank's balanced salt solution,0.9,Accept,Experimental Usage,Cal 520 acetoxymethyl ester (AM) (Abcam ab171868)
PMID:29590612,10.1016/j.celrep.2018.03.014,A Conserved Circadian Function for the Neurofibromatosis 1 Gene.,,buffer with 1 mM probenecid (Abcam ab145725) was added into the wells,0.85,Accept,Experimental Usage,probenecid (Abcam ab145725)
PMID:17216419,10.1007/s10048-006-0078-5,Nf1 expression is dependent on strain background: implications for tumor suppressor haploinsufficiency studies.,,Total RNA was extracted with TRIZOL according to manufacturer's instructions,0.8,Accept,Experimental Usage,TRIZOL
PMID:17216419,10.1007/s10048-006-0078-5,Nf1 expression is dependent on strain background: implications for tumor suppressor haploinsufficiency studies.,,"An amount of 10 μg RNA was treated with DNase (DNA-free, Ambion) and repurified using the Qiagen RNEasy kit",0.85,Accept,Experimental Usage,DNA-free (Ambion)
PMID:17216419,10.1007/s10048-006-0078-5,Nf1 expression is dependent on strain background: implications for tumor suppressor haploinsufficiency studies.,,"An amount of 10 μg RNA was treated with DNase (DNA-free, Ambion) and repurified using the Qiagen RNEasy kit",0.85,Accept,Experimental Usage,Qiagen RNEasy kit
PMID:17216419,10.1007/s10048-006-0078-5,Nf1 expression is dependent on strain background: implications for tumor suppressor haploinsufficiency studies.,,An amount of 50 ng of total mRNA was reverse transcribed into Cdna using oligo dT primers and the SuperScript III First-strand synthesis system (Invitrogen),0.9,Accept,Experimental Usage,SuperScript III First-strand synthesis system (Invitrogen)
PMID:17216419,10.1007/s10048-006-0078-5,Nf1 expression is dependent on strain background: implications for tumor suppressor haploinsufficiency studies.,,ThermalAce DNA polymerase (Invitrogen) was used in all standard PCR reactions,0.85,Accept,Experimental Usage,ThermalAce DNA polymerase (Invitrogen)
PMID:17216419,10.1007/s10048-006-0078-5,Nf1 expression is dependent on strain background: implications for tumor suppressor haploinsufficiency studies.,,"Brilliant SYBR Green (Stratagene), master mix or core kit, was used for each qPCR reaction",0.85,Accept,Experimental Usage,Brilliant SYBR Green (Stratagene)
PMID:16314489,10.1242/dev.02162,Inactivation of NF1 in CNS causes increased glial progenitor proliferation and optic glioma formation.,,"The visualization of primary antibodies was performed with either a horseradish peroxidase system (Vectastain ABC kit, Vector)",0.8,Accept,Experimental Usage,Vectastain ABC kit (Vector)
PMID:18927496,10.4161/cbt.7.12.6942,Suppression of proliferation of two independent NF1 malignant peripheral nerve sheath tumor cell lines by the pan-ErbB inhibitor CI-1033.,,"Gefitinib (AstraZeneca, Alderly Park, UK) and CI-1033 (Pfizer, Groton, CT) were prepared as stock solutions",0.85,Accept,Experimental Usage,gefitinib
PMID:18927496,10.4161/cbt.7.12.6942,Suppression of proliferation of two independent NF1 malignant peripheral nerve sheath tumor cell lines by the pan-ErbB inhibitor CI-1033.,,"Gefitinib (AstraZeneca, Alderly Park, UK) and CI-1033 (Pfizer, Groton, CT) were prepared as stock solutions",0.85,Accept,Experimental Usage,CI-1033
PMID:18671844,10.1186/1741-7015-6-21,Modelling neurofibromatosis type 1 tibial dysplasia and its treatment with lovastatin.,,Serum deoxypyridinoline (D-PYD) was measured with a METRA Serum PYD EIA Kit (Osteomedical GmbH) according to the supplied protocol,0.85,Accept,Experimental Usage,METRA Serum PYD EIA Kit
PMID:18671844,10.1186/1741-7015-6-21,Modelling neurofibromatosis type 1 tibial dysplasia and its treatment with lovastatin.,,tissue samples destined for calcified bone histology and micro computed tomography (μCT) analysis were processed according to the Technovit 9100 Kit manual,0.8,Accept,Experimental Usage,Technovit 9100 Kit
PMID:18984156,10.1016/j.cell.2008.08.041,Nf1-dependent tumors require a microenvironment containing Nf1+/-- and c-kit-dependent bone marrow.,,"Cell proliferation in tumors was evaluated by utilizing a BrdU in situ detection kit (BD PharMingen, San Jose, CA).",0.85,Accept,Experimental Usage,BrdU in situ detection kit (BD PharMingen)
